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1 Introduction
1.1 Innate and Adaptive Immunity
The immune system of vertebrates is a complex network of biological structures (different organelles,
cell types, molecules) and processes within an organism to maintain normal homeostasis and protect
against diseasea. Thus, the most essential attribute of the immune system is to discriminate between
self and non-self. Along this line, it is important to mount efficient immune responses since vertebrates
permanently encounter harmful environmental influences such as microbes (bacteria, viruses, fungi, and
parasites) or degenerated self-cells. These immune responses can be assigned to either the innate or
the adaptive (also known as acquired) immunity. Notably, innate immunity already existed in inverte-
brates and hardly changed during evolution, whereas only jawed vertebrates possess an adaptive immune
system [2]. Innate immunity is characterized by fast pathogen control within minutes or hours upon en-
counter due to pattern recognition. By contrast, jawed vertebrates are able to additionally mount adaptive
immune responses within days or weeks due to highly specialized antigen receptors specific to individual
pathogens. The generation of an immunological memory furthermore enables a faster and more efficient
immune response upon second encounter of the same pathogen. According to their function, the cells
of the immune system can be classified to the innate or the adaptive immunity. All leukocytes of the
myeloid lineage such as granulocytes (eosinophils, basophils, neutrophils), macrophages, mast cells, and
myeloid dendritic cells (DCs) as well as the some cell lines of lymphoid origin such as natural killer (NK)
cells and lymphoid DCs are assigned to the innate immune system. B and T lymphocytes belong to the
major leukocytes of the acquired immunity due to their adaptability against specific pathogens by somatic
recombination of antigen-receptor genes.
The first lines of defense against pathogens are the skin and themucosal epithelia within airways and gut
displaying physical and chemical barriers. Microbes breaching these barriers despite low pH and antimi-
crobial peptides encouter humoral factors in the blood such as plasma proteins of the complement system
or phagocytes leading to an immediate innate immune response. Surface structures of invading bacte-
ria trigger the activation of the zymogens of the complement system inducing a cascade of proteolytic
reactions. Beside cytolysis of bacteria via pore formation induced by the membrane attack complex, op-
sonization with complement fragments leads to the recruitment of and recognition by phagocytes. Upon
identification of the site of infection, e.g. macrophages resident in the nearby tissue recognize opsonized
bacteria by complement-specific surface receptors and directly engulf the pathogen. Moreover, these
macrophages secrete pro-inflammatory cytokines and chemokines to recruit further immune cells such
as neutrophils and monocytes out of the blood stream. Notably, during the respiratory burst, phagocytes
produce reactive oxygen species (NO, H2O2, O2−) to intracellularly degrade the pathogen. Additional
blood clotting within the blood vessels close to the site of infection reduces the risk of pathogen expansion
within the body.
aUnless otherwise denoted, ”Innate and Adaptive Immunity” was reviewed in Janeway et al. (2012) [1].
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Beside the complement system, a limited number of invariant, germline encoded receptors (pattern
recognition receptors, PRRs) such as mannose receptors, toll-like receptors, or scavenger receptors on
macrophages, neutrophils and DCs recognizes pathogen-associated molecular patterns (PAMPs), which
are present on many microbes but not on self-cells. These receptors bind simple molecules and regular
patterns of molecular structures such as mannose-rich oligosaccharides, peptidoglycans or lipopolysac-
charides of the bacterial cell wall. In addition, damage-associated molecular patterns (DAMPs), such
as nuclear or cytosolic proteins of the body released outside the cell or exposed on the cell surface, are
recognized and induce noninfectious inflammatory immune responses due to tissue injury or tumor for-
mation. Notably, upon viral infection, secretion of cytokines such as interferons is induced, which results
in recruitment and activation of NK cells. This granular lymphocyte population of the innate immune
system expresses a large repertoire of germline encoded activating and inhibitory receptors. In general,
immune cells such as NK cells are self-tolerant due to a prevalence of inhibitory signals transduced upon
binding to self-cells. By contrast, interaction with a virus-infected or malignantly transformed cell results
in killing of the target cell, which is induced by a shift of the equilibrium to activating signals.
Immature dendritic cells (iDCs) form a crucial link between the innate and the adaptive immune system.
Upon phagocytosis of the microbe at the site of infection, iDCs migrate via the lymph system to nearby
peripheral lymphoid organs (e.g. lymph nodes, spleen, tonsils, mucosa) for maturation and initiation of
the adaptive immune response by presenting antigens to naive T lymphocytes. Antigen presenting cells
(APCs) such as DCs as well as T and B lymphocytes represent the major cellular components of the
adaptive immune system. Though B and T cells arise both from the bone marrow, B cells mature at their
point of origin whereas T lymphocytes migrate to the thymus for education before congregating in the
lymphoid tissue throughout the body. As humoral part of the adaptive immunity, the B cell recognizes
after clonal selection of the B cell receptor (BCR) a native antigen in its soluble form or presented on
the surface of pathogens. Notably, the BCR is a momoneric membrane-anchored immunoglobulin M
(IgM). Upon antigen binding, IgM is internalized and the antigen is processed for peptide presentation
via major histocompatibility complex (MHC) class II molecules on the B cell surface. These peptide-
MHC II complexes are recognized by T helper cells, which secrete chemokines that stimulate further B
cell proliferation. Additionally, B cells differentiate to plasma cells secreting large amounts of soluble
pentameric IgMs with the same antigen specificity into the bloodstream. In the course of the immune
response, further Ig subtypes such as e.g. IgG, IgA or IgE are expressed (class switching), which differ
in their constant regions. Antibodies bound to the pathogens surface or their products drastically boost
the immune response by i) blocking the access to the host cell (neutralization), ii) induction of antibody-
dependent cellular cytotoxicity (ADCC) via CD16 on NK cells, iii) activation of the classical complement
pathway by interaction of the first complement protein with the constant regions of the bound antibodies,
or iii) opsonization of the pathogens and bacterial toxins, thereby activating other immune cells such
as T lymphocytes. After positive selection two main populations of T cells persist, which differ in their
surface expression of the coreceptors cluster of differentiation (CD) 4 (T helper cells) and CD8 (cytotoxic
T lymphocytes, CTLs). The clonal selection is again accomplished by the T cell receptor (TCR) via
antigen-MHC complex recognition. Notably, the TCR is related to immunoglobulins, but displays a
quite distinct structure and recognition properties. In contrast to the BCR, the T cell receptor function
is dependent on the interaction with its coreceptor CD4 or CD8 for recognition of either MHC class
II or MHC class I molecules, respectively. T helper cells bind antigen-MHC II complexes via the TCR
2
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and CD4molecules resulting in activation of phagocyting macrophages or cytotoxic T lymphocytes (TH1
cells) and the support of B cell proliferation (TH2 cells). By contrast, CTLs are activated by recognition of
antigen-MHC I complexes on virus-infected or malignantly transformed cells by the TCR in combination
with its coreceptor CD8. Upon secretion of enzymes and cytolytic proteins such as granzymes or perforin,
lysis of the target cell and apoptosis via the Fas/Fas-ligand system are induced. Notably, some of the active
B and T lymphocytes remain within the body as memory cells. On a second encounter with a distinct
pathogen, these already differentiated cells can induce a much faster and therefore more effective immune
response.
Similar to the T lymphocytes of the adaptive immune system, the NK cells of the innate immunity in-
duce cell lysis and apoptosis of target cells. There are several reports that demonstrate the central role of
NK cells in immunosurveillance [3], especially in the control and clearance of malignantly transformed
cells [4–8]. Furthermore, the physiological significance of NK cells was supported by observations of pa-
tients with NK cell deficiencies suffering from severe recurrent systemic and life-threatening virus infec-
tions [9–11]. Beside their cytotoxic effector function, NK cells also act as immune regulators by secreting
chemokines or cytokines and directly interacting with other immune cells such as DCs, macrophages, T
cells and endothelial cells [12–14], thereby bridging the innate and the adaptive immunity. However,
killing by NK cells as well as triggering of an adaptive immune response are affected by diverse immune
escape strategies of malignantly transformed or virus-infected cells [15, 16].
1.2 Natural Killer Cells
In the 1970s, natural killer cells were described as large granular lymphocytes of the innate immune sys-
tem from uninfected individuals with an essential contribution to the initial immune response. Within
minutes, these immune cells perform spontaneous cytotoxicity to some nonantibody-coated transformed
and tumor cells in culture [17–24]. Moreover, this cytotoxic activity is drastically increased upon ex-
posure to interferon (IFN)-α and IFN-β, Interleukin (IL)-2, IL-12 or IL-15, which are produced by
macrophages and DCs in early infections. Beside immunosurveillance of tumors as well as combat-
ing microbial and viral infections, NK cells also play important roles in transplantation, autoimmunity,
allergic diseases and pregnancy [25]. Therefore, patients without NK cells in the peripheral blood or with
functional defectives in NK cell activity are susceptible to severe recurrent systemic and life-threatening
infections such as herpesvirus infections, fungal infections, human papilloma virus (HPV)-related can-
cers, and leukemia [9, 10, 26–28]. Although many diseases, drugs, infections, and physiologic states
can affect NK cell numbers, function, or both, NK cell deficiencies are inherent. Therefore, possible
therapeutic approaches are e.g. application of prophylactical antiviral drugs [10, 29], stimulation of the
immune system, HPV vaccination, induction of NK cell cytotoxic function by systemic administration
of cytokine therapies such as IFN-α [30], and hematopoietic stem cell transplantation [31, 32].
NK cells develop from the same progenitor cells as T and B lymphocytes (CD34+ hematopoietic cells)
in the bone marrow [33] and differentiate dependent on DCs, monocytes, and neutrophils mainly in thy-
mus, spleen, liver, tonsils and lymph nodes [33–36]. They comprise approximately 10-15 % of peripheral
blood lymphocytes, have a life span of two weeks in circulation and can be divided into subsets accord-
ing to morphology, sites and pathways of development as well as the expression pattern of CD surface
molecules [33, 37]. In general, NK cells are characterized by a variable expression of the neural cell
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adhesion molecule (CD56) as well as the FcγRIIIA receptor (CD16) [33]. Furthermore, the natural cyto-
toxicity receptor (NCR) NKp46, which is expressed in man and mice, is strictly NK specific and therefore
represents a reliable marker for human (and murine) NK cell identification. Notably, while the NCRs
NKp46 and NKp30 are present in both resting and activated NK cells, the third member of the NCR fam-
ily NKp44 is expressed only in cytokine-activated NK cells [38]. Based on the relative levels of CD56
surface expression, two major subsets can be divided, and related to a distinct localization and function
within the body. CD56dim/CD16bright cells comprise >90 % of peripheral blood NK cells, secrete low
levels of cytokines, and have a high cytolytic capacity [33, 39]. This cytotoxic activity is mediated by
CD16, which is a receptor for direct lysis of some targets by human NK cells [40] or can induce ADCC
by recognition of antibody-decorated target cells [41]. By contrast, CD56bright/CD16dim cells are pre-
dominant (>90 %) in secondary lymphoid organs and execute immune regulatory functions. On the one
hand, NK cells bridge the innate and the adaptive immunity by killing of immature and tolerogenic DCs
to ensure a functional DC population. On the other hand, they secrete cytokines such as tumor necrosis
factor (TNF)-α and IFN-γ to enhance inflammation in tissues, induce differentiation of helper T cells into
TH1 and TH2 cells and maturation of antigen-loaded DCs, which efficiently activate effector cells of the
adaptive immune system [42]. In turn, due to IL-2, IL-12 and IL-15 production of DCs upon phagocyto-
sis, NK cells start proliferation, secrete larger amounts of cytokines, have a reduced threshold to trigger
NK cell cytotoxicity, and therefore display a higher cytolytic potential [43]. The three main functions
of NK cells are: i) promotion and regulation of immunity by costimulatory and regulatory mechanisms
upon contact with DCs, macrophages and T cells [12–14], ii) production of chemokines or cytokines such
as IFN-γ to promote direct anti-disease effects and to further induce or regulate immunity [13, 14], and
iii) mediation of contact-dependent killing of target cells by activating receptors as an innate immune
defense or by recognition of IgG-opsonized cells via CD16 to enable ADCC [41, 44, 45]. Interestingly,
it was demonstrated in mice that beside their innate properties NK cells also display acquired immunity
characteristics. Due to clonal-like expansion upon virus infection, long-lived memory NK cells develop,
which reside in multiple organs and are ready for a robust secondary response [46–50].
NK cells share a common killing mechanism with CD8+ T lymphocytes by using effector molecules
such as perforin and granzymes for induction of target cell apoptosis via the Fas ligand or TRAIL (TNF-
related apoptosis-inducing ligand) signaling [51–53]. However, NK cells perform their effector functions
upon recognition of malignantly transformed and virus-infected cells within minutes and without prior
sensitization [54–60]. Notably, self-MHC class I molecules are recognized by inhibitory NK cell re-
ceptors to restrain the NK cell activity and protect uninfected host cells. Many viruses have evolved
strategies to prevent the infected host cell from presenting peptides to virus-specific CTLs by specifi-
cally downregulating MHC class I molecules. Therefore, the absence or downregulation of MHC class I
molecules (missing-self regocnition) can make infected cells more susceptible to NK cell lysis [61, 62].
Furthermore, activating NK receptors directly recognize particular microbial and viral antigens or stress-
induced ligands upon malignant transformation (induced-self recognition) on the target cell surface, thus
representing an important paradigm by which NK cells combat disease [45,63,64]. Additionally, certain
therapeutic monoclonal antibodies (mAbs) can enable NK cell cytotoxicity by ADCC [65]. Other than T
lymphocytes, NK cells are able to recognize multiple diverse ligands, which are not related in sequence
and structure, despite the expression of invariant surface receptors [66, 67]. The highly sophisticated
mechanisms, which regulate the cytolytic activity, mainly depend on the balance between inhibitory and
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activating signals transduced into the NK cell upon receptor-ligand interaction [68–70].
NK cell cytotoxicity followes a coordinated series of events: i) contact with the target cell, ii) adhesion,
and iii) formation of an activating immunological synapse (IS). The formation of a cleft between the NK
cell and its target cell at the interface protects neighboring cells from exposure to lytic effector molecules
and is dependent on the ordered rearrangement of molecules within the immune cell [57, 71]. Upon
interaction with a healthy cell, the formation of an inhibitory synapse promotes detachment and prevents
the release of the granula. Since the IS formation is transient, highly organized and occupies only small
areas of the cell surface, more than one IS might form at the same time [71, 72]. Interestingly, only a
minority of NK cells (∼20 %) is responsible for the majority of killing events, which is possibly due to
their ability of performing multiple consecutive lytic hits [72–74].
1.3 Regulation of Natural Cytotoxicity
NK cell-mediated cytotoxicity is an effective mechanism to protect the host from microbial or virus in-
fections and malignantly transformed cells by induction of target cell apoptosis within minutes upon
encounter. To prevent killing of healthy cells, the cytolytic process is tightly regulated by sophisticated
mechanismsmainly dependent on the balance between opposite signals from germline-encoded inhibitory
and activating natural killer cell receptors (NKRs). These surface receptors accumulate within the im-
munological synapse to engage respective ligands and mediate downstream signaling (Fig. 1) [60,75,76].
The control mechanism to ensure self-tolerance is mainly based on the recognition of MHC class I pro-
teins by inhibitory NK cell receptors since peptide-presenting MHC class I molecules are present in large
numbers on healthy cells (Fig. 1A) [77]. Self-tolerance and functional competence are attained during
education in the bone marrow by binding to cognate MHC class I molecules and subsequent signaling
via the ITIMs of the inhibitory NK cell receptors [78]. Thus, a prerequisite for the license to kill is the
expression of at least one inhibitory surface receptor specific for self-MHC class I molecules [79]. As
a consequence of malignant transformation or virus infection, MHC class I molecules are often down-
regulated leading to NK cell activity due to decreased binding of inhibitory NK cell surface receptors
(missing-self recognition [61, 62], Fig. 1B). Additionally, upregulation or expression of stress-induced
activating ligands (induced-self recognition [80, 81]) results in NK cell activation despite inhibitory sig-
naling (Fig. 1C). In both conditions, the target cell is eliminiated through NK cell-mediated cytotoxicity
or the production of pro-inflammatory cytokines [75].
There are two main categories of inhibitory NK cell surface receptors defined in humans: (i) the
CD94/NKG2A heterodimer recognizing human leukocyte antigen (HLA)-E, thereby enabling the NK
cell to sense the presence of appropriate expression of MHC class I molecules, since HLA-E mostly
binds leader peptides derived fromMHC class I proteins [82–84], and (ii) the killer-cell immunoglobulin-
like receptors (KIRs), which recognize different allelic groups of HLA-A, -B or -C molecules [85–87]
(Fig. 2). Additionally, the leukocyte Ig-like receptors (LILRs), evolutionary related to the KIR family,
are also expressed by NK cells and recognizes a large spectrum of classical and non-classical HLA I
molecules [88,89], but their importance for NK cell functions has yet to be defined. Mouse NK cells also
have two categories of inhibitory MHC class I receptors: (i) the CD94/NKG2A receptor complex with
functions similar to the human receptor [90], and (ii) diverse family members of Ly49 molecules, which
are phenotypically unrelated to KIRs [91–93].
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Fig. 1: Recognition of tumor cells by natural killer cells
(A) Natural killer (NK) cells are tolerant to healthy host cells, as the strength of the activating signals they receive
on encountering these cells is dampened by the engagement of inhibitory receptors. (B) Tumor cells may lose
expression of MHC class I molecules. NK cells become activated in response to these cells, as they are no longer
held in check by the inhibitory signals delivered by MHC class I molecule engagement. This is known as ”missing-
self” triggering of NK cell activation. (C) In addition, NK cells are selectively activated by ”stressed” cells, which
upregulate activating ligands for NK cells and thereby overcome the inhibitory signaling delivered by MHC class
I molecules. This is known as ”stress-induced self” triggering of NK cell activation. In both conditions, NK cell
activation leads to tumor elimination directly (through NK cell-mediated cytotoxicity) or indirectly (through the
production of pro-inflammatory cytokines, such as interferon-γ). (Modified from [75].)
Among human NK cell receptor families, only the KIR gene family is highly polymorphic and com-
prises 15 genes and two pseudogenes. Related to the function performed, the cytoplasmic domains of
KIRs can feature either a short (activating KIRs) or a long (inhibitory KIRs) tail, denoted with “S” or
“L” in the nomenclature, respectively. Inhibitory KIRs are type I transmembrane glycoproteins of the
Ig superfamily, which are further discriminated by the presence of two (KIR2DL) or three (KIR3DL) Ig
domains within their extracellular part followed by a transmembrane region and the characteristic long
intracellular tail comprising two immunoreceptor tyrosine-based inhibition motifs (ITIMs, Fig. 2) [67].
Upon ligand binding, the tyrosine within the ITIM consensus sequence (I/L/V/SxYxxL/V, where x rep-
resents any amino acid and slashes separate alternative amino acids) becomes phosphorylated by a kinase
of the Src (sarcoma) family, which then binds SHP-1 or SHP-2 (Src homology (SH)-2-domain contain-
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ing protein tyrosine phosphatase). Subsequent dephosphorylation of molecules involved in downstream
signaling of activating receptor results in blocking of activating signal transduction cascades [66,76,94].
Independently of their state of activation, NK cells express functional toll-like receptors (TLRs) to
rapidly respond invading pathogens and synergize with chemokine- or cytokine-mediated signals to ac-
tivate NK cell function [95]. As other innate immune cells express the same TLRs, NK cells interact
with the same pathogen-derived products such as bacterial lipoprotein, flagellin or single- or double
stranded RNA [67]. To overwhelm inhibitory signals, specific activation signals are mainly mediated by
the engagement of activating receptors with non-HLA class I proteins, which are expressed upon cellular
stress [68].
The major human activating NK cell receptors are the C-type lectin-like superfamily member NKG2D
[96] and the heterologous NCRsNKp30, NKp44 and NKp46 (Fig. 2) [97–101]. NKG2D is a type II trans-
membrane glycoprotein, which is constitutively expressed as homodimer on all mouse and human NK
cells, T cells and NKT cells [96,102]. In humans, this NK cell receptor recognizes stress-induced ligands
with structural homology to MHC class I molecules, MICA and MICB (MHC class I chain-related gene
A/B) and the ULBPs (unique long 16-binding proteins) [77,80]. Since activating NK cell receptors do not
comprise any functional activating tyrosine phosphorylation motif within their cytoplasmic tail, they as-
sociate with signaling adaptor molecules via oppositely charged amino acids within their transmembrane
domains (TMDs). NKG2D associates with DNAX-activation protein (DAP) 10 dimers [102], which are
phosphorylated at the tyrosine residue within their YINM-motif upon ligand binding. Subsequently, this
phosphotyrosine recruits the p85 subunit of PI3K (phosphatidylinositol-3-kinase) or Grb2 (growth factor
receptor-bound protein 2) [103], which then transduce the signal intracellularly by the MAP (mitogen-
activated protein) kinase cascade and the JAK/STAT (janus kinase/signal transducers and activators of
transcription) pathway resulting in NK cell cytotoxicity [70].
Similar to NKG2D, the NCR family members are primarily expressed on NK cells but also on distinct
T cell subsets [104–108]. NKp30 and NKp46 are constitutively expressed on all NK cell subsets [109–
111], whereas NKp44 is exclusively found on activated NK cells, thus displaying a marker for cytolytic
activity of NK cells [60, 112]. Notably, NKp46 is the only NCR with a functional orthologue in mice
[113]. The NCRs are a heterogeneous group of type I transmembrane glycoproteins, which belong to
the Ig superfamily. They are comprised of an extracellular ligand binding domain (LBD), a flexible
membrane proximal stalk region, a TMD and a short cytosolic tail. The ectodomains of the NCRs are
phenotypically characterized by two C2-type domains (NKp46), one V-type domain (NKp44) or one I-
type domain (NKp30) [114–117]. Due to the lack of intracellular activating signaling motifs, the NCRs
have to associate with accessory signaling proteins via oppositely charged amino acid residues within the
plasma membrane. Most signaling adaptor proteins contain immunoreceptor tyrosine-based activaing
motifs (ITAMs, consensus sequence D/ExxYxx[L/I]X6−8Yxx[L/I]) within their cytoplasmic domains.
NKp30 and NKp46 interact with CD3ζ and FcϵRIγ homo- or heterodimers, whereas NKp44 associates
with DAP12 homodimers for subsequent activating signal transduction upon ligand engagement [97–
100]. The adaptor proteins contain several tyrosines, which are targeted by kinases of the Src family.
Upon tyrosine phosphorylation, Syk kinases and ZAP-70 (zeta-chain-associated protein kinase 70) are
recruited and activated, which then phosphorylate key enzymes of downstream signaling cascades leading
to NK cell activation and the release of cytotoxic granules [76, 118].
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Fig. 2: Human inhibitory and activating natural killer cell receptors and their corresponding ligands
This is a simplified representation of the major natural killer cell receptors (NKRs) and their identified ligands in-
volved in natural cytotoxicity. The major inhibitory NKRs are the KIR family members KIR2DL and KIR3DL, and
the heterodimer CD94/NKG2A. KIRs belong to the Ig superfamily and possess two (KIR2DL) or three (KIR3DL)
Ig-like domains in their extracellular region. Their cognate ligands are the human leukocyte antigen (HLA)-A, -B
or -C molecules. CD94/NKG2A belongs to the C-type lectin family, contains two lectin-like domain in its extra-
cellular region and binds to HLA-E molecules. All inhibitory receptors have two immunoreceptor tyrosine-based
inhibitory motifs (ITIMs) within their cytoplasmic tail for inhibitory signal transduction. The major activating
NKRs are NKG2D and the members of the natural cytotoxicity receptor (NCR) family NKp30, NKp44 and NKp46.
The NCRs belong to the Ig superfamily and contain either one (NKp30 and NKp44) or two (NKp46) Ig-like do-
mains in their extracellular regions. All of the NCRs bind to viral hemagglutinins (HA). Additionally, the human
cytomegalovirus (HCMV) tegument protein pp65, the BCL2-associated anthanogene 6 (BAG-6) and a structural
homologue of the B7 family (B7-H6) were described as ligands for NKp30. Recently, the proliferating cell nu-
clear antigen (PCNA) and the mixed-lineage leukemia-5 variant 21spe-MLL5 were discovered as novel ligands
for NKp44 on tumor cells. The disulfide-linked homodimer NKG2D belongs to the C-type lectin family, contains
two lectin-like domains in its extracellular region and binds to MICA and MICB (MHC class I chain-related gene
A/B) and to ULBPs (unique long 16-binding proteins). Since none of the activating receptors possesses func-
tional activating tyrosine phosporylation motifs within their cytoplasmic tail, they associate with signaling adaptor
molecules via oppositely charged amino acids in their transmembrane domains. NKp30 and NKp46 associate with
a CD3ζ/FcϵRIγ heterodimer, whereas NKp44 interacts with DNAX-activation protein (DAP) 12. These adaptor
molecules contain immunoreceptor tyrosine-based activating motifs (ITAMs) within their cytoplasmic tails. By
contrast, NKG2D uses a different pathway of activation with two DAP10 molecules, which possesses two YINM
motifs for activating signal transduction. (Modified from [119].)
Several studies demonstrate the diversity of NCR ligands and report of cellular and pathogen-derived
ligands, which are not expressed on healthy cells. All NCRs recognize heparin/heparan sulfate [120–124]
and bacterial structures [125–127]. Furthermore, NKp44 and NKp46 bind to viral hemagglutinins (HAs)
of influenza virus, sendai virus or new castle disease virus, whereas vaccinia virus HA is an other ligand of
NKp30 and NKp46 [63,128–132]. Additionally, the human cytomegalovirus (HCMV) tegument protein
pp65, the BCL2-associated anthanogene 6 (BAG-6, also known as BAT3) and the B7 family member
(B7-H6) were described as ligands for NKp30 [133–136]. Recently, the proliferating cell nuclear antigen
(PCNA) and the mixed-lineage leukemia-5 variant 21spe-MLL5 were discovered as novel ligands for
NKp44 on malignantly transformed cells [137, 138]. Moreover, a so far unknown cellular NKp44L is
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expressed during HIV-1 infection that correlates with both progression of CD4+ T cell depletion and the
increase of viral load [139]. However, due to the broad impact of the NCRs on immunosurveillance, it is
likely that there are other cellular ligands, especially for NKp46, which remain to be discovered [67,140].
NK cell activity largely depends on the natural cytotoxicity receptors NKp30 (NCR3, CD337), NKp44
(NCR2, CD336) and NKp46 (NCR1, CD335), as reduced NCR expression is associated with different
forms of cancer such as acute myeloid leukemia (AML) [141–144]. Especially, reduced NKp30 expres-
sion has clinical implications in patients with AML [144–146], cervical cancer, and high grade squamous
intraepithelial lesions (HGSIL) [141] as well as gastrointestinal sarcoma (GIST) [147]. Longitudinal
analyses of AML patients showed that an NKp30 downregulation on NK cells during leukemia develop-
ment resulted in an NKp30dull phenotype leading to an impaired natural cytotoxicity against leukemia
cells [144–146]. The same effect together with enhanced HPV-16 infections due to NKp30 downregula-
tion was observed in cervical cancer and HGSIL patients. Moreover, due to a retrospective analysis of
GIST patients, the reduced survival was associated with a predominant expression of an immunosuppres-
sive splice variant of NKp30 (isoform c) [147]. Within the activating NK cell receptors, NKp30 displays
a unique role since it is the only receptor involved in tumor immunosurveillance by NK cells as well as
shaping the adaptive immune response, primarily by the NK-DC cross-talk [148, 149].
1.4 Natural Cytotoxicity Triggering Receptor 3 (NCR3, NKp30)
In 1999, Pende and colleagues identified a novel triggering receptor of roughly 30 kDa, which is involved
in natural cytotoxicity [101]. Despite any sequence homology between NKp30, NKp44 and NKp46,
these surface proteins have been grouped to the family of natural cytotoxicity receptors according to the
following features: (i) their expression is mostly restricted to NK cells, (ii) monoclonal antibody (mAb)-
mediated crosslinking triggers and mAb-mediated masking inhibits NK cell cytotoxicity, and (iii) they
specifically recognize non-HLA ligands [150]. Identified as third member of the NCR family, NKp30
was also named natural cytotoxicity receptor 3 (NCR3).
From an evolutionary point of view, the three NCR familymembers putatively emerged in another order
with NKp46 (NCR1) as first and NKp44 (NCR2) as latest member, while NKp30 evolved in between.
This progressive NCR appearance may reflect an increase in the complexity and the fine-tuning of the
innate immune response [151], further confirmed by the fact that most orthologues of NK cell receptors
are not present beyond the mammalian branching [152]. While NKp30 is expressed as a functional
protein on human and primate (Macaca fascicularis and Pan troglodytes) NK cells, chimpanzee NK
cells express NKp30 only upon activation similar to NKp44 [101, 151, 153]. Moreover, NKp30 was
found to be expressed as a functional protein on certain rat NK cell subsets [154–156]. However, in mice
it is only a pseudogene leading to a truncated non-functional protein with exception of the mouse strain
Mus caroli, where NKp30 was found as a potential soluble protein [157–159].
The human NKp30 gene 1C7 is located on chromosome 6. According to phylogenetic analyses of
different mammalian species, the nucleic acid sequences of the NKp30 genes are highly conserved except
in exon 4, which encodes the intracellular domain. In humans, there are six transcript variants (a-f)
resulting from alternative splicing of exon 2 (encoding the extracellular domain) and exon 4 (Fig. S1,
see the appendix 7.1.1) [160], thus differing in the length of the extracellular and intracellular domains.
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Isoforms a-c consist of the complete ectodomain of NKp30, whereas isoforms d-f lack amino acids 66-99b
within the ligand binding domain of NKp30. Additionally, the intracellular domains of the isoforms differ
in their length and amino acid composition. Isoforms a and e contain the longest (36 aa) and isoforms b
and d harbor the shortest (12 aa) intracellular domain, whereas the cytoplasmic tail of the isoforms c and
f consist of 25 aa. All splice variants are translated into cell surface proteins with different expression
levels and tissue distribution. Notably, theNKp30a-c containing the longest extracellular domain aremost
abundant and ubiquitously distributed [159]. According to their structural heterogeneity, the transcripts
adopt different NK cell functions. Activation by isoforms a and b results in stimulation of the immune
system, whereas NKp30c is immunosuppressive [147]. Although the first functional NKp30 protein
identified was isoform b (190 aa), the ”canonical” sequence refers to the longest isoform a (201 aa).
NKp30 is a 201 amino acids (aa) long type I transmembrane protein comprised of (i) a leader se-
quence for plasma membrane targeting, (ii) an extracellular ligand binding domain (LBD), (iii) a flexible
membrane-proximal stalk domain connecting the LBD to (iv) a single TMD, which contains a positively
charged arginine, and (v) a short cytoplasmic tail without tyrosine phosphorylation motif (Fig. 3A and
B). For signaling, NKp30 associates with CD3ζ and FcϵRIγ homo- or heterodimers (although there is
no published experimental evidence regarding an association between NKp30 and FcϵRIγ) [101, 161].
This interaction is mediated by the arginine (R143) within the TMD of NKp30 and a negatively charged
aspartic acid residue within the TMD of the adaptor molecules.
NKp30 plays a pivotal role for the elimination of parasites, malignantly transformed and virus in-
fected cells, and even some healthy cells [140]. While there are still some unknown ligands [3], the
following NKp30 ligands were identified: (i) heparin/heparan sulfate molecules [120, 123, 124], (ii) the
viral HCMV tegument protein pp65 [133], (iii) viral hemagglutinins [130], (iv) Pf EMP1 (Plasmodium
falciparum erythrocyte membrane protein 1) as well as (i) the cellular proteins B7-H6 [134] and BAG-
6 [135, 136]. Beside its influence on NK cell cytotoxicity against pathogens and non-self cells, NKp30
also displays immune regulatory functions. By binding of NKp30 to BAG-6, which is expressed on
the plasma membrane of immature (but not mature) DCs, NK-dependent activation of DCs mediated by
TNF-α and IFN-γ release as well as NK cell killing of immature DCs are induced [135,149]. BAG-6 is a
multifunctional protein mainly located in the nucleus, which is known to be involved in p53-DNA repair
and apoptosis [162, 163]. However, it is also present in various tissues, on the plasma membrane of ma-
lignantly transformed cells as well as on exosomes and as a soluble protein upon cellular stress [136,164].
A recent study identified a sub-domain within the C-terminal half of BAG-6 as inhibitory ligand being
sufficient for receptor docking and inhibition of NKp30-dependent NK cell cytotoxicity. Therefore, sol-
uble BAG-6 represents an important tumor antigen and might be part of a tumor immune escape strategy
reminiscent of the NKG2D ligands ULBP2 and ULBP3 [164–166]. Furthermore, all three NCRs rec-
ognize viral hemagglutinins [63, 128, 130, 132]. These interactions are particularly affected by N-linked
glycosylation of NKp30 or sialic acids attached to galactose of NKp46 and NKp44 [130,167]. However,
whereas the interaction of NKp46 with hemagglutinins of the poxvirus family (such as vaccinia virus)
results in NK cell activation, binding to NKp30 leads to NK cell inhibition [130]. Another known viral
ligand for NKp30 leading to NK cell inhibition is the HCMV tegument protein pp65, which is not se-
creted but released from infected cells upon lysis. Despite a direct receptor-ligand interaction, there is a
mechanistical difference to BAG-6-dependent inhibition of NK cell cytotoxicity. Whereas BAG-6 inter-
bAmino acid annotation refers to the ”canonical” NKp30 sequence (isoform a) depicted in Fig. 3.
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acts with the NKp30 ectodomain, pp65 splits up the interaction between NKp30 and its adaptor proteins,
thus decreasing the activation state of the NK cell [133, 168]. Another pathogen-derived NKp30 ligand
is Pf EMP1, which is presented on the surface of erythrocytes infected with the parasite Plasmodium
falciparum [125]. Additionally, there are controversial experimental studies discussing heparin/heparan
sulfate as potential NCR ligands with varying binding affinities dependent on receptor glycosylation or
as coreceptors in complex with other ligands [120, 123, 124, 169]. Most important for structural analy-
ses and investigation of key features for ligand binding and signaling so far is the second cellular ligand
B7-H6 [117,170]. It is a type I transmembrane glycoprotein that is believed to be exclusively expressed
upon tumor transformation [134]. Similar to the ligands of the other major activating NK cell receptor
NKG2D, B7-H6 ectodomain shedding from the surface of different tumor cells by metalloproteases was
demonstrated as tumor immune escape mechanism [171]. However, by contrast to NKG2D, the known
ligands for NKp30 are not related in sequence and structure.
Fig. 3: Domain organization, amino acid sequence and crystal structure of human NKp30
(A) Domain organization of NKp30. The NKp30 amino acid sequence can be subdivided into five domains: a
leader sequence for plasma membrane targeting (orange), an extracellular ligand binding domain (blue), a flexible
stalk domain (red) connecting the ligand binding domain with a single transmembrane domain (TMD, green), and a
short cytosolic tail (yellow). The first amino acid of each domain is indicatedc. (B) Amino acid sequence of NKp30
isoform a. Consensus sequence forN-linked glycosylationmotifs are depicted in red. (C) Unbound crystal structure
of the NKp30 ectodomain containing amino acids 18-130 (blue); PDB 3NOId. (D) B7-H6 (gray)-bound crystal
structure of the NKp30 ectodomain containing amino acids 19-130 (blue); PDB 3PV6d. The arrow indicates the
area that undergoes reorganization due to ligand binding. (C/D) Cystein residues forming a disulfide bond (orange)
and asparagines within consensus motifs for N-linked glycosylation (red) are depicted with corresponding amino
acid annotation. N- and C-termini are indicated. Structural illustrations weremadewith PyMol software. (Modified
from [119].)
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In 2011, the ligand binding domain of NKp30 (corresponding to the isoforms a-c) was crystallized in
an unbound (PDB: 3NOI [116]) and a B7-H6-bound state (PDB: 3PV6 [117]), which is unique amongst
the NCR family (Fig. 3C and D). Consistently, both crystal structures display an I-type Ig-like domain.
However, upon interaction with B7-H6, there is a slight conformational reorganization of the NKp30
LBD underneath the binding pocket. Since NKp30 ligands are diverse, it remains unclear whether the
identified interface displays a common binding site or whether other ligands would occupy different
binding pockets.
The ligand binding domain of NKp30 is N-linked glycosylated at three asparagines (N42, N68 and
N121, Fig. 3B). Surprisingly, binding studies with glycosylation-deficient variants of NKp30 revealed
that engagement of NKp30 and B7-H6 is mainly dependent on glycosylation of N42, which is located
outside the binding pocket. Moreover, glycosylation of N42 and N68 is essential for efficient intracel-
lular signaling. By contrast, for binding of NKp30 to BAG-6 N68 was critical, whereas glycosylation at
positions N42 and N121 had less impact. On the one hand, the degree of glycosylation could provide a
switch to modulate the ligand binding properties of NKp30, and on the other hand this further suggests the
presence of different ligand binding sites [170]. Beside N-linked glycosylation, the same study identified
the flexible stalk domain of NKp30 as an important feature for ligand recognition and related signaling.
The stalk domain is rich in hydrophobic amino acids, which might promote the formation of NKp30
oligomers, thereby leading to an increased apparent affinity for the ligand due to increased avidity. This
idea could at least partially explain the observation that some cell lines are killed by NK cells but fail to
bind NKp30-Ig proteins without a functional stalk domain [40, 128,170].
1.5 Oligomerization of Natural Killer Cell Receptors
NK cell activity largely depends on the NCRs NKp30, NKp44 and NKp46. Mechanistic details are still
unknown on how these germline-encoded surface receptors are able to recognize multiple ligands like
viral hemagglutinins or proteins from cellular, bacterial or parasitical origin, which are not related in se-
quence or structure [63, 125, 172]. As suggested from the structures of the NCRs, monovalent receptor
ligand interactions are expected. In 2003, Augugliaro and colleagues demonstrated that there would be
a selective cross-talk between the NCRs. A polyclonal NK cell population was stimulated with anti-
NKp30 monoclonal antibodies and cell lysates were immunoprecipitated not only with the NKp30 mAb,
but also with the other anti-NCR antibodies. Notably, anti-NKp44 and anti-NKp46 mAb stimulated NK
cells were analysed in the same way. Controls included immunoprecipitates with mAb directed to CD16
or p50.3 (KIR2DS4) molecules that are known to associate with CD3ζ and DAP12, respectively. Sur-
prisingly, individual activation of one NCR led to tyrosine phosphorylation of the adaptor molecules of
all NCRs, whereas the same adaptor proteins associated with other receptors were not activated [173]. If
nearby adaptor molecules became phosphorylated due to close neighborhood of kinases within the im-
munological synapse or if a specific interaction between the NCRs amplified activating signals, remained
unclear. However, NK cell killing requires the formation of a complex immunological synapse between
the target cell and the NK cell that is highly organized in time and space [44,174,175], which argues for
concerted lateral interactions of receptors at the plasma membrane of the NK cell engaged with a target
cell.
cThe amino acid sequence refers to accession number O14931 found at the UniProt database (http://www.uniprot.org).
dThe PDB accession number refers to the RCSB Protein Data Bank (http://www.rcsb.org).
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Beside complex formation of different NCRs to amplify activating signaling, there are also speculations
on NKp46 homo-oligomerization on the NK cell surface to enable multivalent interactions with trimeric
influenza virus hemagglutinin complexes [63]. Hemagglutinin neuraminidases of newcastle disease virus
form dimers and tetramers on the viral surface. Therefore, oligomeric ligand structures suggest homo-
or heteromeric NCR association [176–178], but to date there is no evidence for preformed or ligand-
induced receptor oligomerization. Notably, it is known that IL-2 activation of NK cells leads to an up-
regulation of NCR expression, especially NKp44 and NKp30 (Fig. S2), and thereby increases cellular
cytotoxicity [68, 179–184].
Beside variable ligand binding affinities due to modulation of the glycosylation state of the NKp30 lig-
and binding domain, formation of de novo binding interfaces by homo-oligomerization could be an addi-
tional mechanism how the NK cell is able to recognize multiple different ligands. Many laboratories have
shown that cell surface detection of NKp30 on NK cell lines or primary NK cells with NKp30-specific
monoclonal antibodies gives rise to a dotted rather than a homogeneous plasma membrane staining sug-
gesting preformed clusters of NKp30. Interestingly, there are further hints from a structural point of view
suggesting a self-association of the NCR ectodomains. In this context, Bezouška and co-workers [185]
have shown that a fraction of the NKp30 ectodomain expressed in Escherichia coli forms oligomers
as detected by size exclusion chromatography. However, the authors have not analyzed this fraction
of NKp30 in more detail. Moreover, although both structures show NKp30 as a monomer, Sun and
co-workers [116] observed a crystallographic dimer of NKp30 arguing for a potential intrinsic capabil-
ity of NKp30 to oligomerize. Similarly, Bordo and co-workers [114] discussed a saddle-shaped dimer
within the crystal structure of NKp44 that is exclusively expressed on activated NK cells. Along these
lines, Porgador and co-workers [186] showed that the membrane proximal domain of NKp46 (NKp46D2)
mediates ligand-induced dimerization of NKp46 in the membrane and contributes to NKp46-mediated
lysis by NK cells. By contrast, the activating NK cell receptor NKG2D assembles a composite binding
site for the interaction with its corresponding cellular ligands by homo-dimerization [187, 188]. Simi-
larly, the natural killer cell receptor KIR2DL2 dimerizes with both receptor ectodomain molecules in the
same orientation via two different interaction sites. Therefore, Snyder and co-workers [189] suggested
formation of KIR2DL2 oligomers within the plasma membrane by alternating dimerization. In addi-
tion, self-assembly of activating KIR2DS1 was shown to be concentration-dependent. Although local
concentration and oligomerization might even be fostered by ligand-induced assembly of a condensed
immunological synapse between the NK cell and its target cell, receptor oligomerization prior to ligand
induction would most likely lead to faster activation of signaling.
1.6 Objectives
Previous studies have shown that dimerization or oligomerization of NK cell surface receptors is a potent
mechanism to achieve functional receptor complexes with enhanced ligand binding affinity or de novo
formed interaction sites [189,190]. Furthermore, Augugliaro and co-workers described a selective cross-
talk between NKp30 and the other NCRs NKp44 and NKp46 within the plasma membrane of NK cells
[173, 189]. They could demonstrate that an engagement of NKp30 resulted in efficient amplification
of the activation signaling cascade associated with the other NCRs. However, in this study, the exact
mechanism of signal transmission between the NCRs and whether this interaction could cause structural
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rearrangements of the NKp30 ectodomains remained unclear. Therefore, the aim of this thesis was to
investigate self-assembly of the human activating NK cell receptor NKp30 as possible key mechanism
to enhance its ligand binding affinity for corresponding ligands by increased avidity.
1. Dotted patterns in confocal immunofluorescence analyses of anti-NKp30 antibody decorated pri-
mary NK cells suggest individual NKp30 complex formation on the surface of natural killer cells. No-
tably, NKp30 surface expression as well as the fluorescence intensity of the dotted pattern increase upon
cytokine activation of the NK cells. So far, it remains unknown whether NKp30 alone is able to form
functional receptor complexes or whether NKp30 complex formation is due to association with other
upregulated surface receptors such as NKp44 and NKp46. In this thesis, different mammalian or insect
cells should be investigated to identify a suitable expression host for the generation of a minimal NK
cell mimic. Full-length NKp30 alone or in combination with NKp44 and NKp46 should be constitu-
tively expressed in a non-immunological background to enable the individual characterization of NKp30
self-association or NCR assembly as well as a putative cross-stimulation in more detail.
2. In general, binding interfaces between NK cell surface receptors and their ligands are located within
the extracellular part of the receptor. Suggesting an NKp30 self-assembly or functional cross-talk be-
tween all NCRs, it is evident to recombinantly express the ectodomain of NKp30 for molecular inves-
tigations. For this purpose, expression and purification schemes should be established to obtain large
amounts of soluble NKp30 ectodomain proteins. As basis for in vitro studies to functionally characterize
as well as to perform structural analyses, the NKp30 ligand binding domain should be produced in E. coli.
Another approach should be based on the expression of soluble and post-translationally modified NKp30
ectodomain proteins produced in insect cells to investigate the oligomeric state of NKp30. Furthermore,
the ligand binding capacity as well as the structure of the oligomeric species should be characterized by
size exclusion chromatography, ELISA and electron microscopy.
3. In a previous study, bivalent NKp30 ectodomain proteins fused to a human IgG1-Fc part were used to
elucidate the NKp30 stalk domain as well as the glycosylation status as key features to modulate NKp30-
dependent NK cell cytotoxicity [170]. Accordingly, in this thesis, insect cell-derived NKp30 ectodomain
proteins with and without the stalk domain should be generated. Furthermore, an antibody, which recog-
nizes a specific epitope within the ligand binding domain, should be purified from rabbit blood serum after
peptide-immunization. The antigen-specificity should be verified by peptide SPOT arrays, whereas the
suitability of the anti-NKp30 antibody for biochemical and cellular applications should be demonstrated
by immunoblot analyses, ELISA as well as cell decoration assays. This novel anti-NKp30 antibody,
which binds to both NKp30 ectodomain variants to the same extent, should allow for the investigation of
the individual impact of the stalk domain on ligand binding activity and oligomerization of NKp30.
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2.1 Materials
2.1.1 Chemicals, Consumables and Instruments
Unless otherwise denoted, all used chemicals were obtained in p. a. quality from the companies Ap-
pliChem (Darmstadt, Germany), Carl Roth GmbH (Karlsruhe, Germany), Life Technologies (Carlsbad,
California, USA), Lonza (Basel, Switzerland), Roche (Mannheim, Germany) or Sigma-Aldrich GmbH
(Saint Louis, Missouri, USA). The cell culture chemicals were obtained from Carl Roth GmbH (Karl-
sruhe, Germany), Life Technologies (Carlsbad, California, USA), Mirus Bio (Madison, Wisconsin, USA)
or PAA (Cölbe, Germany). All consumables used for cell culture, molecular biology and protein biochem-
istry were obtained from the companies Bio-Rad Laboratories (Hercules, California, USA), Carl Roth
GmbH (Karlsruhe, Germany), Greiner Bio-One (Kremsmünster, Austria), Merck Millipore (Darmstadt,
Germany), Miltenyi Biotec (Bergisch Gladbach, Germany), Sarstedt AG & Co (Nümbrecht, Germany),
Thermo Fisher Scientific Inc. (Waltham, Massachusetts, USA) or Whatman (Dassel, Germany). Unless
otherwise denoted, all instruments were common lab equipment.
2.1.2 Enzymes, Inhibitors, Antibiotics, and Additives
Enzyme Supplier
Cre recombinase New England Biolabs
DreamTaq polymerase Thermo Fisher Scientific
FastAP thermo sensitive alkaline phosphatase Thermo Fisher Scientific
FastDigest restriction endonucleases Thermo Fisher Scientific
Phusion polymerase Thermo Fisher Scientific
PNGase F New England Biolabs
Protein Deglycosylation Mix New England Biolabs
T4 DNA ligase Thermo Fisher Scientific
Inhibitor Supplier
complete protease inhibitor cocktail Roche
tunicamycin Sigma-Aldrich
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Antibiotic Supplier
Ampicillin AppliChem
Chloramphenicol Roth
Gentamycin Life Technologies
Kanamycin Roth
Penicillin/Streptomycin Life Technologies
Spectinomycin AppliChem
Tetracycline AppliChem
Zeocin Life Technologies
Additive Supplier
FCS PAA
X-gal Sigma-Aldrich
L-Glutamine PAA
HEPES Life Technologies
Human serum PAA
Interleukin-2 (Proleukin S) Novartis
IPTG Roche
β-Mercaptoethanol Life Technologies
NEAA Life Technologies
Pluronic F-68 Sigma-Aldrich
2.1.3 Antibodies, Isotype Controls and Cell Staining Reagents
Primary Antibody/Isotype Control Supplier
anti-mouse CD4, GK1.5, APC-conjugated (rat IgG2b) eBioscience
anti-His, HIS-1, HRP-conjugated (mouse IgG2a) Sigma-Aldrich
anti-gp64 (FastPlax Titer Kit) (mouse IgG) Merck Millipore
anti-human MICA, polyclonal (goat IgG) R&D Systems
anti-human NKp30, polyclonal (goat IgG) R&D Systems
anti-human NKp30, peptide immunized (rabbit IgG) BioScience/PepScience,
(NH2-CPGKEVRNGTPEFRGR-COOH) this thesis
anti-human NKp30, 210845 (mouse IgG2a) R&D Systems
anti-human NKp30, P30-15 (mouse IgG1) BioLegend
anti-human NKp30, P30-15, APC-conjugated (mouse IgG1) BioLegend
anti-human NKp30, Z25, PE-conjugated (mouse IgG1) Beckman Coulter
anti-human NKp44, Z231, PE-conjugated (mouse IgG1) Beckman Coulter
anti-human NKp46, BAB281, PE-conjugated (mouse IgG1) Beckman Coulter
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Secondary Antibody Supplier
anti-goat IgG, HRP-conjugated (donkey IgG) Jackson ImmunoResearch
anti-human IgG-Fc, DyLight649-conjugated (goat IgG) Jackson ImmunoResearch
anti-human IgG-Fc, HRP-conjugated (goat IgG) Sigma-Aldrich
anti-mouse IgG, HRP-conjugated (goat IgG) Sigma-Aldrich
anti-mouse IgG, Alexa546-conjugated (goat IgG) Life Technologies
anti-mouse IgG, Alexa647-conjugated (goat IgG) Life Technologies
anti-rabbit IgG, HRP-conjugated (goat IgG) Sigma-Aldrich
anti-rabbit IgG, APC-conjugated (goat IgG) Life Technologies
Isotype Control Supplier
mouse (BALB/c) IgG1, MOPC-21, APC-conjugated BioLegend
Cell Staining Supplier
DAPI AppliChem
2.1.4 Kits
Kit Supplier
Gel Filtration Calibration Kit LMW and HMW GE Healthcare
GeneJET Gel Extraction Kit Thermo Fischer Scientific
GeneJET Plasmid Miniprep Kit Thermo Fisher Scientific
NK Cell Isolation Kit, human Miltenyi Biotec GmbH
NucleoBond Xtra Midi/Maxi Macherey-Nagel
2.1.5 Bacterial Strains and Culture Media
Strain Genotype Supplier
BL21(DE3) B strain derivative: F- ompT hsdSB (rB-mB-)gal dcm Life Technologies
[191] (DE3)
BW23473 K-12 strain derivative: ∆lac-169 rpoS(Am) robA1 Life Technologies
[192–194] creC510 hsdR514 uidA(∆MluI)::pir+ endABT333 recA1
DH5α K-12 strain derivative: F-Θ80lacZ∆M15 lacZYA-)∆(argF Life Technologies
[195, 196] U169 recA1 andA1 hsdR17 (rK -mK+) phoA supE44 λ- thi-1
gyrA96 relA1
DH10EmBacY B strain derivative: F-mcrA∆(mrr-hsdRMS-mcrBC) I. Bergere
[197, 198] Θ80lacZ∆M15 ∆lacX74 recA1 endA1 araD139 ∆(ara
leu)7697 galU galK rpsL nupG λ- tonA + helper plasmid for
Tn7 transposon enzyme + yfp reporter gene (KanRTetRCamR)
Origami 2 (DE3) K-12 strain derivative: ∆(ara-leu)7697∆(lacX74) ∆phoA Life Technologies
[199, 200] PvuII phoR araD139 ahpC galE galK rpsL F’[laq+ laqIq pro]
(DE3) gor522::Tn10 trxB (StrRTetR)
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For the cultivation of bacteria, lysogeny broth (LB) medium [201] and agar with the low salt formulation
of Lennox [202] were purchased from Carl Roth. The cryo culture medium is made of 50 % (v/v) LB
medium and 50 % (v/v) sterile glycerol.
2.1.6 Cell Lines and Culture Media
2.1.6.1 Unmodified Cell Lines
Unless otherwise denoted, all used cell lines were either purchased from the American Type Culture
Collection (ATCC), the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) or the Eu-
ropean Collection of Cell Cultures (ECACC).
Cell Line Characteristics Supplier
HEK293 human embryonic kidney cells ATCC (CRL-1573)
A5 murine CD4+ T cell hybridoma, 14.3.d TCR β chain A. Diefenbach [203]
Ba/F3 murine pro B cells DSMZ (ACC 300)
High Five (Hi5) ovarian tissue cells from Trichoplusia ni Life Technologies
Jurkat human T cell lymphoma ATCC (TIB-152)
MiaPaCa-2 human pancreatic cancer cells ATCC (CRL-1420)
NK-92MI human natural killer cells ATCC (CRL-2408)
Sf 9 ovarian tissue cells from Spodoptera frugiperda Life Technologies
2.1.6.2 Gene-Modified Cell Lines
Cell Line Characteristics Supplier
HEK293-30-His codon-optimized human NKp30 full-length protein
containing a C-teminal His-tag; GFP protein expres-
sion under IRES control
this thesis
HEK293-mock no NKp30 insertion; GFP protein expression under
IRES control
this thesis
HEK293T/T17 human embryonic kidney cells, large T antigen ATCC (CRL-11268)
expression
HEK293T-30-His codon-optimized human NKp30 full-length protein
containing a C-teminal His-tag; GFP protein expres-
sion under IRES control
this thesis
HEK293T-mock no NKp30 insertion; GFP protein expression under
IRES control
this thesis
A5-GFP GFP protein expression under control of three NF-AT
binding sites of the Il2 gene
A. Diefenbach
[203, 204]
A5-30FL-His codon-optimized human NKp30 full-length protein
containing a C-terminal His-tag; GFP protein expres-
sion under control of three NF-AT binding sites of the
Il2 gene
K. Oberlef/
J. Hartmann [170]
eThe E. coli strain DH10EmBacY was kindly provided by I. Berger, European Molecular Biology Laboratory, Grenoble,
France.
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Cell Line Characteristics Supplier
A5-mock no NKp30 insertion; GFP protein expression under
control of three NF-AT binding sites of the Il2 gene
K. Oberlef/
J. Hartmann [170]
Ba/F3-B7-H6 human B7-H6 full-length protein; intracellular GFP
expression; puromycin resistance
A. Cohneng [170]
Ba/F3-mock no B7-H6 insertion; intracellular GFP expression;
puromycin resistance
A. Cohneng [170]
Jurkat-30-His codon-optimized human NKp30 full-length protein
containing a C-teminal His-tag; GFP protein expres-
sion under IRES control
this thesis
Jurkat-mock no NKp30 insertion; GFP protein expression under
IRES control
this thesis
2.1.6.3 Culture Media
DMEM
Dulbecco’s modified Eagle medium (DMEM) was supplemented with 25 mM glucose, 10 % (v/v) FCS
(PAA), 50 U/ml penicillin, 50 µg/ml streptomycin, 10 µg/ml gentamicin, 5.5 mM L-glutamine, 1 mM
sodiumpyruvate, 0.1MMEMnon-essential amino acids, 10mMHEPES, and 5.5mMβ-mercaptoethanol.
DMEM was used for the cultivation of A5-GFP cells.
Express Five
Express Five SFM (Gibco) was supplemented with 18 mM L-glutamine and used for the cultivation of
Hi5 insect cells.
Insect Xpress
Insect Xpress medium (Lonza) was supplemented with 0.2 % (v/v) Pluronic F-68 and used for the culti-
vation of Sf 9 insect cells.
RPMI-1
RPMI 1640 was supplemented with 10% (v/v) FCS (PAA), 100 U/ml penicillin, 100 µg/ml streptomycin,
and 2 mM L-glutamine. RPMI-1 was used for the cultivation of HEK293, HEK293T and Jurkat cells.
RPMI-2
RPMI 1640 was supplemented with 10% (v/v) FCS (PAA), 100 U/ml penicillin, 100 µg/ml streptomycin,
2 mM L-glutamine, and 5.5 mM β-mercaptoethanol. RPMI-2 was used for the cultivation of Ba/F3 cells.
RPMI-3
RPMI 1640 was supplemented with 15% (v/v) FCS (PAA), 100 U/ml penicillin, 100 µg/ml streptomycin,
and 2 mM L-glutamine. RPMI-3 was used for the clonal isolation of gene-modified HEK293 cells.
fThe cell line was kindly generated by K. Oberle in the lab of A. Diefenbach, Institute of Medical Microbiology and Hygiene
at the University of Freiburg, Germany.
gThe cell line was kindly generated and provided by A. Cohnen in the lab of C. Watzl, Leibniz Research Centre for Working
Environment and Human Factors, Dortmund, Germany.
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RPMI-4
RPMI 1640 was supplemented with 10 % (v/v) FCS (PAA), 10 % (v/v) horse serum (PAA), 100 U/ml
penicillin, 100 µg/ml streptomycin, 1 mM sodium pyruvate, and 4 mM L-glutamine. RPMI-4 was used
for the cultivation of NK-92 cells.
X-Vivo
X-Vivo10 was supplemented with 5 % (v/v) human serum (PAA), and 1000 U/ml IL-2. X-Vivo was used
for the cultivation of primary human natural killer cells.
2.1.7 Buffers
Unless otherwise denoted, all buffers and solutions were prepared with deionized water, and the pH was
adjusted with HCl or NaOH.
Buffer/Solution Formulation
Agarose Gel Electrophoresis (2.3.6)
TAE Buffer
40 mM Tris
1 mM EDTA
1.14 % (v/v) acetic acid
EtBr solution 10 % (w/v) ethidium bromide (EtBr)
EtBr stain 1 % (v/v) EtBr solutionin TAE buffer
Competent Bacteria (2.2.2)
TFB I buffer
30 mM potassium acetate
10 mM CaCl2
50 mM MnCl2
100 mM RbCl
15 % (v/v) glycerol
adjust to pH 6.8 with acetic acid
TFB II buffer
10 mM MOPS
75 mM CaCl2
10 mM RbCl
15 % (v/v) glycerol
adjust to pH 6.8 with KOH
Deglycosylation Assay (2.5.4)
10x glycoprotein 5 % (v/v) SDS
denaturation buffer 400 mM DTT
10x G7 500 mM Na3PO4
reaction buffer adjust to pH 7.5
10x NP-40 10 % (w/v) NP-40
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Buffer/Solution Formulation
ELISA (2.5.9)
PBS-T 0.05 % (v/v) Tween20in PBS
7.5 % BSA/PBS 7.5 % (w/v) albumin fraction Vin PBS
1 % BSA/PBS 1 % (w/v) albumin fraction Vin PBS
Flow Cytometry (2.4.12), CLSM (2.4.13), Signaling Reporter Assay (2.4.15)
FACS buffer 2 % (v/v) FCSin PBS
5 % BSA/FACS 5 % (w/v) albumin fraction Vin FACS buffer
FACS-fix 1 % (w/v) formalinin FACS buffer
mounting medium
4.8 g Mowiol 4-88
12 g glycerol
12 ml H2O
24 ml 0.2 M Tris pH 8.5
DAPI stain 10 µg/ml DAPIin mounting medium
Immunoblotting (2.5.7), Peptide Spot Array (2.5.8)
transfer buffer
192 mM glycine
25 mM Tris
20 % (v/v) EtOH (pure)
TBS-T
50 mM Tris
150 mM NaCl
0.1 % (v/v) Tween20
blocking buffer 2 % (w/v) milk powderin TBS-T
coumarin solution 90 mM p-coumaric acidin DMSO
luminol solution 250 mM luminolin DMSO
ECL I solution
100 mM Tris pH 8.5
396 µM coumarin
5 mM luminol
ECL II solution 100 mM Tris pH 8.50.02 % (v/v) H2O2
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Buffer/Solution Formulation
Immunoprecipitation (2.5.5)
PBS-T 0.01 % (v/v) Tween20in PBS
PBS-TT 0.5 % (v/v) Triton X-100in PBS-T
DB storage buffer
0.01 % (v/v) Tween20
0.09 % (w/v) NaN3
in PBS
lysis buffer
20 mM Tris pH 7.4
150 mM NaCl
2 mM EDTA
10 mM NaF
10 % (v/v) Triton X-100
10 % (v/v) glycerol
1 mM PMSF
lysis-T buffer 0.01 % (v/v) Tween20in lysis buffer
elution buffer (IP)
100 mM glycine
0.01 % (v/v) Tween20
0.5 % (v/v) Triton X-100
adjust to pH 2.7
Inhibition of Glycoprotein Synthesis (2.4.11)
tunicamycin 1 mg/ml tunicamycinin DMSO
Isolation of Primary NK Cells (2.4.10)
PBS/EDTA 2 mM EDTAin PBS
Protein Purification (2.5.1), Size Exclusion Chromatography (2.5.2)
dialysis buffer (IMAC)
50 mM Tris
500 mM NaCl
10 mM imidazole
adjust pH 8.0 at 4 °C
wash buffer (IMAC)
50 mM Tris
500 mM NaCl
20 mM imidazole
adjust pH 8.0 at 4 °C
elution buffer (IMAC)
50 mM Tris
500 mM NaCl
250 mM imidazole
adjust pH 8.0 at 4 °C
regeneration buffer (IMAC) 100 mM EDTA pH 8.0500 mM NaCl
Ni2+ solution (IMAC) 100 mM NiSO4
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Buffer/Solution Formulation
Protein Purification (2.5.1), Size Exclusion Chromatography (2.5.2)
Tris buffer
50 mM Tris
150 mM NaCl
adjust pH 8.0 at 4 °C
PI mix
0.5 tablet/ml complete protease
inhibitor cocktail
in PBS or Tris buffer
collection buffer (protein A) 1 M Tris pH 8.8
elution buffer (protein A) 100 mM glycine pH 2.7
regeneration buffer (protein A)
20 mM NaH2PO4
0.05 % (w/v) NaN3
adjust pH 7.4 20 mM Na2HPO4
storage buffer (protein A) 0.01 % (v/v) NaN3in PBS
SDS-PAGE (2.5.6)
SDS running buffer
25 mM Tris
192 mM glycine
0.1 % (w/v) SDS
5x SDS sample buffer (non-reducing)
300 mM Tris pH 6.8
10 % (w/v) SDS
50 % (v/v) glycerol
0.005 % (w/v) bromophenolblue
5x SDS sample buffer (reducing)
300 mM Tris pH 6.8
10 % (w/v) SDS
50 % (v/v) glycerol
0.005 % (w/v) bromophenolblue
25 % (v/v) β-mercaptoethanol
Transfection of Mammalian Cells (2.4.5), Lentiviral Particle Production (2.4.7)
TA-trans 18 mM polyethylenimine, branchedin H2O (cell culture grade)
TA-glucose 5 % (w/v) glucosein H2O (cell culture grade)
sucrose solution 20 % (w/v) sucrosein PBS
RPMI/Gln 2 mM L-glutaminein RPMI 1640
RPMI/FCS
100 U/ml penicillin
100 µg/ml streptomycin
5 % (v/v) FCS (PAA)
in RPMI/Gln
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2.1.8 Oligonucleotides
All oligonucleotides (primers) were synthesized by the company Sigma-Aldrich, and their calculated
melting temperatures (TM ) are indicated. The numbers refer to an intralaboratory primer database. Nu-
cleotides matching the annealing sequence are written in capital letters, whereas introduced nucleotides
are indicated by lowercase. Endonuclease recognition sites within the primer sequences are underlined.
Introduced His-tags are double underlined. Start and stop codons are depicted in bold.
No. Name Sequence (5’→3’) TM [°C]
001 NKp30 seq for AGGGAAGGAGGTGAGGAATG 64.2
002 NKp30 seq rev TAGAATCCAGCCCGAAGGAG 65.3
010 NKp44 seq for GAATCTACCGCCCTTCTGAC 62.5
011 NKp44 seq rev AGGGACAGGGATGGTAGATG 62.7
015 NKp46 seq for CCTGGACCCGAAGTGATCTC 65.9
016 NKp46 seq rev CCAGGCATGGTTGTTATAGG 61.7
038 pET16b seq for AGCCAACTCAGCTTCCTTTC 62.4
039 pET16b colony rev GGGAATTGTGAGCGGATAAC 63.1
041 pFastBac1 seq for ATTCATACCGTCCCACCATC 63.3
043 pFastBac1 colony rev TAGGCTCAAGCAGTGATCAG 60.7
049 pGEX-4T-1-F TATAGCATGGCCTTTGCAGG 57.3
050 pGEX-4T-1-R CGGGAGCTGCATGTGTC 57.6
052 pIRES-GFP seq for TGACGCAAATGGGCGGTAGG 72.1
053 pIRES-GFP seq rev AAGCGGCTTCGGCCAGTAAC 69.4
059 pMal-p5X seq for GATGTCCGCTTTCTGGTATG 62.0
060 pMal-p5X seq rev CGTTCACCGACAAACAACAG 64.2
061 LeGO-iG2 seq for ATGACCCTGCGCCTTATTTG 65.9
064 MultiBac colony for CGGGTGATCAAGTCTTCGTC 64.6
074 StuI NKp30 for aaggccttATGGCCTGGATGCTGTTGCTCATATC 81.5
TTG
075 NKp30-His STOP XbaI rev gctctagaTCAGTGATGGTGATGGTGATGGTGAT 85.0
GGTGATGGC
077 BamHI NKp44 for cgcggatcCATGGCCTGGCGAGCCCTACACCCAC 91.5
TGCTACTG
079 NKp44-His STOP XbaI rev gctctagaTCAGTGATGGTGATGGTGATGGTGAT 83.9
GGTGATGC
080 BamHI NKp46 for cgggatcCATGTCTTCCACACTCCCTGCCCTGCT 87.3
CTG
081 NKp46-His STOP StuI rev aaggccttTCAGTGATGGTGATGGTGATGGTGAT 85.8
GGTGATGAAGAG
117 EcoRI NKp30LBDtr for ccggaattcCTCTGGGTGTCCCAGCCCCCTGAG 86.3
118 NKp30LBDtr STOP XhoI rev ccgctcgagtcaCCCTGTCCCGACACCAAGGCCC 92.0
AGCAC
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No. Name Sequence (5’→3’) TM [°C]
119 NKp30LBDtr STOP cccaagctttcaCCCTGTCCCGACACCAAGGCCC 89.7
HindIII rev AGCAC
153 SacII/NdeI/BamHI tccccgcgggggaattccatatgcgcggatccAT 96.6
NKp30opt for GGCCTGGATGCTGCTGCTGATTCTGATTATG
236 NKp30opt-His STOP tccccgcgggggaattccatatgccttaattaat 97.3
PacI/NdeI/SacII rev cagtgatggtgatggtgatggtgatggtgatgTC
CGCCTGGGACTGGGGG
249 NKp30opt-His STOP NotI rev ttttccttttgcggccgcttttttcctttcagtg 99.4
atggtgatggtgatggtgatggtgatgTCCGCCT
GGGACTGGGGGCAGCAGATGAGCAGATGAGCC
2.1.9 Plasmids and Proteins
2.1.9.1 Plasmids
Unless otherwise denoted, all plasmids used were amplified using the Escherichia coli (E. coli) strain
DH5α. Indicated numbers refer to an intralaboratory plasmid database. The corresponding plasmid
maps (7.2) are provided in the appendix.
No. Expression Plasmid (E. coli) Selection Supplier
101 pUC57-NKp30-His AmpR GenScript
102 pUC57-NKp44-His AmpR GenScript
103 pUC57-NKp46-His AmpR GenScript
108 pUC57-NKp30LBDtr-TEV-His AmpR GenScript
109 pUC57-His-TEV-NKp30LBDtr AmpR GenScript
114 pUC57-gp67ss-NKp30LBD-Stalk-TEV-His AmpR GenScript
117 pUC57-NKp30opt AmpR GenScript
127 pUC57-gp67ss-NKp30LBD-TEV-His AmpR GenScript
1901 pET16b-His-TEV-NKp30LBDtr AmpR this thesis
1902 pET16b-NKp30LBDtr-TEV-His AmpR this thesis
2105 pGEX-4T-1-NKp30LBDtr AmpR this thesis
3301 pMAL-p5X-NKp30LBDtr AmpR this thesis
No. Expression Plasmid (Mammalian Cells) Selection Supplier
48 pIRES2-EGFP KanR/GFP Clontech
4805 pIRES2-NKp30opt-His-EGFP KanR/GFP this thesis
813 pcDNA3.1-TNFss-B7-H6-hIgG1-Fc AmpR/NeoR A. Cohnenh
hThe plasmidwas kindly provided byA. Cohnen in the lab of C.Watzl at the Leibniz Research Centre forWorking Environment
and Factors, Dortmund, Germany.
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No. Expression Plasmid (Lentiviral Particles) Selection Supplier
49 LeGO-iG2 AmpR/GFP [205]
4901 LeGO-NKp30opt-His-iG2 AmpR/GFP this thesis
No. Packaging Plasmid (Lentiviral Particles) Selection Supplier
30 pCMV-∆R8.91 AmpR [206]
31 pMD2.G AmpR [207]
No. Expression Plasmid (Insect Cells) Selection Supplier
308 pFastBac1-gp67ss-NKp30LBD-Stalk-TEV-His AmpR/GentR this thesis
315 pFastBac1-gp67ss-NKp30LBD-TEV-His AmpR/GentR this thesis
No. Multigene Transfer Vector (Insect Cells) Selection Supplier
401 pFL-NKp30-His AmpR/GentR J. Hartmanni
501 pSPL-NKp44-Hisj SpecR S. Beyerk
601 pUCDM-NKp46-Hisj CamR J. Hartmanni
2007 pFL-NKp30-His/pSPL-NKp44-His/ AmpR/GentR/ J. Hartmanni
pUCDM-NKp46-His SpecR/CamR
2.1.9.2 Proteins
Indicated numbers refer to the plasmid haboring the corresponding DNA sequence. The theoretical
molecular mass (MW) of monomeric proteins without secretion sequence or post-translational modi-
fication are denoted. The corresponding protein sequences (7.3) are listed in the appendix.
No. Expression in E. coli MW kDa Supplier
1901 His-TEV-NKp30LBDtr 13.9 this thesis
1902 NKp30LBDtr-TEV-His 13.9 this thesis
2105 GST-NKp30LBDtr 37.9 this thesis
3301 MBP-NKp30LBDtr 58.1 this thesis
MICA*04-His 32.0 S. Weill
No. Expression in Mammalian Cells MW kDa Supplier
4805/4901 NKp30opt-His 22.9 this thesis
813 B7-H6-Ig 52.9 this thesish
iThe plasmid was kindly provided by J. Hartmann in the lab of J. Koch at the Georg-Speyer-Haus, Frankfurt am Main, Ger-
many.
jThis multigene transfer vector was amplified using the E. coli strain BW23473.
kThe plasmid was kindly provided by S. Beyer in the lab of J. Koch at the Georg-Speyer-Haus, Frankfurt am Main, Germany.
lThe protein was kindly provided by S. Weil in the lab of J. Koch at the Georg-Speyer-Haus, Frankfurt am Main, Germany.
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No. Expression in Insect Cells MW kDa Supplier
401 NKp30-His 22.9 this thesisi
501 NKp44-His 32.0 this thesisk
601 NKp46-His 35.9 this thesisi
2007 NKp30-His/NKp44-His/NKp46-His this thesisi
308 NKp30LBD-Stalk-His 16.6 this thesis
315 NKp30LBD-His 15.0 this thesis
2.2 Methods of Microbiology
2.2.1 Cultivation of Bacteria
All of the used E. coli strains were either K-12 strain or B strain derivatives. K-12 strains were originally
developed as cloning hosts and mainly used for plasmid amplification in vitro. They are usually recA
mutants. The recA mutation keeps E. coli hosts from recombining homologous sequences of DNA in
genomic clones. In contrast, for gene overexpression E. coli strains with recA function (e.g. BL21
(DE3)) were used.
E. coli cultures were grown in LB medium overnight at 37 °C and 200 rpm in a bacteria shaker. For
the cultivation on LB agar plates, the bacteria suspension was applied onto the plates prior to overnight
incubation at 37 °C. To select for resistent bacteria, the LB medium or LB agar was supplemented with
the relevant antibiotics and additives listed in Tab. 1 [198].
Tab. 1: Antibiotics and additives for selection of resistant bacteria
Antibiotic/Additive Stock concentration End concentration Solvent
Ampicillin 100 mg/ml 100 µg/ml H2O
Chloramphenicol 34 mg/ml 30 µg/ml 70 % (v/v) EtOH
Gentamycin 50 mg/ml 10 µg/ml H2O
Kanamycin 50 mg/ml 50 µg/ml H2O
Spectinomycin 50 mg/ml 50 µg/ml H2O
Tetracycline 10 mg/ml 10 µg/ml 70 % (v/v) EtOH
Zeocin 100 mg/ml 100 µg/ml H2O
IPTG 280 mg/ml 120 µg/ml H2O
X-gal 20 mg/ml 500 µg/ml DMSO
Cultivated bacteria suspensions can be stored for up to one week and bacteria plates for up to one month
at 4 °C. For long-term storage of bacterial strains glycerol stocks are recommended. 1.5 ml of bacteria
suspension were centrifuged for 5 min at 500x g. The bacteria cell pellet was resuspended in 1 ml of cryo
culture medium consisting of 50 % (v/v) sterile glycerol and 50 % (v/v) LB medium supplemented with
the respective antibiotics and stored at -80 °C.
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2.2.2 Generation and Transformation of Rb-Competent Bacteria
The easiest way to amplify plasmid DNA is by cellular replication in E. coli. Via a process called trans-
formation bacteria take up surrounding plasmid DNA. Since this process does not occur naturally in
E. coli strains, the bacteria have to be pretreated to become competent for the introduction of foreign
DNA. Chemically competent bacteria were generated by the CaCl2/RbCl method [208]. 100 ml of LB
medium were inoculated with 2 ml of an E. coli suspension culture and incubated at 37 °C and 200 rpm
in a bacteria shaker until reaching an OD600=0.4-0.6. After incubation on ice for 10 min, the culture was
centrifuged (2,000x g, 10 min, 0 °C). The bacteria cell pellet was resuspended in 7.5 ml of sterile filtered,
ice cold TFB I buffer and incubated for 1 h on ice. After centrifugation (3,000x g, 10 min, 0 °C), the
bacteria pellet was resuspended in 2 ml of sterile filtered, ice cold TFB II buffer. 50 µl aliquots were
shock frozen in liquid nitrogen and stored at -80 °C.
To transform Rb-competent E. coli, one aliquot of bacteria was thawed on ice. Approximately 50 ng
of plasmid DNA or 10 µl of ligation reaction (2.3.3) were added and mixed gently prior to incubation on
ice for 20 min. After a heat shock (90 s, 42 °C), the cells were incubated on ice for 3 min. 500 µl of LB
medium were added to the transformation reaction and incubated at 37 °C and 600 rpm for 60 min. The
bacteria suspension was plated on LB agar supplemented with the respective antibiotics and additives
(Tab. 1) and incubated overnight at 37 °C.
2.3 Methods of Molecular Biology
2.3.1 Plasmid Preparation
Plasmid DNA was prepared from bacteria suspension cultures using the GeneJET Plasmid Miniprep
kit (mini preparation) or the NucleoBond Xtra Midi/Maxi kit (midi or maxi preparation). The basic
principle of these kits is the alkaline lysis of the bacteria cells, neutralization and subsequent precipitation
of proteins and genomic DNA. Plasmid DNA bound to silica gel membranes in the presence of a high
concentration of chaotropic salts is eluted by water or an appropriate buffer.
For purification of low amounts of plasmid DNA (mini preparation), 3 ml of LB selection medium
(Tab. 1) were inoculated with one bacteria colony and incubated overnight at 37 °C and 200 rpm. 2 ml of
bacteria suspension were pelleted (14,000x g, 30 s, 4 °C) and used for the preparation of plasmid DNA
according to the manufacturer’s instructions. The plasmid DNA was eluted with 50 µl of pre-warmed
H2O (50 °C).
To extract larger amounts of plasmid DNA (midi or maxi preparation) 100-1000 ml of LB selection
medium (Tab. 1) were inoculatedwith one bacteria clone or a 2ml preparative culture of one bacteria clone
prior to overnight incubation at 37 °C and 200 rpm. The suspension culture was harvested (9000x g, 5min,
4 °C), and the bacteria cell pellet was used for the plasmid preparation according to the manufacturer’s
instructions. Precipitated and dried plasmid DNA was reconstituted in 0.1-1 ml of pre-warmed H2O
(50 °C). Throughout this thesis, all plasmid DNA preparations were performed according to the high
copy protocol. The concentration of isolated plasmid DNA was determined photometrically (2.3.8).
28
Materials and Methods
2.3.2 Polymerase Chain Reaction
The polymerase chain reaction (PCR) is a method to exponentially and specifically amplify deoxyribonu-
cleic acid (DNA) sequences from different origins such as plasmid or genomic DNA in vitro [209, 210].
This method is based on the ability of thermostable DNA polymerases to synthesize a new strand of DNA
by using single stranded DNA (template) and oligonucleotides (primers), complementary to the offered
template DNA, as an initiation point. Under appropriate reaction conditions, the primers hybridize to the
template DNA, and the DNA polymerase amplifies the DNA fragment in sense (forward) or anti-sense
(reverse) orientation by adding nucleotides onto the pre-existing 3’-OH group of the oligonucleotides.
PCR is a thermal cycling process that starts with denaturation by high temperature, which leads to the
dissociation of the double-stranded DNA. Lowering to moderate temperature enables the primers to hy-
bridize to the complementary single-stranded template DNA (annealing). Elongation of the annealed
primers is initiated by an increase to the working temperature of the DNA polymerase. Since the elonga-
tion products are also used as templates in the next cycles, there is an exponential increase of amplified
DNA fragment mainly dependent on the number of cycles. By respective primer engineering (e.g. intro-
duction of endonuclease restriction sites, point mutations, or addition of nucleotides) PCR can further be
used to alter the amplified sequence or to append new sequence information. Moreover, colony PCR is an
application by which to quickly determine if bacteria clones contain the gene of interest by investigating
bacterial cells instead of plasmid DNA. Since it is not necessary to amplify the whole gene of interest
and moreover, one to five colonies can be used as template in one reaction, it is possible to analyze huge
sets of clones in a short time.
In this thesis, the thermostable DNA polymerases Phusion and DreamTaq were used. The Phusion
polymerase is able to reduce the error rate by its 3’-5’ exonuclease activity (also known as proof-reading)
andwas therefore used for preparative DNA amplification for subsequent cloning. In contrast, theDream-
Taq polymerase has no proof-reading activity and was used for analytical approaches. For optimal reac-
tion conditions, the annealing temperature and the elongation time had to be adjusted for each individual
PCR dependent on the primer melting temperature (TM ) and the extension time, respectively. Generally,
an annealing temperature about 5 °C below the lowest primer melting temperature TM (at best at 55 °C)
was used. The elongation time depended on the length of the amplified DNA fragment and the used
DNA polymerase (Phusion: 15 s/kb at 72 °C; DreamTaq: 1 min/kb at 72 °C). The deoxyribonucleosidt-
riphosphate (dNTP) mix containing 10 mM of each dNTP (dATP, dCTP, dGTP, dTTP) was obtained
from Thermo Scientific, all buffers and additives were supplied with the respective polymerase. After
the preparative amplification for subsequent cloning, the DNA fragments were purified using the Gene-
JET Gel Extraction kit (2.3.7.2), and the DNA concentration of the isolated fragments was determined
photometrically (2.3.8). To investigate a huge set of clones by colony PCR, subsequent colony PCRs
were performed using one to five colonies within one reaction. After identification of reaction mixtures
containing the PCR fragments of the desired size, the corresponding colonies were again analyzed using
only one colony per reaction to obtain single positive clones. PCR reactions containing the amplified
DNA fragment were identified by agarose gel electrophoresis (2.3.6). Standard reaction mixtures and
PCR protocols for preparative (Tab. 2) and analytical PCR (Tab. 3) are depicted.
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Tab. 2: Standard reaction mix and protocol for a PCR with the Phusion polymerase
Reaction mix PCR protocol
20 ng template DNA
0.5 µM forward primer 98 °C 30 s initial denaturation
0.5 µM reverse primer 98 °C 10 s denaturation
0.2 mM dNTP mix 55 °C 15 s 35x annealing
3 % (v/v) DMSO 72 °C 30 s elongation (for <2 kb)
2.5 mM MgCl2 72 °C 5 min final elongation
1x GC buffer 16 °C ∞
0.02 U/µl Phusion
ad to 100 µl with H2O
Tab. 3: Standard reaction mix and protocol for a colony PCR with the DreamTaq polymerase
Reaction mix PCR protocol
1-5 bacterial colonies
1 µM forward primer 98 °C 30 s initial denaturation
1 µM reverse primer 98 °C 10 s denaturation
0.2 mM dNTP mix 55 °C 15 s 25x annealing
2.5 % (v/v) DMSO 72 °C 30 s elongation (for <500 bp)
1x green buffer 72 °C 5 min final elongation
0.025 U/µl DreamTaq 16 °C ∞
ad to 25 µl with H2O
2.3.3 Enzymatic Restriction, Dephosphorylation, and Ligation of DNA
2.3.3.1 Enzymatic Restriction of DNA
Restriction endonucleases are able to bind DNA and are commonly classified into three types. These dif-
fer in their structure andwhether they cut their DNA substrate at their recognition site, or if the recognition
and cleavage sites are separated from one another. For molecular cloning, conventional type II restric-
tion endonucleases are used since they recognize and cleave the DNA at the same site. Most of these
enzymes only require Mg2+ as cofactor. The recognition sites are usually palindromic, 4-8 nucleotides
in length and differ for every restriction endonuclease. According to the position of the double-stranded
cut, restriction endonucleases can produce either blunt ends (no nucleotide overhang) or sticky ends
(with nucleotide overhang). Unless otherwise noted, all DNA restrictions were performed according to
the manufacturer’s instructions using FastDigest restriction endonucleases from Thermo Scientific. All
used enzymes with their recognition sequences and cutting patterns are listed in Table 4.
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Tab. 4: Recognition sequences and cutting patterns of applied type II restriction endonucleases
Cutting sites are indicated by vertical lines.
Enzyme Recognition Sequence Enzyme Recognition Sequence
BamHI 5’…G|GATCC…3’ SalI 5’…G|TCGAC…3’3’…CCTAG|G…5’ 3’…CAGCT|G…5’
EcoRI 5’…G|AATTC…3’ StuI 5’…AGG|CCT…3’3’…CTTAA|G…5’ 3’…TCC|GGA…5’
HindIII 5’…A|AGCTT…3’ XbaI 5’…T|CTAGA…3’3’…TTCGA|A…5’ 3’…AGATC|T…5’
NotI 5’…GC|GGCCGC…3’ XhoI 5’…C|TCGAG…3’3’…CGCCGG|CG…5’ 3’…GAGCT|C…5’
For a preparative restriction reaction (Tab. 5), 1-5 µg of DNA were used. In general, double digests
were performed using the supplied FastDigest buffer. The reaction mixtures were incubated for 25 min
at 37 °C, followed by enzyme inactivation for 10 min at 80 °C. The restriction samples were either first
subjected to agarose gel electrophoresis (2.3.6) or directly purified using the GeneJET Gel Extraction
kit (2.3.7). For analytical restriction reactions (Tab. 5), 0.5-1 µg of DNA were used. For all enzyme
combinations, the supplied FastDigest green buffer was applied. The reaction mixtures were incubated
for 10 min at 37 °C, followed by enzyme inactivation for 10 min at 80 °C. The restriction samples were
analyzed by agarose gel electrophoresis (2.3.6).
Tab. 5: Standard restriction reaction for preparative and analytical applications
For preparative reactions the 10x FastDigest buffer and for analytical reactions the 10x FastDigest green buffer
were used.
Preparative Restriction Analytical Restriction
DNA 1-5 µg 0.5-1 µg
restriction buffer 5 µl 2 µl
restriction enzyme I 2.5 µl 0.5 µl
restriction enzyme II 2.5 µl 0.5 µl
ad with H2O to 50 µl to 20 µl
2.3.3.2 Enzymatic Dephosphorylation of DNA
Enzymatic restriction of DNA generates phosphorylated 5’ ends and hydroxylated 3’ ends. For ligation
of two DNA fragments (2.3.3.3) only one phosphorylated 5’ end is required. To enhance ligation speci-
ficity by reducing the recircularisation capability of the vector DNA, the 5’ ends of the linearized vector
DNA were enzymatically dephosphorylated by an alkaline phosphatase. The phosphorylated 5’ end for
DNA ligation is provided by the insert DNA. A standard dephosphorylation mix consisted of 1-5 µg of
linearized vector DNA, 5 µl of 10x FastAP buffer (supplied with the enzyme), and 1 µl of FastAP ther-
mosensitive alkaline phosphatase. The sample was adjusted to 50 µl with H2O and incubated for 10 min
at 37 °C, followed by enzyme inactivation for 5 min at 75 °C. The dephosphorylated DNA was purified
with the GeneJET Gel Extraction kit (2.3.7.2).
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2.3.3.3 Enzymatic Ligation of DNA
DNA ligases facilitate the joining of two DNA strands by catalyzing the formation of a phosphodiester
bond between a 5’ phosphate and a 3’ hydroxyl group under consumption of ATP. The joining of DNA
is usually performed by ligation of double-stranded nucleic acid molecules digested with the same re-
striction endonucleases. Since the ligation process is initiated by the annealing of the respective DNA
fragments, the ligation efficiency decreases with less nucleotide overhang. To improve the ligation effi-
ciency especially for blunt-end ligations, the reactions could be carried out by overnight incubation with
an increasing temperature gradient from 0 °C to room temperature. One of the most frequently used DNA
ligases in molecular biology is the T4 DNA ligase isolated from the bacteriophage T4.
For the ligation of two DNA fragments a three-fold molar excess of insert to vector DNA was applied.
The total amount of DNA for one ligation reaction was limited to 100 ng, therefore generally 50 ng of
vector DNA were used. The required amount of insert DNA for one ligation reaction was calculated
according to the following equation:
insertDNA (ng) = molar excess× insertDNA (bp)× vector DNA (ng)
vector DNA (bp)
A standard ligation reaction (Tab. 6) was incubated for 60 min at 22 °C in a thermoblock (Eppendorf),
followed by enzyme inactivation for 10min at 65 °C. The 10x T4DNA ligase buffer was supplied with the
enzyme (Thermo Scientific). The ligated DNA was either used directly for transformation of competent
bacteria (2.2.2) or stored at -20 °C.
Tab. 6: Standard DNA ligation reaction
The amount of required insert DNA was calculated for each reaction.
DNA Ligation
insert DNA molar excess of vector DNA
vector DNA 50 ng
10x T4 ligase buffer 2 µl
T4 DNA ligase 5 U
ad with H2O to 20 µl
2.3.4 Multigene Transfer Vector Assembly by In Vitro Cre fusion
Multiprotein interaction studies in a heterologous expression system are challenging due to the low ef-
ficiency of simultaneous introduction of two or more foreign DNAs. Moreover, conventional protein
expressionmethods do not provide enough flexibility to alter the multiprotein composition after biochem-
ical analyses. To address this, Berger and colleagues [197] introduced the MultiBac system, a modular
baculovirus-based system specifically designed for eukaryotic multiprotein expression. Two years later,
new transfer vectors and a combination of DNA recombination-based methods were published [198],
which further facilitate the generation of multigene cassettes for protein co-expression (Fig. 4). The
genes of interest are inserted into a suite of compatible donor and acceptor transfer vectors by conventional
cloning. These progenitor constructs are then joined in the desired combination byCre-loxP recombinase-
mediated in vitro plasmid fusion. Acceptor and donor plasmids all contain the loxP imperfect inverted
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repeat. In contrast to the donor plasmids, the acceptor plasmids and their derivatives additionally contain
elements of the Tn7 transposon. Therefore, derivatives of one acceptor plasmid can be fused to one or
two donor plasmids creating multigene plasmid dimers or trimers, respectively. The integration of the
resulting multigene expression cassettes into the MultiBac baculovirual genome (bacmid), which relies
on Tn7 transposition, is carried out in vivo in E. coli cells suitable for this purpose.
In this thesis, the DNA sequences encoding for the three NCRs NKp30, NKp44 and NKp46, each
fused to a C-terminal deca-histidine tag (His-tag), were integrated into one MultiBac bacmid for the
recombinant co-expression in insect cells. The DNA sequence encoding for NKp30-His was cloned
into the acceptor plasmid pFL, whereas the sequences encoding for NKp44-His and NKp46-His were
introduced into the donor plasmids pSPL and pUCDM, respectively (7.2). The vector assembly to the
multigene plasmid trimer pFL-30-His/pSPL-NKp44-His/pUCDM-NKp46-His was generated by in vitro
fusion (Fig. 4).
Fig. 4:Multigene transfer vector assembly by in vitro Cre fusion.
The acceptor plasmid pFL-NKp30-His and the donor plasmids pSPL-NKp44-His and pUCDM-NKp46-His, which
all contain the loxP imperfect inverted repeat (gray circles), were fused in vitro to one multigene plasmid trimer
using the Cre recombinase. Therefore, the generated multigene plasmid trimer contains NKp30-His, NKp44-His,
and NKp46-His (red arrows) as well as the respective antibiotic resistance genes (GentR, violett box, SpecR, orange
box, and CamR, green box). Expression cassettes in between the Tn7 transposition sequences (black square, Tn7R
→ Tn7L) are integrated into the MultiBac baculovirus genome. Adapted from Fitzgerald et al. (2006) [198].
The plasmid fusion reaction was set up in a 10 µl reaction mix with individual donor and acceptor plasmid
amounts of≈ 500 ng and 1 U of Cre recombinase using the supplied buffer (New England Biolabs). The
reaction mixture was incubated for 30 min at 37 °C in a thermoblock (Eppendorf), followed by enzyme
inactivation for 10 min at 70 °C. 1-5 µl of the Cre recombinase reaction products were directly used for
transformation of competent bacteria (2.2.2). Positive transformants were selected based on the resistance
marker combination.
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Tab. 7: Standard Cre recombinase reaction
DNA Ligation
H2O 2 µl
10x Cre recombinase reaction
buffer
1 µl
Acceptor plasmid (500 ng) 2 µl
Donor plasmid A (500 ng) 2 µl
Donor plasmid B (500 ng) 1 µl
Cre recombinase 1 µl
Tab. 8: Features of the MultiBac acceptor and donor plasmid derivatives.
Vector Marker Host Strain Element Usage
pFL AmpR DH5α loxP, acceptor for plasmid fusions,
GentR TnL7, TnLR integration in MultiBac Tn7 site
pSPL SpecR BW23473 loxP donor for plasmid fusions,
integration in MultiBac loxP site
pUCDM CamR BW23473 loxP donor for plasmid fusions,
integration in MultiBac loxP site
Fig. 5: Integration of the NKp30-His expression cassette into the DH10EmBacY genome
Upon transformation of E. coli DH10EmBacY with the acceptor plasmid pFL-NKp30-His, the expression
cassette in between the Tn7 transposition sequences Tn7R and Tn7L is integrated into the bacmid genome via
the mini-attTn7 site. Since the mini-attTn7 site is located within the lacZ gene, successful transposition can be
identified by blue-white selection. E. coli DH10EmBacY has stably integrated the gene encoding eYFP (yellow
box) as protein expression marker. Both, eYFP and NKp30-His expression are under the control of a polyhedrin
promoter polh. Adapted from Berger et al. (2004) [197].
2.3.5 Generation of Bacmid DNA
The baculovirus expression vector system (BEVS) is used in research for the production of high levels of
properly post-translationally modified (folding, disulfide bond formation, oligomerization, glycosylation,
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acylation, proteolytic cleavage), biologically active and functional recombinant proteins [211,212]. Bac-
uloviruses are rod-shaped dsDNA viruses found mainly in insects. The most common baculovirus used
for expression studies is Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV), which
relies on the lepidopteran species Spodoptera frugiperda and Trichoplusia ni as host insects. AcMNPV
particles surround themselves with a protectivematrix consisting of the protein polyhedrin, which is under
the control of the extremely strong and late promoter polh, resulting in up to 50 % of all cellular protein at
the end of the baculovirus life cycle. However, in cell culture the polyhedrin coat is not essential for virus
propagation and thus heterologous proteins can be expressed under the control of the polh promoter [213].
Therefore, the gene of interest is transferred from a donor plasmid to cloned AcMNPV-DNA (bacmid)
in E. coli DH10Bac via specific transposition with the use of a helper plasmid (Fig. 5), also known as
Bac-to-Bac system [214]. This recombinant baculovirus-DNA can replicate in E. coli and is infectious
for lepidopteran cells. In this thesis, E. coliDH10EmBacY was used. Berger and colleagues stably intro-
duced the gene encoding eYFP into the bacmid genome under control of the polyhedrin promoter polh,
which is used as protein expression marker [197, 198]. To introduce the donor plasmid containing the
gene of interest, E. coli DH10EmBacY were transformed using 100 ng of plasmid DNA adjusted with
deionized, sterile filtered (0.22 µm) water to a final volume of 5 µl. Therefore, a 50 µl aliquot of cells
was thawed on ice, gently mixed with plasmid DNA (without pipetting), and incubated for 30 min on
ice. The heat shock was performed for 45 s at 42 °C prior to incubation on ice for 2 min. 900 µl of LB
medium were added, and the transformation mix was incubated for 4 h at 37 °C and 600 rpm. A dilution
series of the bacteria suspension (pure, 1:10, 1:100, 1:1,000) was plated on LB agar supplemented with
the respective antibiotics and additives (Kan, Tet, Gent, IPTG, X-gal, listed in Tab. 1), and incubated for
24-48 h at 37 °C to perform blue-white selection. Blue colonies contained the donor plasmids, whereas
white colonies integrated the gene of interest into the bacmid genome. To ensure correct discrimination
between blue and white colonies, one blue colony (negative control) and up to ten white colonies were
replated on LB selection agar and incubated again for 24 h at 37 °C. 4 ml of LB medium supplemented
with the appropriate antibiotics (Kan, Tet, Gent) were inoculated with one white colony and incubated
overnight at 37 °C and 200 rpm in a bacteria shaker. The cells were pelleted (9,000x g, 5 min, 4 °C), and
stored at -20 °C or transferred into a 2 ml reaction tube for bacmid preparation. Therefore, 300 µl of solu-
tion 1 to 3 of the NucleoBond Xtra Midi/Maxi kit were used according to the manufacuter’s instructions.
After neutralization, the suspension was centrifuged (14,000x g, 10 min, 4 °C) two to three times, each
time transferring the supernatant into a new reaction tube. The bacmid DNA was precipitated from the
cleared lysates by mixing with 700 µl of isopropyl alcohol, pelleted (14,000x g, 10 min, 4 °C), washed
with 500 µl of 70 % (v/v) EtOH (pure), and thereby transferred into a new 1.5 ml reaction tube. The
DNA pellet was dried and gently reconstituted using the appropriate amount (50-100 µl) of pre-warmed
(50 °C) deionized, sterile filtered (0.22 µm) water. Intensive pipetting was avoided to prevent fragmen-
tation of the large genomic bacmid DNA. The concentration of isolated bacmid DNA was determined
photometrically (2.3.8). Bacmid DNA was stored at 4 °C until it was used for transfection.
2.3.6 Agarose Gel Electrophoresis
Agarose gel electrophoresis is a method for separation and analysis of DNA (or RNA) molecules based
on their size. DNA molecules are negatively charged due to their phosphate backbone. Therefore, they
migrate from the cathode to the anode after applying an electric current in the agarose gel. Since poly-
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merized agarose acts as a molecular sieve, the migration speed of each DNAmolecule is dependent on its
size. Small DNA fragments migrate faster through the agarose matrix than large fragments, thereby sep-
arating from one another. The applied agarose concentration depends on the size of the DNA fragments
to be analyzed; most agarose gels are made with between 0.7 % (w/v) (good resolution of large 5-10 kb
DNA fragments) and 2 % (w/v) (good resolution of small 0.2-1 kb DNA fragments) agarose dissolved in
electrophoresis buffer.
In this thesis, 0.8 % (w/v) agarose gels were used for separation of fragments >1 kb, whereas 1.2-
2 % (w/v) agarose gels were applied for smaller DNA fragments. The gels were produced by adding
the respective amount of agarose in TAE buffer. After heating, the emulsion in a microwave oven until
the solid agarose dissolved, the agarose solution was casted into a tray to polymerize. Unless DNA
samples did not already contain DreamTaq green buffer (2.3.2) or FastDigest green buffer (2.3.3), DNA
samples were supplemented with 6x DNA loading dye (Thermo Scientific) and applied to the agarose gel.
GeneRuler 1 kb Plus DNA ladder (Thermo Scientific) was used as size standard. The electrophoresis was
performed at 160 V for approximately 45 min in a WIDE MINI-SUB cell GT chamber (Bio-Rad) filled
with TAE buffer. Since ethidium bromide (EtBr) intercalates between DNA strands and can be visualized
under UV light (254 nm), agarose gels were incubated for 15 min in EtBr stain. DNA fragments were
detected and photographically documented using a Gel Doc 2000 gel documentation system (Bio-Rad).
2.3.7 Isolation of DNA from Agarose Gels, Purification of DNA
2.3.7.1 Isolation of DNA from Agarose Gels
After the separation by agarose gel electrophoresis (2.3.6), DNA fragments can be isolated from the
gel matrix for subsequent cloning. Since long exposure with short-wave (high intensity) UV light can
damage the DNA, agarose gels used for DNA isolation were exposed with long-wave (low intensity) UV
light (302 nm). After electrophoretic separation, the agarose gel was cut as close as possible around the
respective DNA fragment to decrease impurities or the loss of DNA, and transferred into a 2.0 ml tube.
The purification was performed using the GeneJET Gel Extraction kit according to the manufacturer’s
instructions. The DNA containing agarose fragment was melted in a buffer with high concentration of
a chaotropic salt, which allows for the binding of the DNA to silica gel membranes. To elute the DNA
from the silica gel membrane, 50 µl of H2O (50 °C) were used, followed by the determination of the
DNA concentration (2.3.8).
2.3.7.2 Purification of DNA
To prepare the DNA for subsequent applications, enzymes and disturbing buffer components after PCR
(2.3.2), restriction (2.3.3.1), or dephosphorylation (2.3.3.2) were removed using the GeneJETGel Extrac-
tion kit according to the manufacturer’s instructions. The DNA fragments bind to silica gel membranes
in the presence of a chaotropic salt. Thus, all enzymes are removed while the DNA is retained and can be
eluted with water or appropriate buffers. DNA fragments derived from restriction or dephosphorylation
reactions were eluted in 50 µl of pre-warmed H2O (50 °C). DNA fragments from PCR reactions were
eluted in one-fifth of the original volume. The concentration of purified DNA fragments was determined
photometrically (2.3.8).
36
Materials and Methods
2.3.8 Determination of DNA Concentration
The spectrophotometric quantitation of nucleic acids, which is based on the absorbance of UV light (Amax
= 260 nm) by the purine and pyrimidine bases of the DNA, is performed to determine the purity and the
average concentration of DNA present in a mixture. Using the Lambert-Beer law it is possible to relate
the amount of light absorbed to the concentration of the absorbing molecule. The ratio of the absorbance
260/280 nm is commonly used to assess the purity of the DNA, since aromatic amino acids of proteins
absorb UV light at 280 nm. Pure DNA possesses a value of roughly 1.8.
In this thesis, the spectrophotometric quantitation of DNA was performed with a NanoDrop ND 1000
(PeqLab Biotechnologie). To assess the DNA concentration and purity, the UV absorbance spectrum
between 220 nm and 300 nm of 1-2 µl of isolated DNA either from plasmid preparation (2.3.1), DNA
purification (2.3.7.2), or agarose gel extraction (2.3.7.1) was measured. H2O was used as blank, since all
DNA samples were dissolved in water.
2.3.9 Nucleic Acid Sequencing
Nucleic acid sequencingwas performed by sequencing service from the companyGATCBiotech (Cologne,
Germany) using the chain-termination method developed by Sanger [215]. For this purpose, sequencing
samples containing 5 µl of DNA (80-100 ng/µl) and 5 µl of the respective primer (5 pmol/µl) were pre-
pared in a 1.5 ml reaction tube. A standard sequencing run is able to sequence up to 600 bp of the DNA
sample proceeding from the primer binding region.
2.3.10 Cloning Strategies
For the following cloning processes, the full-length sequence of the human NCR3 gene or variants were
synthesized de novo either with wild type (wt) or codon-optimized (opt, indicated) codon usage by the
company GenScript. The synthesized genes were delivered in pUC57 plasmids and served as templates
for PCR amplification (2.3.2) or subsequent cloning (2.3.3). All used oligonucleotides with their corre-
sponding numbers are listed (2.1.8), and the generated constructs were verified by nucleotide sequencing
(2.3.9). The corresponding plasmid maps (7.2) and protein sequences (7.3) are listed in the appendix.
2.3.10.1 Full-Length NKp30-His Constructs for Expression in Mammalian Cell Lines
To investigate self-assembly ofNKp30 or interactionwith other cell surfacemolecules, full-lengthNKp30
with a C-terminal deca-histidine tag (His-tag) for detection was generated for the transient introduction
into NKp30 negative mammalian cell lines. For this purpose, the primer combinations 153/236 (listed
in 2.1.8) and pUC57-NKp30opt (plasmid 117, listed in 2.1.9.1) as template were used to introduce en-
donuclease recognition sites as well as the His-tag by PCR (2.3.2). The amplified DNA fragment was
enzymatically digested using SacII (2.3.3.1). After purification (2.3.7.2) of the digested and dephos-
phorylated (2.3.3.2) expression vector pIRES2-EGFP (Clontech, 5308 bp), the purified NKp30opt-His
encoding DNA fragment (689 bp) was enzymatically ligated (2.3.3.3) generating pIRES-NKp30-His-
EGFP (plasmid 4805). Positive clones with correct insert orientation were identified by colony PCR
using the primer combinations 052/236 or 153/053. For nucleotide sequencing (2.3.9), the primers 052
and 053 were applied.
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For stable integration of the full-length NKp30-His by lentiviral particles into NKp30 negative mam-
malian cell lines, the NKp30-His encoding DNA fragment was introduced into the transfer vector LeGO-
iG2 ( [205]). Therefore, the primer combinations 153/249 and pUC57-NKp30opt (plasmid 117) as tem-
plate were used to introduce endonuclease recognition sites as well as the His-tag by PCR. The amplified
DNA fragment was enzymatically digested using BamHI and NotI. After purification of the digested and
dephosphorylated transfer vector LeGO-iG2 (7771 bp), the purified NKp30opt-His encoding DNA frag-
ment (653 bp) was enzymatically ligated generating LeGO-NKp30optHis-iG2 (plasmid 4901). Positive
clones were identified by colony PCR using the primer combination 061/053. For nucleotide sequencing,
the same oligonucleotides were applied.
2.3.10.2 Constructs for Co-Expression of NKp30, NKp44, and NKp46 in Insect Cells
Multiprotein interaction studies in a heterologous expression system are challenging due to the low ef-
ficiency of simultaneous introduction of two or more foreign DNAs. To analyze the possible cross-talk
between the NCRs NKp30, NKp44, and NKp46 in a non-immunological background, the MultiBac sys-
tem was applied to introduce the genetic information of all three NCRs simultaneously into insect cells
using baculoviral particles. For this purpose, monomeric acceptor (pFL-NKp30-His (plasmid 401)) and
donor plasmids (pSPL-NKp44-His (plasmid 501), pUCDM-NKp46-His (plasmid 601), listed in 2.1.9.1)
were generated prior to combination via in vitro Cre fusion (2.3.4). To generate the MultiBac accep-
tor plasmid pFL-NKp30-His, the primer combinations 074/075 (listed in 2.1.8) and pUC57-NKp30-His
(plasmid 101) as template were used to introduce endonuclease recognition sites by PCR. The amplified
DNA fragment was enzymatically digested using StuI and XbaI (2.3.3.1). After purification of the di-
gested and dephosphorylated (2.3.3.2) transfer vector pFL ( [197,198], 5410 bp), the purified NKp30-His
encoding DNA fragment (641 bp) was enzymatically ligated. Positive clones were identified by colony
PCR using the primer combination 001/002. To generate the MultiBac donor plasmids pSPL-NKp44-His
and pUCDM-NKp46-His, the primer combinations 077/079 or 080/081, respectively, as well as the ap-
propriate template pUC57-NKp44-His (plasmid 102) or pUC57-NKp46-His (plasmid 103) were used to
introduce endonuclease recognition sites by PCR. The amplified DNA fragment was enzymatically di-
gested using BamHI and XbaI or BamHI and StuI. After purification of the digested and dephosphorylated
transfer vectors pSPL (2786 bp) and pUCDM (2947 bp) [197,198], the purified NKp44-His (867 bp) and
NKp46-His (954 bp) encoding DNA fragments were enzymatically ligated. Positive clones were iden-
tified by colony PCR using the primer combination 010/011 or 015/016, respectively. For nucleotide
sequencing, the oligonucleotides 064 and 001, 010 or 015 were applied (2.3.9).
2.3.10.3 NKp30 Ligand Binding Domain Constructs for the Expression in Escherichia coli
The 3D structure of the NKp30 ligand binding domain had not been solved until 2011 [116,117]. There-
fore, a de novo model of the NKp30 ligand binding domain, based on structural homologies, was cal-
culated using the protein structure prediction service PHYRE (ProteinHomology/AnalogY Recognition
Engine [216]). Based on this model predicting the globular ligand binding domain of NKp30 from amino
acidM1 to G120 (NKp30 protein sequence listed in 7.3), a truncated version of the NKp30 ligand binding
domain (30LBDtr) lacking eight amino acids at the C-terminus was used for these expression and purifi-
cation analyses. To obtain large amounts of protein for biochemical approaches, 30LBDtr was expressed
in E. coli. The E. coli BL21 (DE3) strain was especially constructed for high-level protein expression
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of recombinant proteins. Moreover, inducibility by IPTG could minimize the toxic effects of some re-
combinant proteins. To identify optimal expression and purification conditions of the 30LBDtr protein,
variants with an N- or C-terminal deca-histidine tag (His-tag), and an additional glycine-serine linker
flanked TEV cleavage site for optional removal of the His-tag were synthesized by GenScript (pUC57-
NKp30EC-TEV-His (plasmid 108) and pUC57-His-TEV-NKp30EC (plasmid 109), listed in 2.1.9.1). Af-
ter enzymatic restriction of the plasmids 108 and 109 using NcoI and XhoI (2.3.3.1), the DNA fragments
encoding His-30LBDtr and 30LBDtr-His (both 380 bp) were isolated from agarose gels after separation
(2.3.6 and 2.3.7.2). The expression vector pET-16b (Merck Millipore) was digested (NcoI and XhoI,
5643 bp) and dephosphorylated (2.3.3.2) prior to ligation of the inserts (2.3.3.3) generating the plasmids
pET16b-His10-TEV-NKp30EC (plasmid 1901) and pET16b-NKp30EC-TEV-His10 (plasmid 1902), re-
spectively. Positive clones were identified by colony PCR (2.3.2) using the primer combination 038/039
(listed in 2.1.8).
To increase the solubility of the 30LBDtr protein during protein expression, larger purification tags such
as GST (glutathion-S-transferase, encoded by the vector pGEX-4T-1, GE Healtcare) or MBP (maltose
binding protein, encoded by the vector pMAL-p5X, New England Biolabs) were fused at the N-terminus.
For this purpose, the primer combinations 118/119 or 117/119, respectively, and pUC57-NKp30EC-
TEV-His (plasmid 108) as template were used to introduce endonuclease recognition sites and amplify
30LBDtr encoding fragments by PCR. These amplified DNA fragments were enzymatically digested
using EcoRI and XhoI or EcoRI and HindIII, respectively. After purification of the digested and dephos-
phorylated expression vectors pGEX-4T-1 (4954 bp) and pMAL-p5X (5729 bp), the purified 30LBDtr
encoding DNA fragments (both 315 bp) were enzymatically ligated with the respective vector fragment
generating the GST-30LBDtr (pGEX-4T-1-NKp30EC (plasmid 2105)) and MBP-30LBDtr (pMal-p5X-
NKp30EC (plasmid 3301)) encoding expression plasmids. Positive clones were identified by colony PCR
using the primer combinations 049/050 and 059/060, respectively. For nucleotide sequencing (2.3.9), the
same oligonucleotides were applied.
2.3.10.4 NKp30 Ectodomain Constructs for the Expression in Insect Cells
Previous studies concerning ligand binding and signaling were performed with bivalent Ig fusion pro-
teins exhibiting post-translational modifications such as glycosylation. This modification may provoke
a conformational change of the NKp30 ectodomain when compared to the non-glycosylated NKp30
ectodomain produced in E. coli and most probably increases the protein stability in solution. However,
these fusion proteins display an antibody-like architecture. This forced dimerization could have a boost-
ing or even impeding influence on the interaction of NKp30 with its binding partners. Moreover, not
only the ligand binding domain alone but also the membrane proximal stalk domain could participate in
interaction events. Therefore, variable monovalent NKp30 ectodomain constructs with and without the
NKp30 stalk domain were generated for the expression in insect cells (30Stalk-His: amino acids L19-
R143, 30LBD-His: amino acids: L19-E128). Both NKp30 ectodomain variants were N-terminally fused
to a gp67 secretion sequence, and had a C-terminal deca-histidine tag (His-tag) with an additional glycine-
serine linker flanked TEV cleavage site for optional removal of the His-tag. The constructs pUC57-
gp67ss-NKp30LBD-Stalk-TEV-His (plasmid 114, listed in 2.1.9.1) and pUC57- gp67ss-NKp30LBD-
TEV-His (plasmid 127) were synthesized by GenScript. After enzymatic restriction of the plasmids 114
and 127 using XhoI and HindIII (2.3.3.1), the DNA fragments encoding 30Stalk-His and 30LBD-His
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(576 and 531 bp) were isolated from agarose gels after separation (2.3.6 and 2.3.7.2). The baculovirus
expression vector pFastBac1 (Life Technologies) was digested (XhoI and HindIII , 4758 bp) and dephos-
phorylated (2.3.3.2) prior to ligation of the inserts (2.3.3.3) generating the plasmids pFastBac1-gp67ss-
NKp30LBD-Stalk-TEV-His (plasmid 308) and pFastBac1-gp67ss-NKp30LBD-TEV-His (plasmid 315),
respectively. Positive clones were identified by colony PCR (2.3.2) using the primer combination 041/043
(listed in 2.1.8).
2.4 Methods of Cell Biology
2.4.1 Protein Production in Eschericia coli
E. coli is one of the most widely used expression host for recombinant protein production. Overex-
pression of the gene of interest in this system is facilitated by a high copy-number of the plasmid DNA
introduced by transformation or by increased binding strength of the promoter region, thereby assisting
transcription. In general, a combination of both is applied by high copy-number plasmids containing
the strong lac promoter upstream the gene of interest. Upon successful transformation of E. coli with
the expression vector, recombinant protein production can be induced by the lactose analog isopropyl
β-D-1-thiogalactopyranoside (IPTG).
In this thesis, the bacteria strains E. coli BL21 (DE3) and Origami (DE3) were applied for recombinant
30LBDtr protein production. Therefore, an aliquot of bacteria cells was transformed with the respective
plasmid DNA (2.2.2) prior to inoculation of an appropriate volume of LB selection medium for overnight
incubation under standard conditions (2.2.1). For recombinant protein expression, fresh LB selection
medium was inoculated with 1/10 Vol of the preparative culture and incubated under standard conditions
following the optical density at 600 nm (OD600). At an OD600 of 0.6, recombinant gene expression was
induced by addition of 1 mM IPTG to the bacteria suspension. 4 h post IPTG induction, bacteria cells
were harvested by centrifugation (5,000x g, 20 min, 4 °C). Bacteria cell pellets were stored at -20 °C or
used directly.
To visualize time-dependent recombinant protein expression by SDS-PAGE (2.5.6) and immunoblot
analyses (2.5.7), samples corresponding to an OD600 of 1 were taken prior to and every hour post IPTG
induction. After centrifugation of these samples (300x g, 5 min, 4 °C), the supernatant was discarded, and
the bacteria cell pellet was resuspended in 100 µl of PBS. To distinguish between soluble and aggregated
recombinant proteins (inclusion bodies), the samples were sonicated for 5 min at high power using a
Bioruptor Standard (Diagenode). Inlusion bodies and soluble recombinant proteins were separated by
centrifugation (14,000x g, 10 min) prior to SDS-PAGE and immunoblot analyses.
2.4.2 Cultivation of Cell Lines
2.4.2.1 Maintenance of Insect Cells
Sf 9 or Hi5 insect cells were cultivated in suspension culture under serum-free conditions in the appro-
priate medium (2.1.6.3) at 27 °C and 90 rpm in an incubation shaker (Multitron Standard, HT Infors,
Bottmingen, Switzerland). To passage insect cells, the cell number was determined using a counting
chamber (Neubauer counting chamber improved (bright-lined), Carl Roth). The cell viability was as-
sessed by trypan blue staining. Insect cells were passaged three times a week to maintain mid-log phase
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of growth (2x106 to 4x106 cells/ml) and seeded between 3x105 to 5x105 viable cells/ml.
Sf 9 suspension cultures were utilized for virus amplification. For this purpose, the cells were diluted
to a cell density of 7x105 cells/ml in a volume of 25 to 50 ml (250 ml-shaker flask) prior to infection
and cultivated under standard conditions. Hi5 suspension cultures were utilized for protein production.
For this purpose, the cells were diluted to a cell density of 7x105 cells/ml in a volume of 150 to 500 ml
(2 l-shaker flask) prior to infection and cultivated under standard conditions.
For long term storage, cryo cultures were prepared and kept in liquid nitrogen or at -80 °C. For this
purpose, cells being in a logarithmic growth-phase were used. Insect cells were pelleted (200-300x g,
5 min, 4 °C), resuspended in an appropriate volume of freezing medium (45% (v/v) conditioned medium,
45 % (v/v) fresh medium, 10 % DMSO, sterile filtered) to achieve a cell density of 2-3x107/ml. 1 ml-
aliquots of the cell suspension were prepared in cryogenic vials, transferred in a freezing container (Mr.
Frosty, Nalgene) and incubated at -80 °C. After 24 h, the vials were stored in the gas phase of liquid
nitrogen or remained at -80 °C.
To initiate an insect cell culture, a cryogenic vial of cells was thawed in a 37 °C water bath and immedi-
ately transferred into 30 ml of fresh, prewarmed (27 °C) medium. To remove cytotoxic DMSO, the cells
were pelleted (200-300x g, 5 min), reconstituted in 30 ml fresh medium and seeded into a 250 ml-shaker
flask.
2.4.2.2 Maintenance of Mammalian Cells
Mammalian cell lines were cultivated in the appropriate medium (2.1.6.3) in a cell culture incubator (ATP
Line CB, Binder GmbH) at 37 °C, 5 % CO2 and saturated water atmosphere. The cells were passaged 2-3
times a week to maintain optimal growth conditions. For this purpose, adherent cells were washed once
with PBS prior to trypsin (1x trypsin/EDTA, PAA) or accutase (PAA) treatment. An appropriate fraction
of detached cells was seeded into a new cell culture flask with fresh medium. To passage suspension
cells, the cell number was determined using a counting chamber (Neubauer counting chamber improved
(bright-lined), Carl Roth). After counting, the appropriate fraction of cells was pelleted (200-300x g,
3 min), reconstituted in fresh medium and seeded into a new culture flask.
For long term storage of cells, cryo cultures were prepared and kept in liquid nitrogen or at -80 °C. For
this purpose, cells being in a logarithmic growth-phase were used. Detached adherent cells or suspension
cells were pelleted (200-300x g, 3 min, 4 °C), resuspended in an appropriate volume of freezing medium
(45 % (v/v) conditioned medium, 45 % (v/v) fresh medium, 10 % DMSO, sterile filtered (0.22 µm)).
Aliquots of the cell suspension were prepared in cryogenic vials, transferred in a freezing container (Mr.
Frosty, Nalgene) and incubated at -80 °C. After 24 h, the vials were stored in the gas phase of liquid
nitrogen or remained at -80 °C.
To recover the cells from long term storage, a cryogenic vial of cells was thawed at 37 °C and imme-
diately transferred into 10 ml of fresh, prewarmed medium. To remove cytotoxic DMSO, the cells were
pelleted (200-300x g, 3 min), reconstituted in fresh medium and seeded into an appropriate culture flask.
2.4.3 Production of Baculovirus Particles
Baculovirus particles are used to introduce foreign DNA into lepidopteran cells such as Spodoptera
frugiperda or Trichoplusia ni, especially for recombinant protein production from higher eukaryotes.
Characteristic for the infection cycle is the generation of two different virion types: at early time points
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(6-8 h after infection), there is the budded virus (BV) located at the plasma membrane and at later time
points (18 h after infection), there is occlusion-derived virus (ODV) found in the nucleus. BV is infec-
tious in cell culture, since the virus enters into the host cell via receptor-mediated endocytosis. Gp64
(also known as gp67), a membrane fusion protein, is essential for the entry of BV into the cell [217].
For baculovirus particle production, Sf 9 insect cells were transfected with recombinant bacmid DNA
in a 6-well plate according to the manufacturer’s instructions using the TransIT-LT1 transfection reagent
(Mirus Bio). Therefore, 1x106 cells per 6-well were seeded in a final volume of 3 ml of Insect Xpress
medium (2.1.6.3) and incubated for approximately 30 min at 27 °C to adhere. 5 µg of bacmid DNA
were added to 250 µl of Insect Xpress medium in a 1.5 ml reaction tube and mixed gently. 15 µl of
pre-warmed (room temperature) TransIT-LT1 were added, mixed gently and incubated for 15-30 min
at room temperature. The transfection mixture was distributed dropwise all over the 6-well. 60 h after
transfection, the initial virus-containing supernatant (V0) was collected and used directly for infection
of an Sf 9 suspension culture or stored at 4 °C. 3 ml of fresh medium were added to the 6-well and
incubated for further 72 h at 27 °C. To investigate the transfection efficiency, the cytosolic YFP expression
was analyzed. Therefore, the supernatant was discarded, the cells were gently washed by rinsing with
PBS, resuspended in 500 µl of PBS, and transferred into a 1.5 ml reaction tube. The cell suspension
was sonicated for 5 min at high power using a Bioruptor Standard (Diagenode). After centrifugation
(14,000x g, 10 min), 150 µl of the YFP containing cell lysate were transferred into a 96-well plate (solid
black flat bottom, Corning) to measure the YFP fluorescence intensity (excitation: 485 nm, emission:
520 nm) using a FluoStar Optima device (BMG Labtech). To amplify the virus stock, an Sf 9 suspension
culture (7x105 cells per ml in 25 ml) was infected using the total V0 from one 6-well (approximately
3 ml). Suspension cultures of infected cells were split every 24 h until cell proliferation arrest occurred.
48 h after proliferation arrest, the amplified virus-containing supernatant (V1) was collected (300x g,
5 min), sterile filtered (0.22 µm), and stored in a dark 50 ml tube at 4 °C.
2.4.4 Protein Production in Insect Cell Lines
Protein expression in insect cell lines was applied since the produced proteins exhibit post-translational
modifications similar to mammalian producer cells. In this thesis, on the one hand insect cells were func-
tionalized with either full-length NKp30 alone or in combination with full-length NKp44 and NKp46. On
the other hand, the NKp30 ectodomain variants 30Stalk-His and 30LBD-His were produced by secretion
into the cell culture supernatant due to an N-terminal glycoprotein (gp) 67 secretion signal. Therefore,
High Five insect cell suspension cultures with 7x105 cells per ml were infected with 1 ml of V1 (2.4.3) per
100 ml. After 72 h of incubation under standard conditions (2.4.2.1), the functionalized insect cells were
applied to further analyses such as flow cytometry (2.4.12) and CLSM (2.4.13). To purify the secreted
30Stalk-His and 30LBD-His proteins from the cell culture supernatant, the cells were pelleted (1,000x g,
10 min, 4 °C). The supernatant was sterile filtered (0.22 µm), supplemented with 0.025 % (v/v) sodium
azide and stored at 4 °C. To remove the baculovirus particles prior to purification by IMAC (2.5.1.1), the
protein containing supernatants were ultracentrifuged (100,000x g, 2 h, 4 °C). Moreover, L-glutamine
was decreased from the expression medium by dialysis to minimize unfavorable occupation of binding
places during protein purification. Therefore, up to 200 ml of the supernatant were transferred into a
dialysis tube, which was incubated overnight at 4 °C in stirred 5 l of dialysis buffer (2.1.7).
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2.4.5 Transfection of Mammalian Cell Lines
Transfection is the process of deliberately introducing foreign DNA or RNA into eukaryotic cells. There
are various methods to introduce nucleic acids into cells, which can be categorized into physical (e.g.
electroporation) or chemical (e.g. calcium phosphate precipitation or lipofection) treatment. For some
applications of transfection, it is sufficient if the introduced genetic material is only transiently expressed.
Thus, the foreign DNA will be diluted through mitosis following cell division or degraded. In contrast,
a stable transfection assures that the transfected DNA remains in the genome of the cell and its daughter
cells. Stable integration of a co-transfectedmarker gene (e.g. resistance to a certain toxin) into the genome
leads to a selection advantage and the survival of the respective cells. After applying the selection pressure
for an appropriate time, only the stably transfected cells remain and can be further cultivated.
In this thesis, the chemical transfection with polyethylenimine (PEI) was used. PEI is a highly branched
and positively charged organic polymer with primary, secondary and tertiary amino groups. It binds to
the negatively charged phosphate groups of the nucleic acid backbone, and thereby condenses DNA into
positively charged particles. It facilitates the attachment to the cell surface leading to endocytosis of the
foreignDNA [218,219]. Once inside the cell, protonation of the amines results in an influx of counter-ions
and increase of the osmotic potential. Due to osmotic swelling of the endosomes, the bursting vesicles
release the polymer-DNA complex into the cytoplasm. After unpacking from the complex, the DNA is
free to diffuse to the nucleus.
For transient transfection of HEK293T cells, 1x107 cells were seeded into a T175 culture flask with
20 ml of prewarmed RPMI-1 medium 24 h before transfection. Immediately before the transfection, the
medium was replaced by 13 ml of prewarmed RPMI/Gln medium. The transfection mix consists of two
solutions (solution A and B). To prepare solution A, 65 µg of DNA was supplemented with 310 µl of
TA-glucose. Solution B consists of 65 µl of TA-trans and 310 µl of TA-glucose. Both solutions were
intensively mixed for 1 min at maximum speed (Vortex Genie 2, Scientific Industry). After incubation
for 10 min at room temperature (RT), solution A was added to solution B, intensively mixed for 1 min
and again incubated for 10 min at RT. The transfection mix was supplemented with 1 ml of RPMI/Gln
medium, mixed and added directly to the cells. After 4-6 h, the medium was replaced by 25 ml of
prewarmed RPMI/FCS medium.
2.4.6 Protein Production in Mammalian Cell Lines
Protein expression in mammalian cell lines was applied since the produced proteins exhibit post-transla-
tional modifications (PTMs) similar to their natural producer cells. Common PTMs are methylation,
phosphorylation, glycosylation and disulfide bond formation. In this thesis, B7-H6-Ig fusion protein was
produced by secretion into the cell culture supernatant due to an N-terminal tumor necrosis factor (TNF)
secretion signal. Therefore, HEK293T cells were transiently transfected with the pcDNA3.1(+)-TNFss-
B7-H6-hIgG1-Fc plasmid (2.4.5). After 72 h of incubation under standard conditions, the cell culture
supernatant was collected and centrifuged (1,000x g, 10 min, 4 °C) to remove remaining cells and cell
debris. The supernatant was sterile filtered (0.22 µm), supplemented with 0.025% (v/v) sodium azide and
stored at 4 °C. The secreted protein was purified from the supernatant by protein A affinity purification
(2.5.1.2).
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2.4.7 Production and Concentration of Lentiviral Particles
Viral particles are a common tool in the field of molecular biology to deliver genetic material into cells in
vitro or in vivo. In this thesis, human immunodeficiency virus (HIV)-1-derived lentiviral particles were
used for the stable introduction of the genes encoding recombinant NKp30-His and, moreover, the green
fluorescent protein (GFP) as marker for gene expression into HEK293 cells. Lentivirus is a genus of
viruses of the retroviridae family, which has the unique ability to infect both dividing and non-dividing
cells. Since these particles are created from a pathogenic virus, they are Gene-modified to be replication-
incompetent. For the production of infectious particles, viral genes are segregated onto three different
plasmids: (i) a transfer plasmid (harboring the transgene), (ii) a packaging plasmid (encoding for viral
structural proteins and enzymes), and (iii) an envelope plasmid (encoding for envelope proteins). Tran-
sient co-transfection of these three types of plasmids into HEK293T cells (triple transfection) ensures
the assembly of lentiviral particles containing only the transgene of choice but no gene for viral replica-
tion. Moreover, triple transfection allows for rapid change of tropism or virus type by applying another
envelope or packaging plasmid.
Generation of lentiviral particles was achieved by triple transfection ofHEK293T cells with LeGO-iG2-
NKp30-His opt or LeGO-iG2 as mock control (transfer plasmid), pCMV-∆R8.91 (packaging plasmid)
harboring the HIV-1 genes gag and pol, and pMD2.G (envelope plasmid) encoding the vesicular stom-
atitis virus (VSV)-G envelope protein. Transfection was performed in T175 culture flasks based on the
PEI method (2.4.5). In contrast to a single transfection approach, solution A contains 70.5 µg of DNA in
total (35 µg of transfer plasmid, 23 µg of packaging plasmid, and 12.5 µg of envelope plasmid). To ob-
tain sufficient lentiviral particles from one transfection, two T175 culture flasks of HEK293T cells were
transfected. 4-6 h after transfection, the medium was replaced by 25 ml of prewarmed RPMI-1 medium.
72 h later, the cell culture supernatant containing the lentiviral particles was collected and sterile filtered
(0.45 µm). 5 ml of the supernatant were either used directly for transduction (2.4.8) or stored at -80 °C
in 1 ml-aliquots. To obtain more concentrated lentiviral particles, 30 ml of the remaining supernatant
were transferred into a sterile thinwall polyallomer tube (Beckman Coulter) and layered with below 5 ml
of sucrose solution. After ultracentrifugation (100,000x g, 2 h, 4 °C; Optima L-70, SW32Ti, Beckman
Coulter), the pellet was resuspended in 1 ml of appropriate medium. Aliquots of 500 µl were stored at
-80 °C.
2.4.8 Transduction of Mammalian Cell Lines
Lentiviral particles can mediate the efficient delivery, integration and stable expression of transgenes.
This method called transduction is commonly used for cell lines that are hard to transfect. Another
benefit of transduction with lentiviral particles is the stable integration of the delivered transgene into the
genome of the transduced cell, generating stable transgene expressing cell lines.
For transduction of HEK293T cells with LeGO-iG2-NKp30-His opt or LeGO-iG2 as mock control,
about 3x105 cells were seeded into a single well of a 6-well plate. The next day, the medium was re-
placed by 1 ml of prewarmed RPMI/Gln medium supplemented with 8 µg/ml protamine sulfate per well.
The cationic polymer protamine sulfate enhances the transduction efficiency by neutralizing the charge
repulsion between the lentiviral particles and the cell surface [220]. Immediately before centrifugation,
1 ml of fresh or thawed lentiviral particle suspension (2.4.7) was added to one well of cells. To force
lentiviral particles onto the cells, the plate was centrifuged for 1 h at 1,800x g and 32 °C. After incu-
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bation of the cells under standard conditions for 6-12 h, the supernatant was replaced by 2 ml of fresh,
prewarmed RPMI-1 medium. After 24 h, single cell clones were isolated (2.4.9) and the transduction
efficiency was assessed by GFP expression analyses using a fluorescence microscope (Eclipse TE 300,
Nikon Instruments, Melville, USA).
2.4.9 Clonal Isolation of Gene-modified Cell Lines
Though transduction with lentiviral particles (2.4.8) is a very efficient method to introduce foreign DNA,
not every single cell stably integrates the transduced DNA into the host genome. Even if the integration
was successfull, there can be single cells expressing only low amounts of the transgene. If there is no
selection pressure due to the transgene (resistance to a toxin), these cells obtain a selection advantage
and could overgrow the culture, thus losing the transgene expression at all over time. Therefore, gene-
modified single cell clones with high expression of the transgene have to be isolated. In this thesis, a
limiting dilution approach in a 96-well plate was performed. The 96-well plate was prepared with 100 µl
of prewarmed RPMI-3 medium per well. 1x105 cells in 100 µl of prewarmed RPMI-3 medium were
seeded into the first well of the 96-well plate, gently mixed, and 100 µl of this cell suspension were
transferred into well below. This step was repeated up to the last well of the row. The remaining 100 µl
of cell suspension were discarded. With an 8-channel micropipette, 100 µl of prewarmed RPMI-3 were
added to the first row, gently mixed, and 100 µl of cell suspension were again transferred into the next
wells. This step was repeated up to the last row. Finally, 100 µl of prewarmed RPMI-3 were added to each
well, following cell cultivation under standard conditions. After 24 h, wells with only one single cell,
which expresses the transgene (GFP), were identified by fluorescencemicroscopy (Eclipse TE 300, Nikon
Instruments, Melville, USA). These gene-modified single cell clones were cultivated until an appropriate
cell number for subsequent analyses was reached.
2.4.10 Isolation and Cultivation of Primary Natural Killer Cells
Primary Natural Killer (pNK) cells can be isolated from peripheral blood, bone marrow, and umbilical
cord blood via density gradient centrifugation using ficoll medium. Ficoll is a neutral, highly-branched,
hydrophilic polymer of sucrose that dissolves readily in aqueous solution. It is placed at the bottom of a
conical tube, and blood is then slowly layered above. After centrifugation the following layers are visible
(from top to bottom): blood plasma and other constituents, an intermediate layer of peripheral blood
mononuclear cells (PBMCs) and platelets called buffy coat, ficoll, and a pellet comprising erythrocytes
and granulocytes. To exclude red blood cell trapping, which could partly remain in the PBMC fraction,
the anticoagulant ethylene diamine tetra acetic acid (EDTA) is supplemented during the washing steps.
Primary NK cells are isolated using a kit developed for the untouched isolation of NK cells from human
PBMCs. Non-NK cells, i.e. T cells, B cells, stem cells, dendritic cells, monocytes, granulocytes, and
erythroid cells, are magnetically labeled by using a cocktail of biotin-conjugated antibodies and the NK
Cell MicroBead Cocktail. Isolation of highly pure NK cells is achieved by depletion of magnetically
labeled cells.
In this thesis, primary human natural killer cells were isolated from buffy coats (kindly provided by
H. Bönig, DRK, Frankfurt, Germany) by ficoll gradient (Biozol). Therefore, the buffy coat was diluted
1:3 to 1:4 with PBS/EDTA, and transferred into conical tubes prior to applying ficoll (15 ml). After cen-
trifugation (400x g, 15 min, 4 °C, no deceleration, low acceleration), the intermediate layers of two tubes
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were transferred into one new tube, thereby reducing the working volume. After subsequent washing
with PBS/EDTA (300x g, then two times 200x g, 15 min, 4 °C) under stepwise reduction of the working
volume, the pNK cells were isolated by negative selection from the residing PBMCs using the NK Cell
Isolation Kit (Miltenyi Biotec). The cells were seeded at 1.5-2x107 cells/ml in X-Vivo medium (2.1.6.3)
and cultivated under standard conditions for up to 10 days. The cell density was adjusted every three
days by adding new medium with fresh IL-2 for activation. After 7 days, the pNK cells were prepared
for flow cytometry (2.4.12) or CLSM analyses (2.4.13).
2.4.11 Inhibition of Protein Glycosylation
To inhibit protein glycosylation during protein synthesis in eukaryotic cells, tunicamycin was used. Tuni-
camycin is a mixture of homologous nucleoside antibiotics that blocks the synthesis of all N-linked gly-
coproteins and causes cell cycle arrest. Glycosylation inhibition during protein synthesis was performed
to validate the suitability of insect cells to perform N-linked glycosylation at the three identified acceptor
sites (N42, N68, N121 [170]) by comparison with the native non-glycosylated NKp30 ectodomain with
respect to their molecular mass.
For this purpose, insect cells were infected with baculovirus encoding for 30Stalk-His (2.4.4) 1 h prior
to addition of 1µg/ml tunicamycin, andmaintained under standard conditions. 72 h post infection, the cell
culture supernatant was harvested (1,000x g, 10 min, 4 °C), sterile filtered (0.22 µm), supplemented with
0.025 % (v/v) sodium azide and stored at 4 °C. The secreted protein was purified from the supernatant
by IMAC (2.5.1.1).
2.4.12 Flow Cytometry
Flow cytometry is a laser-based technology that is employed in cellular approaches such as cell counting,
cell sorting or biomarker detection according to the cellular shape, surface expression of proteins or
intrinsic fluorophore expression. The method is based on the detection of light scattering as well as
fluorescence features of a single cell solution. The light scattering is dependent on the size and granularity
of the cells, wheras fluorescence results from intrinsic fluorophore expression or labeling of proteins with
fluorophore-conjugated antibodies.
Flow cytometry analyses were performed on a FACSCantoII system (BD). For this purpose, 4x105 sus-
pension cells per sample were harvested (200x g, 3 min, 4 °C), washed with 1 ml FACS buffer (200x g,
3 min, 4 °C), and incubated with 50 µl of 5 % (w/v) BSA/FACS for 15 min on ice. To investigate sur-
face NKp30-His expression on adherent cell lines upon transfection or lentiviral transduction, cells were
detached with accutase (NKp30 is trypsin sensitive) prior to washing and incubation with 5 % (w/v)
BSA/FACS. The cells were washed prior to appropriate antibody or recombinant protein incubation
(Tab. 9). All proteins or antibodies were diluted in FACS buffer as shown in Tab. 10. For one sam-
ple, 40 µl of antibody or recombinant protein solution were used. Control cells were incubated with
40 µl of FACS buffer. To specifically block protein interactions, cells or recombinant proteins were
pre-incubated with the respective blocking antibody for 1 h on ice. The cells were incubated with uncon-
jugated proteins, antibodies or protein-antibody complexes at least for 1 h on ice. After each antibody or
recombinant protein incubation step, all samples were washed twice prior to incubation with the appropri-
ate fluorophore-conjugated antibodies for at least 15 min on ice in the dark. The cells were washed twice
and fixed in 300 µl FACS-fix. The samples were either used directly for flow cytometry analyses or kept
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overnight at 4 °C in the dark (for up to one week). Approximately 5x104 cells per sample were analyzed
using FACSDiva 6.0 software (BD). To determine the rate of unspecific staining, samples decorated with
isotype control or detection antibodies only were analyzed.
Tab. 9: Recombinant protein and antibody combinations for flow cytometry and CLSM analyses
Protein expression was detected by antibody or recombinant protein staining. Unlabeled antibodies were detected
by secondary fluorophore-conjugated antibodies.
Recombinant Protein/Antibody Antigen/Isotype Detection Antibody
B7-H6-Ig human IgG anti-human IgG-Fc, DyLight649-conjug.
30Stalk-His NKp30 anti-human NKp30, pep. immun.
30LBD-His NKp30 anti-human NKp30, pep. immun.
anti-human NKp30, 210845 mouse IgG2a anti-mouse IgG, Alexa647-conjug.
anti-human NKp30, pep. immun. rabbit IgG anti-rabbit IgG, APC-conjug.
anti-human NKp30, Z25, PE-conjug. mouse IgG1 anti-mouse IgG, Alexa546-conjug.
anti-human NKp44, Z231, PE-conjug. mouse IgG1 anti-mouse IgG, Alexa546-conjug.
anti-human NKp46, BAB281, PE-conjug. mouse IgG1 anti-mouse IgG, Alexa546-conjug.
Tab. 10: Dilutions for recombinant proteins and antibodies for flow cytometry and CLSM analyses
Antibodies and recombinant proteins were diluted in FACS buffer according to the manufacturer’s recommendation
or tested in this thesis.
Recombinant Protein/Antibody Antigen/Isotype Dilution
B7-H6-Ig human IgG 50 µg/ml
30Stalk-His NKp30 50-75 µg/ml
30LBD-His NKp30 50-75 µg/ml
anti-human NKp30, 210845 mouse IgG2a 25-250 µg/ml
anti-human NKp30, pep. immun. rabbit IgG 50 µg/ml
anti-human NKp30, Z25, PE-conjug. mouse IgG1 1:20
anti-human NKp44, Z231, PE-conjug. mouse IgG1 1:20
anti-human NKp46, BAB281, PE-conjug. mouse IgG1 1:20
anti-mouse IgG, Alexa647-conjug. goat IgG 1:200
anti-rabbit IgG, APC-conjug. goat IgG 1:100
anti-human IgG-Fc, DyLight649-conjug. goat IgG 7.5 µg/ml
anti-mouse IgG, Alexa546-conjug. goat IgG 1:200
2.4.13 Confocal Laser Scanning Microscopy
Immunohistochemistry is a common method to detect intracellular antigens or biomarkers on the cell
surface by specific antibody binding. Due to fluorophore-conjugated antibodies, proteins can be visu-
alized by immunofluorescence microscopy. Simultaneous staining with antibodies againts biomarkers
within different cellular compartments allows protein localization within the cell. In this thesis, the con-
focal TCS-SP5 laser scanning microscope (CLSM, Leica) was used. In contrast to an epifluorescence
microscope, a CLSM is able to generate optical sections of the sample resulting in a better transverse
resolution of the fluorescent image and the determination of the cellular localization of the respective
antigens [221]. For this purpose, cells were decorated with unconjugated proteins, antibodies or protein-
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antibody complexes and further stained with fluorophore-conjugated antibodies as described for flow
cytometry analyses (2.4.12). The following steps were performed at room temperature in the dark. After
fixation, 50 µl of the sample were centrifuged (200x g, 3 min, 4 °C), washed with FACS buffer, pelleted,
and the supernatant was discarded. The remaining cell pellet was resuspended in 7 µl of DAPI stain
(nuclear stain), and transferred onto the microscope slide. By applying the cover slip (12 mm in diam-
eter), the cell suspension was distributed avoiding air bubbles. Prepared microscope slides were stored
for up to four weeks at 4 °C in the dark. Fluorescent images were obtained using a HCX PL APO Lbd.
Bl 63x/1.4-0.6 oil objective, a diode laser (405 nm) to detect DAPI (emission: 410-550 nm), an argon
laser (488 nm) to detect GFP (emission: 490-580 nm) or YFP (emission: 515-615 nm), and a HeNe laser
(633 nm) to detect APC (emission: 635-750 nm) or DyLight649 (emission: 660-720nm). Analyses of
the fluorescent images were performed with the LAS-AF lite 2.0 software.
2.4.14 Quantification of Cell Decoration
Images of single B7-H6 transduced Ba/F3 cells decorated with 30Stalk-His and 30LBD-His proteins
(2.4.13) were quantitatively analyzed using the cell image analysis software CellProfiler [222]. NKp30
ectodomain protein clusters (diameter of 4-40 pixel) were identified on grayscale images of the APC
channel by pixel intensity (thresholding method: kapur global, correction factor: 2). The cluster area
was determined as actual number of pixels in the region. Statistical significance was determined by the
Mann-Whitney test using the Prism 5 software (Graph Pad): not significant (n.s.), >0.05; *, p = 0.01-0.05;
**, p = 0.001-0.01; ***, p < 0.001.
2.4.15 Signaling Reporter Assay
A signaling reporter assay is a rapid, sensitive and quantitative approach to assess the activation of re-
ceptor signal transduction pathways due to ligand binding. Upon induction of the signaling pathway, the
activity of downstream transcription factors is analyzed by reporter gene expression. A well-established
signaling pathway is the initiation of interleukin-2 expression during T cell activation. Signaling of the
T cell receptor complex activates the transcription factor NF-AT (nuclear factor of activated T cells),
which binds to NF-AT binding sites within the promoter region of the IL-2 gene, thereby initiating gene
expression. Within the TCR complex, the CD3ζ chains are responsible for signal transduction. In this
thesis, the A5-GFP reporter cell line (mouse T cell hybridoma) was used, which constitutively expresses
the CD3ζ chains. The IL-2 gene was substituted by a GFP reporter gene that is under the control of
the IL-2 promoter, which harbors three NF-AT binding sites [203, 204]. To analyze NKp30-dependent
signaling, the A5-GFP cells were retrovirally transduced with the NKp30 full-length receptor or control
vector [170]. Thus, ligand-induced NKp30-dependent signaling via CD3ζ can be investigated due to
subsequent GFP expression.
To investigate the NKp30 signal transduction capacity after B7-H6 ligand binding, the following ef-
fector (A5-30FL-His) to target (Ba/F3-B7-H6) ratios were applied: 2:1, 1:1, and 0.5:1. Both cell lines
were washed with FACS buffer (200x g, 3 min), and 7.5x107 Ba/F3-B7-H6 cells were resuspended in
1.5 ml of DMEM medium without gentamycin (DMEM/-). 100 µl of target cells (corresponding to
2.5x105) were mixed with 5x105, 2.5x105, or 1.25x105 effector cells in a final volume of 200 µl DMEM/-
medium. After co-incubation for 16 h (37 °C, 5 % CO2 and saturated water atmosphere), the cells were
pelleted (200x g, 3 min) and incubated for 1 h with 100 µl of APC-conjugated anti-mouse CD4 antibody
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(0.2 µg/ml in FACS buffer) to discriminate the effector from the target cells. To validate appropriate
NKp30 expression, the cells were incubated for 1 h with 100 µl of APC-conjugated anti-human NKp30
antibody (0.02 µg/ml in FACS buffer). The GFP expression of CD4+ reporter cells was determined by
flow cytometry. As signaling control, reporter cells were incubated for 16 h without target cells or in
the presence of 50 ng/ml PMA (phorbol 12-myristate-13-acetate) and 750 ng/ml ionomycin (constitutive
stimulation of NF-AT [223]). To investigate the concentration-dependent signal inhibition capacity of
the NKp30 ectodomain proteins, Ba/F3-B7-H6 target cells were pre-incubated with graded amounts of
30Stalk-His (3.1 and 6.2 µM) or 30LBD-His proteins (2.7, 5.4, 10.8 and 21.6 µM) for 1 h at 37°C prior to
co-incubation with A5-30FL-His effector cells at a 1:1 ratio. As reference, Ig fusion proteins (30Stalk-Ig:
2.5 µM, Ifnar2-Ig: 2 µM, [170]) were used. To validate signal inhibition by blocking the effector-target
cell interaction, A5-30FL-His reporter cells were pre-incubated with an anti-human NKp30 blocking
antibody (0.25 µM).
2.5 Methods of Protein Biochemistry
2.5.1 Protein Purification from Cell Culture Supernatant or Rabbit Serum
Protein purification methods are applied to isolate the protein of choice from a complex mixture. For this
purpose, recombinantly expressed proteins are often tagged with short amino acid sequences to allow for
affinity purification. In this thesis, all recombinantly expressed proteins contain a specific signaling motif
at the N-terminus to facilitate secretion into the cell culture supernatant, thereby reducing the content
of disturbing components which bind unspecifically to the affinity matrix during protein purification.
The basic principle of affinity purification is protein absorption to a purification matrix, washing away
contaminants, elution of the protein, and regeneration of the matrix. In this thesis, different affinity-
based chromatographic methods were applied for protein purification by gravity flow: (i) the NKp30
ectodomain proteins (30Stalk-His and 30LBD-His) contain a C-terminal deca-histidine tag, by which the
proteins can be purified via immobilized metal ion affinity chromatography (IMAC); (ii) the secreted
recombinant ligand B7-H6 is fused C-terminal to a human IgG1-Fc part (B7-H6-Ig), and can thus be
purified via the affinity to protein A; and (iii) the antibodies within the rabbit antiserum after peptide
immunization can be purified after binding to this peptide, which is coupled to a sepharose resin.
2.5.1.1 Immobilized Metal Ion Affinity Chromatography
Immobilized metal ion affinity chromatography (IMAC) is based on the specific chelate formation of
amino acids such as histidines or cysteines to metal ions. In this thesis, Ni2+ ions are complexed by ni-
trilotriacetic acid (Ni-NTA), which is cross-linked to agarose beads (Protino Ni-NTA agarose, Macherey-
Nagel). The soluble NKp30 ectodomain variants 30Stalk-His and 30LBD-His are fused to a C-terminal
deca-histidine tag to allow for high-affinity binding to the Ni-NTA matrix, and thereby specific protein
purification.
For this purpose, an appropriate amount of Ni-NTA agarose (binding capacity up to 50 mg/ml) was ap-
plied onto an Econo-Pac column (Bio-Rad) including a bed support frit (30 µm, polyethylene), washed
with 10 column volumes (CV) deionized water, and equilibrated with 10 CV wash buffer to reduce un-
specific protein binding. After adding the appropriate amount of Ni-NTA agarose beads to the dialysed
NKp30 ectodomain protein containing cell culture supernatant (2.4.4), the suspension was incubated for
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at least 3 h at 4 °C on a tilt/roller mixer. To avoid loss of protein activity, all of the following purification
steps were performed on ice and with ice cold buffers. To collect the Ni-NTA agarose beads, the suspen-
sion was again applied onto the Econo-Pac column. The flow-through was stored at 4 °C. The collected
Ni-NTA agarose beads were washed with 10 CV of wash buffer, collecting the last milliliter in a reac-
tion tube. To elute the protein from the Ni-NTA agarose beads by high concentrations of the competitor
molecule imidazole, 20 CV of elution buffer were applied and collected in 1 ml fractions. Regeneration
of Ni-NTA agarose beads was performed by washing with 10 CV of deionized water prior to applying
5 CV of regeneration buffer to remove the complexed Ni2+ ions. The Ni-NTA agarose beads were again
washed with 10 CV of deionized water prior to recharging with 2 CV of Ni2+ solution. The regenerated
Ni-NTA agarose beads were washed again with deionized water prior to resuspension in 20 % (v/v) of
EtOH for storage at 4 °C. To analyze the purification process, 50 µl of each purification step (input, flow-
through, wash, and elution fractions) were subjected to SDS-PAGE (2.5.6) and immunoblot analyses
(2.5.7).
To concentrate the purified protein, all elution fractions were combined and applied to an Amicon
Ultra-15 centrifugal filter unit (Merck Millipore) with 3 kDa molecular weight-cut off (MWCO). The
elution suspension was concentrated to 1 ml (5,000x g, >60 min, 4 °C), and washed three times with
5 ml of Tris buffer. Finally, the protein suspension was concentrated to 0.3-1 ml, transferred into a 1.5 ml
reaction tube and supplemented with 4 % (v/v) PI mix. After protein concentration determination (2.5.3),
the protein suspension was either stored at 4 °C for up to one month or supplemented with 25 % (v/v) of
glycerol for long-term storage at -20 °C.
2.5.1.2 Protein A Affinity Chromatography
The bacterial surface protein A binds specifically to the constant region of immunoglobulins from many
mammalian species, most notably IgGs. Therefore, matrix-bound protein A was utilized to affinity purify
IgG1-Fc (Ig) tagged proteins. For this purpose, an appropriate amount of rec-Protein A-Sepharose 4B
Conjugate (protein A beads, Life Technologies) was washed twice with PBS (1,000x g, 3 min). For each
25 ml of supernatant, 10 µl of settled protein A beads were applied. After adding the appropriate amount
of protein A beads to the sterile filtered Ig fusion protein containing cell culture supernatant (2.4.6), the
suspension was incubated overnight at 4 °C on a tilt/roller mixer. To avoid loss of protein activity, all of
the following purification steps were performed on ice. To collect the protein A beads, the suspension was
applied onto an Econo-Pac column (Bio-Rad) including a bed support frit (30 µm, polyethylene). The
flow-through was stored at 4 °C. The collected protein A beads were washed with 20 column volumes
(CV) of PBS, collecting the last milliliter in a reaction tube. Elution of the protein was performed by pH
shift. Adding collection buffer (1/10 of the volume of the elution fractions) into the collection tubes prior
to elution facilitates neutralization of the pH within the protein suspension immediately after elution
from the beads. To elute the protein from the protein A beads, 10 CV of elution buffer were applied
and collected in 0.5 ml fractions. Regeneration of protein A beads was performed by adding 10 CV of
regeneration buffer onto the beads. The protein A beads were transferred into a reaction tube and washed
once again with PBS. The settled beads were suspended in storage buffer and stored at 4 °C. To analyze
the purification process, 50 µl of each purification step (input, flow-through, wash, and elution fractions)
were subjected to SDS-PAGE (2.5.6) and immunoblot analyses (2.5.7).
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To concentrate the purified protein, all elution fractions were combined and applied to anAmiconUltra-
4 centrifugal filter unit (Merck Millipore) with 50 kDa molecular weight-cut off (MWCO). The elution
suspension was concentrated to 1 ml (7,500x g, 5-10 min, 4 °C), and washed three times with 4 ml of
PBS to exchange the buffer. Finally, the protein suspension was concentrated to 0.3-1 ml, transferred
into a 1.5 ml reaction tube and supplemented with 4 % (v/v) PI mix. After protein concentration deter-
mination (2.5.3), the protein suspension was either stored at 4 °C for up to one month or supplemented
with 25 % (v/v) of glycerol for long-term storage at -20 °C.
2.5.1.3 Immunoaffinity Chromatography
Immunoaffinity chromatography is a method applied to purify antibodies from blood serum. This serum
could be derived from an organism that was immunized with an antigen such as a peptide or recombi-
nant protein. When the peptide antigens are produced synthetically, a terminal cysteine residue is added
at either the N- or C-terminus of the peptide. This cysteine residue contains a sulfhydryl and/or amine
functional group which allows the peptide to be easily conjugated to a carrier protein (e.g. Keyhole
Limpet Hemocyanin (KLH)). The same peptide is also immobilized onto a solid support such as agarose
or sepharose resin through the cysteine residue and is then used as an affinity ligand in purifications of an-
tibodies from the antiserum. Elution of the antibodies is most often achieved using a low pH buffer such
as it is described for Protein A chromatography (2.5.1.2). In this thesis, an anti-NKp30 antibody with a
defined epitope (amino acids P62 to R75) situated within the NKp30 ligand binding domain was gener-
ated. Therefore, two rabbits were immunized with the peptide NH2-CPGKEVRNGTPEFRGR-COOH
(Bioscience, Göttingen) to obtain the antiserum. The same peptide was used for the immunoaffinity
chromatography. Peptide loading as well as antibody purification steps were performed on ice and with
ice-cold buffers. The sepharose resin (1 ml), which was stored in isopropanol, was washed in a first step
with 20 column columes (CV) of 0.1 M HCl. For optimal peptide loading, the matrix was adjusted to
pH 8.5 by washing with 20 CV of ice-cold PBS (pH 8.5). 4 mg of peptide were resolved in 50 µl of
DMSO and adjusted to 1 ml with ice-cold PBS (pH 8.5). The peptide suspension was incubated with
the sepharose resin overnight at 4 °C on a tilt/roller mixer. Peptide binding onto the matrix was checked
by determination of the protein concentration of the flow-through. To block residual binding places, the
matrix was incubated for 1 h with 15 ml of 1 M Tris (pH 8.8) at 4 °C on a tilt/roller mixer, and then
equilibrated with 10 CV of PBS (pH 8.5). 25 ml of the rabbit antiserum were centrifuged (9,000x g,
30 min, 4 °C) and sterile filtered (0.45 µm) to remove cellular components and larger protein aggregates
prior to incubation with the peptide-loaded sepharose resin overnight at 4 °C on a tilt/roller mixer. The
matrix was washed with 20 CV of PBS (pH 8.5) and 20 CV of PBS (pH 4.6) to reduce unspecific binding.
300 µl of ice-cold 1 M Tris (pH 8.8) were added into ten reaction tubes prior to collection of 700 µl elu-
tion fractions using ice-cold 100 mM glycine (pH 2.7). The sepharose resin was neutralized with ice-cold
PBS, and stored in PBS supplemented with 3 mM NaN3 at 4 °C.
To concentrate the purified peptide-specific antibodies, all elution fractions were combined and applied
to an Amicon Ultra-4 centrifugal filter unit (Merck Millipore) with 50 kDa molecular weight-cut off
(MWCO). The elution suspension was concentrated to 1 ml (7,500x g, 5-10 min, 4 °C), and washed
three times with 4 ml of PBS to exchange the buffer. Finally, the protein suspension was concentrated to
0.3-1 ml, transferred into a 1.5 ml reaction tube and supplemented with 4 % (v/v) PI mix. After protein
concentration determination (2.5.3), the protein suspension was stored in 30 µl aliquots at -20 °C.
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2.5.2 Size Exclusion Chromatography
Size exclusion chromatrography or gel filtration allows for separation of analytes on the basis of their
size or hydrodynamic volume using porous beads in a column [224]. The separation is dependent on the
pore size of the beads as well as the buffer conditions. An important value is the retention volume (Vr) of
the separated analyte molecules, which is determined by UV absorption at 280 nm. Small molecules are
retained by easy entering pores, and thereby increasing Vr. Conversely, larger analytes spend less, if any,
time in the pores and are eluted quickly. Analytes, which are not retained, are eluted with the free volume
outside of the particles, also known as void volume (V0). The void volume is known to be approximately
1/3 of the column volume and can be determined by using Blue Dextran 2000 (molecular mass of∼2000
kDa, GE Healthcare). There is a limited range of molecular mass that can be separated by each column.
Therefore, it could be necessary to use several columns with different pore sizes in tandem to fully resolve
the sample having a broad molecular mass range. To estimate the retention volume/molecular size of the
protein(s) of interest, commercially available calibration standards (highly purified, well-characterized,
globular proteins) are used.
In this thesis, prepacked analytical Superdex 200 10/300 GL (24 ml, fractionation range: 1x104 to
6x105 Da) and Superose 6 10/300 GL (24 ml, fractionation range: 5x103 to 5x106 Da) columns were
used in an Äkta Prime FPLC system (GE Healthcare). All buffers and solutions were prepared at 4 °C
and sterile filtered (0.22 µm) to remove particles and air bubbles. Both columns were stored in 20 % (v/v)
of EtOH. Therefore, they were washed with 1.5 CV of deionized water prior to equilibration with 1.5 CV
of Tris buffer (pH 8.0). Concentrated protein samples were injected via an appropriate sample loop.
Size exclusion chromatography was performed in Tris buffer (pH 8.0) with flow rates of 0.5 ml/min and
0.3 ml/min, respectively. Elution fractions were collected according to the following application. Molec-
ular weight and void volume determination was carried out according to the manufacturer’s instructions
using the Gel Filtration LMW and HMW Calibration Kits (GE Healthcare). The respective retention
volumes are shown in Tab. 11. For the long-term storage, the columns were washed with 1.5 CV of
deionized water prior to 20 % (v/v) of EtOH.
Tab. 11: Retention volumes (Vr) of the calibration standards on Superdex 200 and Superose 6 column
Respective standard proteins were mixed and applied to SEC using Tris buffer.
Calibration Standard Molecular Weight Superdex200 Superose6
Blue Dextran 2000 V0 2,000 kDa 8 ml 8 ml
Thyroglobulin T 669 kDa 8 ml 13.7 ml
Ferritin F 440 kDa 10.0 ml 15.2 ml
Aldolase Ald 158 kDa 13.6 ml 16.8 ml
Conalbumin C 75 kDa 15.2 ml 17.0 ml
Ovalbumin O 44 kDa 17.0 ml 18.2 ml
Ribonuclease A R 13.7 kDa 19.9 ml
2.5.3 Determination of Protein Concentration
Proteins in solution absorb ultraviolet (UV) light with absorbance maxima at 280 nm (aromatic rings of
amino acids) and 200 nm (peptide bonds). The secondary, tertiary and quaternary structure can affect
the absorbance, therefore factors such as pH or ionic strength can alter the absorbance spectrum. The
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spectrophotometric quantification of proteins is based on the Lambert-Beer law relating the amount of
absorbed light to the amount of protein in the mixture. For this purpose, 2 µl of a protein solution were
measured at 280 nm using the NanoDrop ND 1000 (PeqLab Biotechnologie) device. The corresponding
buffer solution was used as blank.
2.5.4 Enzymatic Protein Deglycosylation
Glycosylation is one of the most common post-translational modifications of proteins to facilitate correct
folding, stability, and function. Oligosaccharides can be attached either at asparagine residues (N-linked
glycosylation) or serine or threonine residues (O-linked glycosylation) on the core protein. To asses if
a protein is glycosylated, enzymatic deglycosylation is performed. Treatment with specific glycosidases
provides complete sugar removal without protein degradation. Peptide-N-Glycosidase (PNGase) F is an
amidase that cleaves between the innermost N-Acetylglucosamine (GlcNAc) and asparagin residues of
high mannose, hybrid, and complex oligosaccharides from N-linked proteins [225]. PNGase F treatment
of glycoproteins is the most effective method for removing almost all N-linked oligosaccharides. How-
ever, oligosaccharides containing a fucoseα1-3-linked to the glycan core are restitant to PNGase F, which
can occur on some plant, insect and mammalian glycoproteins [226, 227]. In contrast, O-linked glycans
were removed stepwise by a series of exoglycosidases such asO-Glycosidase, α(2-3,6,8)-Neuraminidase,
β(1-4)-Galactosidase, and β-N-Acetylglucosaminidase. This combination of enzymes will not remove
all O-linked oligosaccharides but should remove many common oligosaccharide structures.
In this thesis, enzymatic deglycosylation assays were performed using PNGase F (New England Bi-
olabs) for removal of only N-linked oligosaccharides, and an enzyme mix (New England Biolabs) for
removal of N- and O-linked glycosylation. All enzymes were supplied with buffers. A standard deg-
lycosylation mix was performed according the manufacturer’s instructions. Therefore, 5 µg of purified
protein were mixed with 1 µl of 10x glycoprotein denaturation buffer and adjusted to a final volume
of 10 µl with deionized water. To denature the protein and thereby provide better accessibility for the
glycosidases, the protein solution was incubated for 10 min at 100 °C. After cooling down, the reaction
mixture was supplemented with 2 µl of NP-40, 2 µl of G7 reation buffer, 1 µl PNGase F (500 U) or protein
deglycosylation mix, and adjusted to a final volume of 20 µl with deionized water. The reaction mix was
incubated at 37 °C for 4 h, followed by incubation overnight at 4 °C to ensure complete oligosaccharide
removal. Potential reduction in molecular mass was investigated by SDS-PAGE (2.5.6) and immunoblot
analyses (2.5.7).
2.5.5 Immunoprecipitation
Immunoprecipitation (IP) is a biochemical method to isolate and concentrate a protein of interest from
a protein solution mixture by applying specific antibodies. These protein solutions could be obtained
by total cell lysis or preparation of specific cellular fractions such as crude membranes and cytosolic
fractions prior to IP. For this purpose, 1x107 cells were harvested (200x g, 3 min) and washed once
with PBS (200x g, 3 min). Cell pellets were either stored at -20 °C or immediately used for cell lysis.
Therefore, the cell pellet was resuspended in 200 µl of lysis buffer, incubated for 20 min on ice mixing
the suspension every 5 min, and centrifuged for 30 min at 20,000x g and 4 °C. The supernatant containing
the solubilized proteins was transferred into a low protein binding reaction tube (Kiskers Biotech) and
supplemented with 10 µg of anti-human NKp30 (P30-15) antibodies. After incubation for 4 h at 4 °C on a
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tube rotator (LD 79, Labinco BV), 2 µl of 1 % (v/v) of Tween20 were added to the solution. To isolate the
antibody-bound proteins from the solution, magnetic beads coupled with Protein A (Dynabeads Protein
A, Life Technologies) were applied. For one sample, 50 µl of the Dynabeads Protein A suspension was
used. The beads were washed twice with 1 ml of lysis-T buffer utilizing a magnetic separation rack
(New England Biolabs). The beads were reconstituted in the reaction mixture containing the antibody-
bound proteins and incubated overnight at 4 °C on a tube rotator. The beads were washed three times
with PBS-TT and transferred into a new low protein binding reaction tube. To elute the bound proteins
by applying a pH shift, the beads were reconstituted in 50 µl of elution buffer and incubated for 1 min
at room temperature. The eluate suspension was transferred into a new low protein binding reaction
tube containing 3 µl of collection buffer to neutralize the pH, and subjected to SDS-PAGE (2.5.6) and
immunoblot analyses (2.5.7). The remaining magnetic beads were washed twice with 1 ml of PBS-T,
resuspended in 50 µl of DB storage buffer and stored at 4 °C.
2.5.6 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophorsis
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is an analytical method in bio-
chemistry, which allows the separation of protein mixtures according to their molecular mass after apply-
ing an electric current. The most common procedure to separate molecules between 5 to 250 kDa is the
discontinuous SDS-PAGE. This method relies on the concentration of the proteins on a barrier between
stacking and resolving gel due to different pH and pore sizes [228]. The basic principle of the method is
to shield the native charge of denatured proteins by hydrophobic interaction with the anionic detergent
sodium dodecyl sulfate (SDS). The generated negatively charged micelles migrate from the cathode to
the anode after applying an electric current in the polyacrylamide gel. Since the gel acts like a molecular
sieve, similar to agarose gels (2.3.6), denatured SDS treated protein mixtures are separated dependent on
their size. Additional treatment with the reducing agents β-mercaptoethanol and/or dithiothreitol (DTT)
reduces disulfide bonds within proteins, promoting further protein denaturation.
To prepare protein samples for SDS-PAGE, protein solutions were mixed with the appropriate amount
of either reducing or non-reducing 5x SDS sample buffer (to a final concentration of 1x SDS sample
buffer). Samples containing reducing sample buffer were additionally supplemented with 200-300 mM
DTT (final concentration). All samples were heated, either for 5 min at 95 °C (purified protein sample) or
30 min at 37 °C (total cell lysates), and centrifuged for 5 min at 20,000x g. An appropriate amount of the
samplewas applied to a polyacrylamide gel (Tab. 12) including a PageRuler variant (Thermo Scientific) as
size standard. The electrophoresis was performed at 200 V for approximately 60-90 min (according to the
pore size) in aMini-PROTEAN II electrophoresis cell (Bio-Rad) filledwith SDS running buffer according
to Laemmli [228]. Polyacrylamid gels were either subjected to coomassie staining or to immunoblot
analysis (2.5.7).
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Tab. 12: SDS polyacrylamide gel composition
Dependent on the molecular mass of proteins to be separated, different acrylamide concentrations were used. APS
and TEMED start polymerization, and are therefore added last. The instruction refers to the preparation of two
gels (100 x 100 x 1 mm).
Resolving Gel Stacking Gel
Component 12 % 15 % 5 %
30 % acrylamide 4.0 ml 5.0 ml 1.0 ml
H2O 3.3 ml 2.3 ml 4.0 ml
1.5 M Tris pH 8.8 2.5 ml 2.5 ml —
1.5 M Tris pH 6.8 — — 750 µl
20 % SDS 50 µl 50 µl 30 µl
10 % APS 100 µl 100 µl 60 µl
TEMED 4 µl 4 µl 6 µl
To visualize proteins on polyacrylamide gels, PageBlue protein staining solution (Thermo Scientific)
was applied according to the manufacturer’s instructions. PageBlue is based on the coomassie brillant
blue G-250 dye, which binds unspecifically to cationic and hydrophobic amino acid residues. The sen-
tivity allows for detection of only 5 ng depending on the protein properties. To fix the proteins in the
gel matrix, gels were incubated in 10 % (v/v) acetic acid for 10 min. Since SDS interferes with Page-
Blue staining, gels were additionally washed twice with water. Staining was performed for 1-2 h at room
temperature. To reduce background staining, stained gels were washed twice with water.
2.5.7 Immunoblotting
The immunoblotting method, also known as western blotting, facilitates the transfer of proteins from a
gel matrix onto a membrane (e.g. nitrocellulose or PVDF) prior to immunodetection by specific antibod-
ies [229]. Therefore, a mixture of proteins is separated by SDS-PAGE according to their molecular mass
(2.5.6). During the transfer onto the membrane, an electric current is applied to pull the proteins from the
gel onto the membrane, maintaining the same organization as in the gel matrix. The blotted proteins are
exposed on a thin surface layer and can be visualized by immunostaining, allowing specific detection of
the protein of interest. The uniformity and overall effectiveness of transfer from the gel to the membrane
can be checked by staining the membrane with Ponceau S dye, which can be easily removed by wash-
ing with deionized water. A common method to analyze immunoblots is enhanced chemiluminescence
(ECL). For this purpose, horseradish peroxidase (HRP) enzymes are tethered to the protein of interest by
applying HRP-coupled antibodies. HRP catalyzes the conversion of ECL substrate (based on p-coumaric
acid and luminol) in the presence of hydrogen peroxide to a light emitting product, which can be detected
and documented using photographic films.
To transfer proteins from SDS polyacrylamide gels onto nitrocellulose membranes, a Trans-Blot SD
Semi-Dry transfer cell (Bio-Rad) was used according to the manufacturer’s instructions. Therefore, two
blotting papers (1.0 mm) and the nitrocellulose membrane were soaked with transfer buffer prior to as-
sembly into a stack of blotting paper, membrane, SDS polyacrylamide gel, and blotting paper. After
blotting at 15 V for 16 min (one blot) or 25 V for 30 min (four blots), the membranes were incubated in
blocking buffer for 30 min at room temperature (RT) to prevent unspecific antibody binding. For specific
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protein staining, membranes were incubated overnight at 4 °C with the appropriate antibody diluted in
blocking buffer (Tab. 13). The membranes were washed three times for 5-10 min at RT with TBS-T to
remove unbound antibodies. To detect unlabeled antibodies, the appropriate HRP-conjugated secondary
antibody was applied and incubated for 2-4 h at RT prior to ECL detection. Therefore, membranes were
washed again three times with TBS-T to remove unbound HRP-conjugated antibodies. For ECL detec-
tion, the membranes were incubated with ECL I solution for 5 min following incubation with ECL II
solution for 1 min. The chemiluminescence signals were documented using Super RX medical X-ray
film 100NIC (FujiFilm Europe GmbH).
Tab. 13: Antibody dilutions for immunoblot analyses
Antibodies were diluted in blocking buffer according to the manufacturer’s recommendation or tested in this
thesis.
Antibody Antigen/Isotype Dilution
anti-human NKp30, pep. immun. rabbit IgG 1:500
anti-human NKp30, polyclonal goat IgG 1:1,000
anti-rabbit IgG, HRP-conjug. goat IgG 1:10,000
anti-goat IgG, HRP-conjug. donkey IgG 1:30,000
anti-His, HIS-1, HRP-conjug. mouse IgG2a 1:2,000
anti-human IgG-Fc, HRP-conjug. goat IgG 1:10,000
2.5.8 Peptide Spot Array
Peptide arrays on cellulose membranes are synthesized with the unique SPOT technology, which allows
for efficient and inexpensive antibody epitope mapping or protein-protein interaction studies. In this
thesis, thismethodwas applied to determine the epitope(s) of the antibodies purified from rabbit antiserum
after peptide immunization. Therefore, peptide arrays of human NKp30 (18 amino acids, off-set by one
amino acid) were synthesized by Fmoc chemistry at activated PEG spacers on cellulose membranes by
automated parallel peptide synthesis on a MultiPep RS instrument (Intavis) [230, 231]. To use these
membranes for binding experiments, they were rehydrated by incubation with pure ethanol and stepwise
dilution with deionized water until there is no ethanol left. The membranes were washed three times with
TBS-T for 5 min and incubated with the blocking solution for 1 h at room temperature (RT). Antibody
incubation (anti-human NKp30, pep. immun.; anti-rabbit-IgG, HRP-conjug.) and ECL detection were
performed as described for immunoblot analyses (13).
2.5.9 Enzyme-Linked Immunosorbent Assay
Enzyme-linked immunosorbent assay (ELISA) is an approach to assess the amount of substances or bind-
ing affinities by color change applying HRP-conjugated antibodies. The basic principle of an ELISA is
to immobilize a protein on a solid support and incubate either with an interacting protein prior to or di-
rectly apply a specific antibody for detection. Notably, the absorbance (A) of a chromogenic substrate
converted by HRP is proportional to the amount of specifically bound detection antibody. In a satura-
tion binding experiment, the concentration (c) of the interacting protein/antibody is stepwise increased
from blank (buffer control) up to complete occupation of all binding places on the immobilized protein.
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Multiple washing steps ensure that only specifically bound proteins and/or antibodies are detected.
In this thesis, the Langmuir adsorption model is used to quantify specific binding as a function of the
concentration at room temperature. Assuming one site specific binding, the equilibrium binding constant
KD (ligand concentration that binds to half the receptor sites at equilibrium) and the maximum number
of binding sites Bmax are determined according to the following equation using the Prism 5 software
(GraphPad).
A = Bmax × c
KD + c
To asses the ligand binding affinity of the soluble NKp30 ectodomain proteins to the recombinant lig-
and B7-H6-Ig, 0.5 µg of B7-H6-Ig were coated overnight at 4 °C into one well of a 96-well MICROLON
microtiter plate (Greiner Bio-One) in a total volume of 100 µl of PBS. All further incubation and wash-
ing steps were performed at room temperature. The plate was washed four times with 300 µl of PBS-T
per well. To inhibit unspecific protein binding, the plate was incubated with 300 µl of 7.5 % BSA/PBS
per well for 1 h, and washed again four times with PBS-T. To apply graded amounts of soluble NKp30
ectodomain proteins, a 1:1 dilution series was generated using 1 % BSA/PBS covering a protein concen-
tration range of 400 nM-1.6 nM as well as a blank (buffer control) for background subtraction. Notably,
for determination of binding affinities, each data point represents the mean of triplicates whereas the
identification of 30Stalk-His or 30LBD-His protein containing SEC fractions (500 µl) was performed
in duplicates. 100 µl of each dilution or SEC fraction were applied to one well and incubated for 1 h.
The plate was washed four times with PBS-T prior to incubation with 100 µl per well of an anti-human
NKp30 antibody (Tab. 14) for 1 h.
Tab. 14: Antibody dilutions for ELISA
Antibodies were diluted in 1 % BSA/PBS according to the manufacturer’s recommendation or tested in this thesis.
Antibody Antigen/Isotype Dilution
anti-human NKp30, 210845 mouse IgG2a 10 µg/ml
anti-human NKp30, pep. immun. rabbit IgG 5 µg/ml
anti-human NKp30, polyclonal goat IgG 0.5 µg/ml
anti-human MICA, polyclonal goat IgG 0.5 µg/ml
anti-rabbit IgG, HRP-conjug. goat IgG 1:10,000
anti-goat IgG, HRP-conjug. donkey IgG 1:5,000
anti-human IgG-Fc, HRP-conjug. goat IgG 1:50,000
The plate was washed four times with PBS-T and incubated with 100 µl per well of the respective HRP-
conjugated detecion antibody for 1 h. The plate was washed four times with PBS-T prior to detection of
bound antibodies using 100 µl per well of 1-Step Ultra TMB-ELISA solution (Pierce) according to the
manufacturer’s instructions. TMB (3,3’,5,5’-tetramethylbenzidine) is a chromogenic substrate for HRP,
turning blue upon oxidization. To stop the reaction, 50 µl per well of 1 N sulfuric acid was applied, and
the color change to yellowwas detected at 450 nm in a microplate reader (Kinetic-QCL, Anthos Labtech).
As control protein, soluble MICA04-His (kindly provided by S. Weil in the lab of J. Koch at the Georg-
Speyer-Haus, Frankfurt am Main, Germany) was used. To verify the specificity of the NKp30-B7-H6
interaction by ELISA, the dilution series was pre-incubated with an anti-humanNKp30 blocking antibody
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(67 nM, clone 210845) for 1 h at 4 °C prior to application of 100 µl of this antibody-protein-complex
suspension per well as described for the protein dilution series.
2.5.10 Negative-Stain Electron Microscopy and 2D Class Averaging
Molecular transmission electron microscopy (TEM) in combination with image processing and recon-
struction techniques provides 3D structure information such as composition, size, flexibility and hetero-
geneity on single biomacromolecules [232]. To sustain the native structure of the proteins or protein com-
plexes during observation by TEM, the samples are fixed by rapid freezing for performing cryo electron
microscopy at liquid helium temperature (0 K at 1 atm). Due to technical limitations, the negative-stain
fixation method is applied more frequently. Upon adsorption on a solid support, the proteins are em-
bedded using a heavy metal salt such as uranyl acetate, which contrasts the structure and conserves the
structural information at moderate solution. To obtain information on the 3D structure, single particles
are identified on digital images (2D). Due to complex calculations using classification algorithms, similar
projections of the molecules are identified and summarized in 2D classes. Each of these classes repre-
sents a 2D projection of the investigated 3D complexes at a distinct solid angle. Upon characterization
of the respective spatial directions, a 3D modell can be combined [232].
To analyze the geometry of the NKp30 ectodomain oligomers (in cooperation with K. Davies from
the Department of Structural Biology at the Max Planck Institute of Biophysics, Frankfurt am Main,
Germany), the elution fractions of the size exclusion chromatography (Superose 6 10/300 GL column)
with the highest protein amount were chosen (2.5.2). The concentration of the oligomers was adjusted
to 0.1 mg/ml with buffer (50 mM Tris, 150 mM NaCl, pH 8, 4°C). To obtain a suitable distribution of
the oligomeric particles, the samples were diluted 1:4 (30Stalk-His) or 1:25 (30LBD-His) with the same
buffer. 3 µl of sample were applied to glow-discharged EM grids (400 mesh) containing a continuous
carbon support film. After 1 min, the samples were washed drop-wise with 20 µl of 1 % (w/v) uranyl
acetate and then incubated with 3 µl of stain for a further minute. Excess stain was removed with filter
paper (#4, Whatman). Electron microscopy was performed using a Tecnai Spirit electron microscope
(FEI, Eindhoven, The Netherlands) operating at 120 kV. Images were acquired at a nominal magnification
of 34,000x on a 4,096x4,096 pixel CCD (Ultrascan 4000, Gatan), which corresponds to a specimen pixel
size of 0.36 nm.
To get a first impression of the structural heterogeneity of the oligomeric complexes, more than 6.000
single particles for both the 30Stalk-His and 30LBD-His proteins were isolated from 2D images to iden-
tify similar projections for averaging in 2D classes (calculations kindly perfomed by K. Davies from
the Department of Structural Biology at the Max Planck Institute of Biophysics, Frankfurt am Main,
Germany).
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So far, there is only little known about how the germline-encoded NK cell receptor NKp30 is able to
recognize and interact with multiple ligands that are not related in sequence and structure. In this thesis,
a cross-talk between NKp30 and the other NCRs or NKp30 self-assembly were assumed to be possible
mechanisms to enhance ligand binding affinity for corresponding ligands by increased avidity. From
various eukaryotic cell lines, insect cells were identified as appropriate expression host for analyses of
single full-length NCRs or NCR combinations on the plasma membrane, representing a minimalistic NK
cell mimic without immunological background. Furthermore, soluble variants of the NKp30 ectodomain
were generated to investigate its oligomerization potential. Thereby, receptor homo-oligomerization was
identified as a key mechanism to increase the ligand binding affinity of NKp30. The generation of all
used full-length NCR and NKp30 ectodomain variants is described in detail in the ”Cloning Strategies”
section (2.3.10) and therefore, it is not further mentioned in the ”Results” section. Parts of this thesis are
published in Hartmann et al. (2012), Binici et al. (2013), and Herrmann et al. (2014) [166, 170, 233].
3.1 Functional Cooperation Between the NCRs
NKp30, one of the major activating NK cell receptors, recognizes multiple non-related ligands on various
pathogens, malignantly transformed cells, virus-infected cells, and even immature dendritic cells, thereby
bridging innate and adaptive immunity [3]. Interestingly, the molecular details of ligand recognition by
NKp30 and the NCRs in general are poorly characterized. In 2003, Augugliaro and colleagues [173]
could demonstrate a functional cross-talk between different NCRs within the plasma membrane of NK
cells. They found that the engagement of a single NCR resulted in the activation of the signaling cascade
associated with the other NCRs, which efficiently amplified activating signals. However, it is conceiv-
able that this cross-talk could also cause structural rearrangements of the NCR ectodomains and thereby
result in de novo formation of a composite binding site. Notably, an encounter of all three NCRs could
only occur on activated NK cells due to IL-2 dependent induction of NKp44 expression [99,100]. More-
over, upon IL-2 stimulation of NK cells not only NKp44 but a variety of activating NK cell receptors
including NKp30 are upregulated on the plasma membrane [68, 179–184]. This was also demonstrated
in this thesis by confocal laser scanning microscopy (CLSM) of freshly isolated (2.4.10) and IL-2 acti-
vated primary NK cells using an anti-NKp30 antibody (peptide immunized, Fig. 6). This increased local
concentration of NKp30 on the NK cell surface could drive homo-oligomerization resulting in improved
ligand recognition.
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Fig. 6: Increased NKp30 surface expression by IL-2 activation of primary NK cells
Primary NK cells were isolated from buffy coat and activated with IL-2 for seven days. NKp30 surface expression
of freshly isolated and activated primary NK cells was analyzed by confocal laser scanning microscopy (CLSM)
using an anti-NKp30 antibody (NKp30, red; DAPI, blue; size bar corresponds to 5 µm).
Interestingly, the heterogeneous decoration pattern upon binding of a recombinant NKp30 ectodomain
protein (30Stalk-Ig, detected by CLSM after decoration with FITC-coupled anti-hIgG1 antibodies) to
NKp30 ligand expressing HEK293T cells indicates crowding of ligand molecules on the target cell
surface (Fig. 7). Notably, ligand-induced receptor clustering is a common mechanism for receptor-
mediated signaling in immune responses [234–236]. This strengthens the hypothesis of NKp30 homo-
oligomerization for improved ligand recognition and increased binding affinity.
Fig. 7: Decoration pattern upon binding of 30Stalk-Ig proteins on NKp30 ligand positive HEK293T cells
Binding of 30Stalk-Ig proteins to HEK293T cells was analyzed by CLSM using an anti-hIgG1-Fc antibody (anti-
hIgG1-Fc, green; To-Pro-3, blue; size bar corresponds to 8 µm, modified from [170]).
3.2 Insect Cells as Tool for Indivdiual Analyses of Recombinant
Full-Length Natural Cytotoxicity Receptors
3.2.1 Full-Length NKp30 Surface Expression on Mammalian Cell Lines
Crowded ligand molecules on the target cell surface as well as an increased local receptor concentration
on the plasma membrane upon IL-2 stimulation of primary NK cells indicate pre-clustering of NKp30 to
facilitate specific ligand binding and efficient signal transduction for enhanced NK cell cytotoxicity. To
investigate the homo-oligomerization potential of NKp30, different eukaryotic cell lines were analyzed
with respect to recombinant receptor surface expression level.
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For transient expression of the recombinant full-length NKp30 receptor fused to a C-terminal deca-
histidine tag (NKp30-His), HEK293T cells were transfected with the construct pIRES2-NKp30opt-His-
EGFP using the PEI transfection method (2.4.5). As mock control, HEK293T cells were transfected with
empty vector. Due to an IRES element, all transfectants constitutively expressed cytosolic GFP. 72 h
post transfection, the transfection efficiency (GFP expression) and the NKp30 surface expression (anti-
NKp30, polyclonal) were monitored by flow cytometry (2.4.12) (Fig. 8). Based on the GFP expression,
less than 50 % of the cells were transfected. Moreover, only moderate and inhomogeneous expression of
surface NKp30-His was found on the plasma membrane of transfected HEK293T cells. Similar results
were obtained by S. Weil (in the lab of J. Koch at the Georg-Speyer-Haus, Frankfurt am Main, Germany
[237]). Notably, transfection of other eukaryotic cell lines such as the human pancreatic carcinoma cell
line MiaPaCa-2 did not improve the transfection efficiency (data not shown).
Fig. 8: Surface expression of NKp30-His on transfected HEK293T cells
HEK293T cells were transfected with pIRES2-NKp30opt-His-EGFP (NKp30-His) or pIRES2-EGFP (mock) plas-
mids. NKp30-His surface expression was analyzed 72 h post transfection by flow cytometry using an anti-NKp30
antibody (anti-NKp30, red line; antibody control, dashed line; cytosolic GFP, green line).
To increase the surface expression level of NKp30, HEK293 cells were transduced with lentiviral par-
ticles for stable integration of the introduced NKp30 DNA into the genome. For this purpose, lentiviral
particles were produced by HEK293T cells upon triple transfection with the LeGO-NKp30opt-His-iG2
construct (encoding for NKp30-His) or empty vector (mock control) and two helper plasmids using the
PEI method (2.4.7). 24 h post transfection, GFP expression was monitored by fluorescence microscopy
(Fig. 9A). Notably, after transfection with the LeGO-NKp30opt-His-iG2 construct, less HEK293T cells
survived suggesting that recombinant full-length NKp30-His might be cytotoxic. However, since the
transfection efficiency was determined at 80-90 % for mock and 50 % for NKp30-His, lentiviral parti-
cles were harvested 72 h post transfection from the cell culture supernatants and used for transduction
of HEK293 cells or stored. As this approach was a proof of concept, virus titers of lentiviral particles
for NKp30-His and mock expression have not been adapted. Four weeks after lentiviral transduction
of the HEK293 cells, GFP expressing single cell clones were isolated by limiting dilution to generate a
cell line with high NKp30 surface expression. After seven weeks of proliferation, surface NKp30-His
(anti-NKp30, polyclonal) and GFP expression of the remaining single cell clones (six clones for both
NKp30-His and mock control) were investigated by flow cytometry. Dot plots of the clones with highest
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NKp30-His surface and/or GFP expression are shown in Fig. 9B. Though stable integration obviously
enhanced the GFP expression in the mock control (more than 90 % GFP positive cells), this was not the
case for transduction with lentiviral particles encoding NKp30-His (51 % GFP positive cells). Moreover,
only 10 % of these GFP positive cells expressed NKp30-His on the cell surface (anti-NKp30, polyclonal)
implying difficulties with the receptor transport to or the stabilization on the plasma membrane.
Fig. 9: Generation of NKp30-His expressing cells by lentiviral transduction
(A) HEK293T cells were transfected with LeGO-NKp30opt-His-iG2 (NKp30-His) or LeGO-iG2 (mock) and two
helper plasmids for lentiviral particle production. After 24 h, the transfection efficiency was determined by fluo-
rescence microscopy based on the number of cells expressing GFP (cytosolic GFP, GFP; transmitted light, trans).
Size bar corresponds to 70 nm. (B) GFP expressing single HEK293 cell clones were isolated by limiting dilution
four weeks after lentiviral transduction. After seven weeks of proliferation, NKp30-His surface expression was an-
alyzed by flow cytometry using an anti-NKp30 antibody. Dot plots of cell clones with the highest GFP expression
are shown. (C) One week after lentiviral transduction of Jurkat cells, NKp30-His surface expression was analyzed
by flow cytometry using an anti-NKp30 antibody.
For intracellular signaling, NKp30 associates with its adapter protein CD3ζ via opposite charged amino
acid residues within their transmembrane domains. However, it is still unknown whether CD3ζ could im-
prove the NKp30 surface expression by assistance during the transport to or even by stabilization within
the plasma membrane of the expression host. To provide this putative support, Jurkat cells (human T
cell lymphoma cell line constitutively expressing CD3ζ) were transduced with the lentiviral particles
for stable NKp30-His surface expression. Notably, the same preparation of lentiviral particles that was
applied for the transduction of the HEK293 cells was used in this approach. One week after lentiviral
transduction of the Jurkat cells, cytosolic GFP and surface NKp30-His expression were analyzed by flow
cytometry using an anti-NKp30 antibody (polyclonal). Since HEK293 cells are much easier to transfect
or transduce, a decrease of the transduction efficieny was expected. This assumption was confirmed by a
lower percentage (77%) of GFP expressingmock transduced Jurkat cells. Furthermore, after transduction
with NKp30-His encoding lentiviral particles a very low transduction efficiency (7 % GFP positive cells)
and thereby no relevant surface NKp30-His expression could be observed (Fig. 9C). Although NKp30
expression was observed in a HeLa cell line, which stably expresses recombinant CD3ζ [238], an asso-
ciation with the adapter protein CD3ζ in Jurkat cells did not enhance the NKp30-His surface expression.
As mentioned above, the functional cross-talk between the NCRs concerning intracellular signaling was
already demonstrated [173]. In this respect, NKp46 alone or in combination with NKp44 might stabilize
NKp30 on the cell surface.
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3.2.2 Co-Expression of Full-Length NCRs on the Plasma Membrane of Insect Cells
Since NKp30-His surface expression upon transfection or lentiviral transduction of mammalian cells was
not sufficient and moreover, the constitutive expression of the adapter protein CD3ζ alone could not sta-
bilize NKp30-His on the cell surface, all three recombinant NCRs were produced simultaneously and
with comparable expression levels within one cell. For this purpose, the MultiBac expression system for
insect cells was used. A multigene transfer vector was generated, which contained all the three genes en-
coding NKp30-His, NKp44-His and NKp46-His (2.3.4). Upon optimization of the transfection protocol
(collaboration with I. Berger, European Molecular Biology Laboratory, Grenoble, France), baculovirus
particles were produced (2.4.3) for the infection of Sf 9 insect cells (2.4.4). Transfection and infection
efficiencies were monitored by intrinsic YFP expression of the insect cells (Fig. S3A and C, see 7.1.3).
96 h post baculoviral infection, recombinant NCR expression on the insect cell surface was analyzed by
CLSM with NCR-specific antibodies in combination with a detection antibody (Alexa546-conjugated
anti-mouse IgG antibody, Fig. 10). Strikingly, not only NKp30-His but also NKp44-His and NKp46-His
were expressed on the surface of all YFP expressing cells.
Fig. 10: Simultaneous NCR surface expression on insect cells post baculoviral infection
Sf 9 insect cells were infected with baculovirus particles encoding for NKp30-His, NKp44-His, and NKp46-His
simultaneously. NCR surface expression was analyzed by CLSM using NCR-specific antibodies (anti-NKp30,
anti-NKp44, anti-NKp46, red; cytosolic YFP, green; size bar corresponds to 10 µm).
Intriguingly, insect cells are capable of presenting all three recombinant NK cell receptors in combina-
tion on the cell surface. To clarify if recombinant NKp30-His surface expression on insect cells was due
to an interaction with NKp46-His and/or NKp44-His or maybe resulted from changing the expression
system, the NKp30-His surface level on insect cells functionalized only with the single recombinant NK
cell receptor was analyzed.
3.2.3 Expression of Functional Full-Length NKp30 in Insect Cells
Based on the successful surface expression of all three NCRs, insect cells were infected with baculovirus
particles encoding only NKp30-His. Notably, High Five insect cells were applied for further experiments
due to their increased recombinant protein expression level. Transfection and infection efficiencies were
again monitored by intrinsic YFP expression (Fig. S3A and B, see 7.1.3). 96 h post baculoviral infection
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of High Five insect cells, full-length NKp30-His protein was detected by immunoblot analysis (anti-
NKp30, polyclonal) after immunoprecipitation (anti-NKp30, clone P30-15) from lysates of NKp30-His
infected but not from lysates of non-infected insect cells (Fig. 11A). NKp30-His (predicted molecular
mass from primary sequence: 23 kDa) was detected as a protein band with an apparent molecular mass
of roughly 30 kDa indicating post-translational modifications. In order to investigate whether NKp30-His
was targeted to the insect cell surface, CLSM and flow cytometry analyses (anti-NKp30, clone P30-15)
were performed (Fig. 11B and C). NKp30-His was exclusively found on the plasmamembrane of infected
insect cells. These data suggest that the overall folding of NKp30-His was correct since it had passed the
endoplasmic reticulum (ER) quality control. Surprisingly, the expression level was significantly higher
when compared to the NKp30-His surface expression of transfected or lentivirally transducedmammalian
cell lines.
Fig. 11: Expression of functional NKp30-His on insect cells
High Five insect cells were infected with baculovirus particles encoding NKp30-His. (A) Immunoblot after im-
munoprecipitation of NKp30-His (anti-NKp30) from lysates of infected or non-infected insect cells. (B/C) Deco-
ration of NKp30-His infected and non-infected insect cells with an anti-NKp30 antibody to analyze NKp30 surface
expression by CLSM (anti-NKp30, red; DAPI, blue; size bar corresponds to 20 µm) and flow cytometry (unstained,
solid gray; antibody control, dashed line; anti-NKp30, red line). (D/E) B7-H6-Ig fusion protein binding to NKp30-
His infected and non-infected insect cells was analyzed by CLSM (B7-H6-Ig fusion protein, red; DAPI, blue; size
bar corresponds to 20 µm) and flow cytometry (unstained, solid gray; antibody control, dashed line; B7-H6-Ig
fusion protein, red line, modified from [233]).
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In order to prove that NKp30-His adopts a ligand binding receptive conformation, decoration ofNKp30-
His infected and non-infected insect cells with recombinant B7-H6-Ig fusion protein was analyzed by
CLSM and flow cytometry (DyLight649-conjugated anti-hIgG1-Fc, Fig. 11D and E). Strikingly, bind-
ing of the recombinant ligand B7-H6-Ig to NKp30-His was detected only at the plasma membrane of
infected insect cells, demonstrating that NKp30-His expressed in insect cells is functionally equivalent
to that derived from human expression hosts.
3.3 Soluble NKp30 Ectodomain Proteins for Investigation of the NKp30
Homo-Oligomerization Potential
Full-length NKp30-His presented on the surface of baculovirus-infected insect cells displays a functional
equivalent to NKp30 derived from NK cells. Therefore, insect cells are a suitable expression host for in-
vestigation of recombinant NKp30-His. However, the baculovirus infectionmethod is both beneficial and
disadvantageous. Since in cell culture the polyhedrin coat is not essential for virus propagation, recom-
binant gene expression is under control of the extremely strong and late polyhedrin promoter facilitating
high recombinant protein expression levels. However, to further spread baculovirus infection to the sur-
rounding cells, occlusion bodies are released by viral cell lysis at approximately the same time point when
high levels of full-length NKp30-His proteins are located within the plasmamembrane (compare YFP ex-
pression level, Fig. S3B, see 7.1.3). Therefore, molecular investigation of NKp30 homo-oligomerization
within an intact plasma membrane of infected insect cells would only be possible at early time points
after infection. Since NKp30 self-assembly is assumed to occur at high local concentrations, these stud-
ies would be unreliable. Besides, not only ligand binding but also possible self-assembly or interaction
with other surface molecules are expected to occur via the extracellular part of NKp30. Therefore, an
individual investigation of the NKp30 ectodomain as soluble protein turned out to be more reasonable to
identify putative interaction sites.
So far, bivalent NKp30 ectodomain proteins fused to an human IgG1-Fc part were produced in mam-
malian host cell lines and employed for cell decoration experiments to elucidate NKp30 target cell lines
or novel cellular NKp30 ligands [124, 125, 133, 134, 136]. Furthermore, studies concerning ligand bind-
ing and signaling of NKp30 were performed with these bivalent NKp30-Ig fusion proteins exhibiting
post-translational modifications. It was demonstrated that the stalk domain as well as the N-linked gly-
cosylation of the acceptor sites N42, N68 and N121 within the NKp30 ectodomain are crucial for ligand
binding [170]. However, these fusion constructs are constituted in an antibody-like architecture. This
induced dimerization could have a boosting or even impeding influence on the NKp30 self-assembly or
interaction with binding partners. To reveal the impact of the stalk domain on NKp30 self-assembly and
its promoting influence on ligand binding, monovalent, post-translationally modified NKp30 ectodomain
proteins with (30Stalk-His) and without (30LBD-His) membrane proximal stalk domain were produced.
Sincemammalian cells were again not applicable (H. Berberich, in the lab of J. Koch at the Georg-Speyer-
Haus, Frankfurt am Main, Germany, data not shown [239]), insect cells were used due to their proven
record of succes in expression of functional NKp30-His (3.2.3).
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3.3.1 Expression of Soluble Variants of the NKp30 Ectodomain in Insect Cells
In 2011, the 3D structure of the NKp30 ligand binding domain was solved by two independent groups
revealing a globular Ig domain comprising the amino acids L19 to E128 [116,117]. Moreover, Mariuzza
and colleagues determined the structure of NKp30 in complex with its ligand B7-H6 and validated the
contacts by equilibrium binding of wild-type NKp30 and mutant versions to B7-H6 [117]. Interestingly,
interaction studies with bivalent NKp30-Ig fusion proteins showed that the NKp30 ligand binding domain
is sufficient for B7-H6 binding. Furthermore, these studies clearly demonstrated that the membrane prox-
imal stalk domain significantly increases NKp30-B7-H6 binding [170], but the precise role of the NKp30
stalk domain on ligand binding remained obscure. A direct participation of the NKp30 stalk domain in
B7-H6 binding was rather unlikely since this interaction would strongly decrease the flexibility of the
stalk domain and thus increase its crystallizability. In contrast, an NKp30 ectodomain self-assembly to a
larger complex via the stalk domain would be more reasonable, which results in enhanced ligand binding
affinity by increased avidity. To confirm this hypothesis and compare ligand binding with previous stud-
ies, the construct design for the recombinant expression of the globular NKp30 ligand binding domain
(30LBD-His, amino acids L19-E128) and the entire ectodomain of NKp30 including its stalk domain
(30Stalk-His, amino acids L19-R143) was in analogy to the NKp30-Ig fusion proteins [170]. Notably,
both constructs contain an N-terminal gp67 secretion sequence and a C-terminal deca-histidine tag for
affinity purification.
To produce baculovirus particles encoding 30LBD-His or 30Stalk-His proteins, Sf 9 insect cells were
transfected with plasmid pFastBac1-gp67ss-NKp30LBD-TEV-His or pFastBac1-gp67ss-NKp30LBD-
Stalk-TEV-His (2.4.3). Since both constructs are under the control of the extremely strong and late
polyhedrin promoter, highest recombinant gene expression was observed at 72 h post infection of the
High Five insect cells (2.4.4, compare YFP expression level, Figures S3D and E, see 7.1.3). Due to viral
host cell lysis, at this time large amounts of baculovirus particles were present in the 30Stalk-His and
30LBD-His proteins containing cell culture supernatants, which might interfere with subsequent assays
and therefore had to be removed. To investigate whether the baculovirus particles were depleted during
affinity purification, samples prior to and post dialysis as well as post IMAC were collected (2.5.1.1).
According to the glycoprotein 64 containing baculovirus envelope, baculovirus particles containing sam-
ples were identified by immunoblot analyses (anti-gp64, exemplarily shown for 30Stalk-His containing
supernatant, Fig. 12A). Since baculovirus contaminations persisted during affinity purification, an ultra-
centrifugation step for virus depletion (2.4.4) prior to IMACwas added. Immunoblot analysis (anti-gp64)
of supernatants containing 30Stalk-His proteins prior to and post ultracentrifugation confirmed complete
removal of baculovirus contamination (Fig. 12B).
However, not only baculovirus particles but also large amounts of 30Stalk-His proteins were detected
in precipitates from ultracentrifugation by immunoblot analysis (anti-NKp30, polyclonal, Fig. 12C). By
contrast, 30LBD-His protein precipitation was not observed (data not shown). Interestingly, this drasti-
cally decreased amount of 30Stalk-His proteins by ultracentrifugation due to its intrinsic affinity to form
higher molecular complexes indicated for the first time a potential relevance of the stalk domain for
naturally occuring self-assembly of NKp30 ectodomains.
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Fig. 12: Reduced yield of soluble 30Stalk-His proteins due to depletion of baculovirus particles
Infected insect cell culture supernatant contains secreted 30Stalk-His proteins and baculovirus particles. (A)
30Stalk-His containing aliquots from different purification steps were analyzed for baculovirus particle contami-
nation by immunoblot (anti-gp64). Arrow, baculoviral glycoprotein 64 (gp64). (B) Aliquots of 30Stalk-His con-
taining insect cell culture supernatants prior to and post ultracentrifugation were analyzed for baculovirus particle
contamination by immunoblot (anti-gp64). Arrow, baculoviral glycoprotein 64 (gp64). (C) Precipitate from ultra-
centrifugation was analyzed for 30Stalk-His depletion by immunoblot (anti-NKp30). Arrow, 30Stalk-His proteins.
Generally, per litre insect cell culture supernatant more than 5 mg 30LBD-His proteins were obtained
whereas only up to 1.5 mg 30Stalk-His proteins could be purified to homogeneity by IMAC as demon-
strated by non-reducing SDS-PAGE and corresponding immunoblot analyses (anti-NKp30, polyclonal,
Fig. 13). Since the volumes of cell culture supernatants for purification and aliquots for SDS-PAGE
and immunoblot were equal for 30Stalk-His and 30LBD-His proteins, figure 13 illustrates the difference
in total protein amount after purification. Notably, differences in the molecular mass (double or triple
protein bands) reflect incomplete post-translational protein modification most likely due to a capacity
overload of the glycosylation machinery.
Fig. 13: Affinity purification of soluble variants of the NKp30 ectodomain produced in insect cells
(A/B) Non-reducing SDS-PAGE (coomassie-stained) and immunoblot (anti-NKp30) of aliquots (input, flow-
through (ft), wash, and eluates) from purification after ultracentrifugation and dialysis of cell culture supernatants
containing (A) the entire NKp30 ectodomain (30Stalk-His) and (B) the NKp30 ectodomain without stalk domain
(30LBD-His). Arrow, fully glycosylated NKp30 ectodomain protein. (Modified from [233].)
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Insect cells are able to perform post-translational modifications such protein glycosylation or forma-
tion of disulfide bonds between cystein residues. The ectodomain of NKp30 contains two cysteins (C39
and C108) which form an intramolecular disulfide bond [116,117]. To exclude the formation of artificial
intermolecular disulfide bonds, which might occur due to incomplete protein folding and exposure of
reactive sulfhydryl groups, both NKp30 ectodomain proteins were investigated at reducing (+DTT) and
non-reducing (-DTT) conditions. As shown by SDS-PAGE and corresponding immunoblot (anti-NKp30,
polyclonal) analyses, there is no difference in the apparant molecular mass of the 30Stalk-His or 30LBD-
His proteins at both conditions indicating correct protein folding and the absence of artificial intermolecu-
lar disulfide bonds (Fig. 14A). As expected from the results of full-length NKp30-His expression (3.2.3),
the apparent molecular mass of the 30-Stalk-His (20 kDa vs. 16.6 kDa) and the 30LBD-His proteins
(18 kDa vs. 15 kDa) differed from that predicted from primary sequence indicating post-translational
modification. Glycosylation of the three acceptor sites for N-linked glycosylation within the ectodomain
of NKp30 was investigated by reducing SDS-PAGE and immunoblot (anti-NKp30, polyclonal) analyses
after enzymatic deglycosylation with PNGase F (cleavage of N-linked glycans) or with an enzyme mix
(cleavage of N- and O-linked glycans, Fig. 14B).
Fig. 14: Post-translational modifications of soluble NKp30 ectodomain proteins
(A) Non-reducing (-DTT) and reducing (+DTT) SDS-PAGE (coomassie-stained) and immunoblot (anti-NKp30,
polyclonal) of purified 30Stalk-His and 30LBD-His proteins. (B) Reducing SDS-PAGE (coomassie-stained) and
immunoblot (anti-NKp30, polyclonal) of untreated (30Stalk-His: lane 1, 30LBD-His: lane 4), PNGase F (30Stalk-
His: lane 2, 30LBD-His: lane 5) or enzyme mix treated (30Stalk-His: lane 3, 30LBD-His: lane 6) NKp30
ectodomain proteins. Arrows, tri-, di-, mono- and non-glycosylated proteins. Asterisk, PNGase F. (C) Immunoblot
(anti-NKp30, polyclonal) of purified 30Stalk-His protein without (lane 1) or with (lane 2) tunicamycin treatment
1 h post infection prior to protein expression to inhibit N-linked protein glycosylation. Arrows, tri-, di-, and non-
glycosylated protein. (Modified from [233].)
For both, the 30Stalk-His and the 30LBD-His proteins, a distinct pattern of protein bands was observed
due to incomplete deglycosylation corresponding to tri-, di-, mono- and non-glycosylated proteins. No-
tably, modification of the assay conditions, such as increasing the amount of enzyme or extending the
incubation time, did not influence the relative amount of differentially glycosylated forms of NKp30.
Most likely this is due to insect cell-specific glycosylation of proteins with an α1-3 fucose residue at the
innermost N-acetylglucosamine (GlcNAc) residue of the glycoprotein, which is resistant to PNGase F
cleavage. Therefore, tunicamycin was employed to inhibit the first step of N-linked glycosylation. Strik-
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ingly, tunicamycin treatment of the insect cell culture 1 h post infection (2.4.11) quantitatively blocked
N-linked glycosylation of the NKp30 ectodomain as shown by comparative immunoblot analysis (anti-
NKp30, polyclonal) of purified 30Stalk-His proteins (Fig. 14C). Moreover, the reduction of the total
protein amount (reflected by protein bands in figure 14C as well as YFP fluorescence intensities in fig-
ures S3D and F, see 7.1.3) as a consequence of imperfect protein folding and thus increased protein
degradation underlines the impact of glycosylation on protein folding and stabilization in general. In
conclusion, these studies show, that the ectodomain of NKp30 produced in insect cells is N-linked gly-
cosylated at its three known acceptor sites (N42, N68, N121) in the absence ofO-linked glycans and thus
represents a molecular equivalent to the ectodomain of human NKp30 which can be employed for further
studies.
3.3.2 An Antibody with Defined Specificity for the NKp30 Ligand Binding Domain
To date, several anti-human NKp30 antibodies are commercially available, which are suitable for differ-
ent biochemical and cellular approaches. In general, these antibodies are not characterized extensively
concerning their epitopes, blocking capacities and application possibilities. Hence, an antibody, suitable
for diverse applications such as cell decoration assays, ELISA or immunoblot analyses, was generated.
Due to a defined epitope (amino acids P62 to R75) situated within the NKp30 ligand binding domain
(Fig. 15A), the antibody consequently binds to both 30Stalk-His and 30LBD-His proteins to the same ex-
tent. This peptide stretch is located outside of the NKp30-B7-H6 binding pocket with close proximity to
the plasma membrane, which allows for the investigation of putative homo-oligomerization for enhanced
ligand binding affinity by increased avidity. Notably, this sequence is of further interest, since it contains
N68, one of the three known acceptor sites for N-linked glycosylation. NKp30 ectodomain glycosyla-
tion at position N68 was identified to be essential for efficient intracellular signaling upon engagement
of B7-H6 [170].
To generate antibodies recognizing a defined epitope located within the NKp30 ligand binding do-
main, the antigenic peptide NH2-CPGKEVRNGTPEFRGR-COOH was synthesized for immunization
of two rabbits (BioScience/PepScience, Göttingen, Germany). Roughly 1 mg of peptide specific anti-
bodies could be purified from 25 ml of rabbit antiserum by immunoaffinity chromatography (2.5.1.3).
Multiple protein bands in reducing SDS-PAGE and corresponding immunoblot (anti-rabbit IgG) analyses
of concentrated peptide antibody as well as aliquots from purification illustrated the heterogeneity of the
purified rabbit IgG antibody subtypes (Fig. 16A). However, antigen-specificity was exemplarily demon-
strated by immunoblot analyses of recombinant 30Stalk-His proteins (Fig. 16B). For reference, the same
amount of 30Stalk-His proteins (2 µg) was detected with the polyclonal anti-NKp30 antibody. Higher
signal intensities obtained for the polyclonal (goat) when compared to the peptide immunized anti-NKp30
antibody (rabbit) were either due to different antibody affinities or due to recognition of the entire NKp30
ectodomain, and thereby binding of more than one antibody molecule per 30Stalk-His protein.
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Fig. 15: Epitope of the ligand binding domain-specific anti-NKp30 antibody
(A) B7-H6 (gray) bound crystal structure of the NKp30 ligand binding domain (blue, amino acids L19-E130); PDB
3PV6. The peptide stretch used for immunization is shown in green. Asparagines within consensus motifs for N-
linked glycosylation are depicted in red with corresponding amino acid annotation. N- (yellow) and C-terminus
(orange) are indicated. The structural illustration was made with PyMol software. (B) Overlapping peptide arrays
(18 amino acids long peptides, off-set by one amino acid) of human NKp30 were probed with purified anti-NKp30
antibody (peptide immunized) and detected with a rabbit-IgG-specific HRP-conjugated antibody. The identified
interaction hot-spot is marked with a black box. The interaction hot-spot containing the entire peptide sequence
used for immunization is marked with a red box. (C) Sequences of human NKp30 peptides identified as interaction
hot-spots shown in B (green: sequence of peptide used for immunization; red: peptide spots containing the entire
peptide sequence used for immunization).
In general, linear antibody epitopes comprise six to nine amino acids. Epitopes ofmonoclonal and poly-
clonal antibodies binding to linear peptide stretches can be identified by overlapping sequences from pep-
tide spot arrays. To verify the recognition of the expected linear sequence within the NKp30 ectodomain,
peptide spot arrays of human NKp30 (18 amino acids, off-set by one amino acid) were synthesized and
probed with the purified anti-NKp30 peptide antibody (2.5.8). A binding region of 37 amino acids in
length (peptide spots B16 to B35, Fig. 15B) was identified demonstrating the presence of three or more
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antibody variants within the peptide purified antibody pool. These antibodies recognize different, proba-
bly overlapping epitopes with at least six amino acids of the selected region of the NKp30 ligand binding
domain (see sequence of spot B35, Fig. 15C). N- and C-terminal truncations of this 37 amino acids long
binding region could possibly narrow down but not definitely identify all distinct epitope sequences due to
their putative overlap. However, the anti-NKp30 antibody variants obtained from peptide immunization
specifically bind to the linear amino acid sequence of denatured NKp30 ectodomain proteins (Fig. 16B),
and moreover recognize the epitope in its native conformation validated by detection of folded NKp30
ectodomain proteins in cell decoration and ELISA experiments (Fig. 17).
Fig. 16: Purification of and immunoblot with the ligand binding domain-specific anti-NKp30 antibody
(A) Non-reducing SDS-PAGE (coomassie-stained) and immunoblot (anti-rabbit IgG) of aliquots (input, flow-
through (ft), washes, eluates, and concentrated (conc.)) from purification of rabbit antiserum after peptide immu-
nization. Arrows, heavy and light chains of rabbit IgG. (B) Specificity of commercially available polyclonal (goat)
and peptide immunized (rabbit) anti-NKp30 antibodies for the detection of 30Stalk-His proteins in immunoblot
analyses.
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3.4 Homo-Oligomerization of the NKp30 Ectodomain Increases the
Binding Affinity for Its Cellular Ligand B7-H6
3.4.1 High Affinity Binding of the NKp30 Ectodomain Proteins to B7-H6
In order to examine the ligand binding properties of the soluble NKp30 ectodomain proteins and to study
the contribution of the stalk domain to ligand binding, cell decoration experiments, signaling reporter
cell assays, and ELISA were performed. For cell decoration experiments, NKp30 ligand-negative Ba/F3
cells stably transduced with the cellular NKp30 ligand B7-H6 and GFP (Ba/F3-B7-H6) or GFP only
(Ba/F3-GFP) were incubated with 30Stalk-His and 30LBD-His proteins (2.4.12). Plasma membrane-
attached NKp30 ectodomain proteins were visualized with anti-NKp30 antibody (peptide immunized)
by CLSM. Specific binding of the 30Stalk-His and 30LBD-His proteins to B7-H6 on the plasma mem-
brane of Ba/F3-B7-H6 cells was detected (Fig. 17A). In accordance with previous cell decoration studies
with NKp30-Ig fusion proteins [170], binding of soluble 30Stalk-His proteins to plasma membrane B7-
H6 was significantly stronger than that of 30LBD-His proteins. This observation was nicely reflected by
flow cytometry measurements performed with these cells (Fig. 17B). Again, decoration of Ba/F3-B7-H6
cells with 30Stalk-His proteins led to much higher signal intensities when compared to 30LBD-His pro-
teins. For reference, no binding of 30Stalk-His or 30LBD-His proteins to Ba/F3-GFP cells was observed.
Importantly, the receptor ligand interaction was highly specific since it could be quantitatively competed
with an anti-NKp30 blocking antibody (clone 210845).
As demonstrated by representative NKp30 stainings of Ba/F3-B7-H6 cells in Figure 17A, a distinct
dotted pattern was observed upon decoration with the 30Stalk-His and 30LBD-His proteins suggesting
formation of oligomeric receptor-ligand complexes. Quantitative analyses of a large number of cells
(30Stalk-His: n=42; 30LBD-His: n=56) revealed an equal average number of clusters per cell (30Stalk-
His: 53.4 ± 1.7 pixel; 30LBD-His: 53.1 ± 1.5 pixel) following binding of the NKp30 ectodomain pro-
teins (Fig. 17C top). These data imply that the number of clusters is mainly dependent on the ligand
concentration on the target cell. By contrast, the mean cluster size following binding of 30Stalk-His pro-
teins (257.7 ± 16.9 pixel) was significantly increased when compared to the clusters induced by binding
of 30LBD-His proteins (123.5 ± 6.5 pixel, Fig. 17C bottom). Thus, the investigation of receptor-ligand
complexes on target cells decorated with soluble NKp30 ectodomain proteins strengthened the hypothesis
that the stalk domain promotes formation of NKp30 ectodomain oligomers.
In order to test whether the soluble ectodomain variants of NKp30 can inhibit a productive NKp30-
dependent NK cell-target cell interaction, signaling reporter assays were performed in the absence and
presence of 30Stalk-His and 30LBD-His proteins (2.4.15). Therefore, the A5-30FL-His reporter cell line
was employed as an effector cell, which couples NKp30/CD3ζ chain-dependent signaling to proportional
GFP expression (Fig. 17D) [170]. Ba/F3-B7-H6 cells were used as target cells. The extend of signaling
was measured by flow cytometry based on the percentage of GFP positive A5-30FL-His reporter cells
(Fig. 17E). In the absence of blocking proteins, Ba/F3-B7-H6 cells induced robust NKp30-dependent sig-
naling of the A5-30FL-His reporter cells, which could be inhibited by binding of an anti-NKp30 blocking
antibody (clone P30-15) to the A5-30FL-His reporter cells (blocking control). Furthermore, signaling
was decreased by decoration of the Ba/F3-B7-H6 cells with 30Stalk-Ig proteins but not influenced by a
non-relevant control protein (Ifnar2-Ig).
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Fig. 17: High affinity binding of NKp30 ectodomain proteins to the cellular ligand B7-H6
(A) Binding of 30Stalk-His or 30LBD-His proteins to B7-H6 transduced Ba/F3 cells was monitored by an anti-
NKp30 antibody via CLSM (anti-NKp30, red; GFP, green; DAPI, blue; size bar corresponds to 5 µm). (B) Binding
of 30Stalk-His and 30LBD-His proteins (red line) and specific blocking with an anti-NKp30 antibody (dashed line)
were analyzed by flow cytometry (antibody control, solid gray). (C) Quantification of clusters observed on B7-H6
transduced Ba/F3 cells after decoration with 30Stalk-His and 30LBD-His proteins. Data points represent the num-
ber of clusters (upper panel) and the mean cluster size (lower panel) on a large number of individual cells decorated
with 30Stalk-His (red) or 30LBD-His (blue) proteins. Mann-Whitney test: ns, p = 0.9914; ***, p < 0.0001. (D)
A5-30FL-His reporter cells were mixed with B7-H6 transduced Ba/F3 target cells. Upon NKp30-B7-H6 interac-
tion, downstream signaling via CD3ζ results in GFP expression in the A5-30FL-His reporter cells. Pre-incubation
of Ba/F3-B7-H6 target cells with 30Stalk-His or 30LBD-His protein blocks the effector-target interaction as in-
dicated by the absence of GFP expression in the A5-30FL-His reporter cells. (E) The Ba/F3-B7-H6 target cells
were pre-incubated with blocking proteins (30Stalk-His, red; 30LBD-His, blue; 30Stalk-Ig, dark gray; Ifnar2-Ig
(control), light gray; concentrations indicated) prior to co-incubation (16 h) with A5-30FL-His reporter cells. As
control, A5-30FL-His reporter cells were pre-incubated with an anti-NKp30 antibody (white) to inhibit signaling.
For reference corresponding signaling without blocking protein (black) was normalized to 100 %GFP positive A5-
30FL-His reporter cells. (F) Binding of graded amounts of 30Stalk-His (red square, KD: 5 ± 3 nM), 30LBD-His
(blue circle,KD: 29 ± 1 nM) or MICA*04-His (control, gray triangle) proteins to recombinant B7-H6-Ig fusion
protein analyzed by ELISA. Data were fit to a 1:1 Langmuir binding model to determine equilibrium binding con-
stants (KD). A representative of eight independent experiments is shown. (G) Binding of 30Stalk-His (100 nM,
red) and 30LBD-His (100 nM, blue) proteins to recombinant B7-H6-Ig fusion protein analyzed by ELISA. Pre-
incubation of the 30Stalk-His proteins with an anti-NKp30 antibody (white) specifically blocks the NKp30-B7-H6
interaction. Notably, analogous blocking was observed for the 30LBD-His proteins (not shown). A representative
of five independent experiments is shown. (H) KD values of different NKp30 ectodomain proteins. (Modified
from [233].)
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Strikingly, both the 30Stalk-His and 30LBD-His proteinswere efficient competitors of NKp30-dependent
signaling when bound to the Ba/F3-B7-H6 cells, indicating their ligand specificity. Importantly, quan-
titative blocking of the NKp30-B7-H6 interaction was achieved already at a concentration of 3.1 µM
for the 30Stalk-His protein, whereas inhibition remained incomplete (75 %) for the 30LBD-His proteins
even at a seven-fold higher concentration of 21.6 µM (Fig. 17E). In conclusion, these studies show that
the ectodomain of NKp30 produced in insect cells specifically recognized its ligand B7-H6 on target cells
with a strong contribution of its stalk domain to high-affinity binding.
To determine the apparent ligand binding affinities of the soluble 30Stalk-His and 30LBD-His proteins,
ELISA experiments with recombinant B7-H6-Ig were performed (2.5.9). Therefore, B7-H6-Ig was im-
mobilized and probed with graded amounts of 30Stalk-His and 30LBD-His proteins prior to detection of
ligand-bound NKp30 with a polyclonal anti-NKp30 antibody. Both NKp30 variants bound specifically
and dose-dependent to B7-H6-Ig with very low equilibrium binding constants (30Stalk-His: 5 ± 3 nM;
30LBD-His: 29 ± 1 nM, Fig. 17F, G and H). Surprisingly, these apparent binding affinities were higher
than those published for the monovalent NKp30 ectodomain proteins refolded from E. coli inclusion
bodies (1000 ± 200 nM, determined by SPR measurements), and even the bivalent 30Stalk-Ig (76 ±
20 nM, determined by SPR measurements) and 30LBD-Ig (149 ± 19 nM, determined by SPR measure-
ments) fusion proteins (Fig. 17H [117,170]). Therefore, these data suggest that NKp30might form higher
molecular order complexes, which display a higher apparent ligand binding affinity by increased avidity
of the oligomeric complex. Notably, the Bmax values of the 30Stalk-His (1.58 ± 0.6) and the 30LBD-
His proteins (1.01 ± 0.4) for binding to B7-H6-Ig were drastically different (Fig. 17F). The Bmax is an
indicator for the maximum number of ligand binding receptive receptors in the solution. Therefore, this
observation argued for a stalk-dependent difference in the architecture of the oligomeric self-assembly
of the 30Stalk-His and the 30LBD-His proteins, which might in turn lead to a different degree of avidity
and apparent affinity to B7-H6-Ig. This hypothesis was also supported by the much stronger inhibition
of NKp30/B7-H6-dependent signaling of A5-30FL-His reporter cells by the 30Stalk-His proteins when
compared to the bivalent 30Stalk-Ig proteins (Fig. 17E).
3.4.2 NKp30 Ectodomain Proteins Self-Assemble Homo-Oligomers
In order to investigate the oligomeric state of NKp30, size exclusion chromatography (SEC) was per-
formed using a Superdex 200 column (2.5.2). Surprisingly, an equilibrium of three major protein species
in solutions of 30Stalk-His and 30LBD-His proteins corresponding to monomers, dimers and oligomers
of soluble NKp30were found. Interestingly, at the same protein concentration of both NKp30 ectodomain
proteins, the relative content of oligomers was much higher for the 30Stalk-His when compared to the
30LBD-His proteins. Notably, the degree of oligomerization and the relative ratio of oligomers, dimers
and monomers was dependent on the concentration of the protein solution, with a tendency to oligomer
formation at higher protein concentrations. As demonstrated by figures 18A and B, the main fraction of
separated 30Stalk-His proteins consisted of oligomers (approximately 75 %), whereas only 5 % dimeric
and 20%monomeric 30Stalk-His proteins were separated. By contrast, the different forms of the 30LBD-
his proteins were distributed more equally with a tendency to stay monomeric (35 %) or form dimers
(40 %), but only 25 % of the isolated 30LBD-His proteins were oligomers. With reference to SEC runs
with a commercial calibration standard, the molecular mass of the oligomers was estimated at 360-440
kDa (elution volume 9.5 ml, corresponding to 18-22 30Stalk-His monomers) and 250-290 kDa (elution
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volume 12 ml, corresponding to 14-16 30LBD-His monomers). Interestingly, even at higher protein con-
centrations the molecular mass of the oligomers remained constant demonstrating formation of defined
oligomers rather than non-functional aggregates. Notably, after repeting SEC analyses of concentrated
oligomeric, dimeric or monomeric 30Stalk-His and 30LBD-His protein peaks, the distribution of these
NKp30 species was restored (data not shown).
Due to the intrinsic capacity of 30LBD-His and the drastically increased tendency of the 30Stalk-His
proteins to oligomerize, two specific binding sites, located in the ligand binding domain and the stalk
domain, are proposed for contribution to NKp30 self-assembly. So far, the results suggested an avidity-
driven increase of the apparent affinity of the 30Stalk-His and 30LBD-His proteins (Fig. 17F), but the
functional significance of the NKp30 ectodomain oligomers was uncertain. Therefore, fractions from
SEC, containing 30Stalk-His or 30LBD-His proteins as determined by ELISA (anti-NKp30, polyclonal,
Fig. 18C and D), were probed for binding to B7-H6-Ig in an ELISA setup described above. Strikingly,
all of the oligomeric species (monomers, dimers and oligomers) of soluble NKp30 bound to B7-H6-
Ig (anti-NKp30, polyclonal, Fig. 18E and F). In accordance with previous data, binding of 30Stalk-His
to B7-H6-Ig was stronger than that of 30LBD-His, confirming the importance of the stalk domain for
ligand binding. Moreover, an ELISA with separated 30Stalk-His oligomers, which were probed with
recombinant B7-H6-Ig protein (detected with HRP-conjugated anti-hIgG-Fc antibodies), demonstrated
again that NKp30 ectodomain oligomers had a very high apparent affinity for B7-H6 as indicated by the
KD (1.04 ± 0.21 nM) and Bmax (1.12 ± 0.03) values. Notably, KD and Bmax values of 30Stalk-His
dimers and monomers were not determined due to very low protein amounts after separation.
Figures 18E and F demonstrate the binding capacities of all oligomeric 30Stalk-His and 30LBD-His
proteins. Since detection with polyclonal anti-NKp30 antibodies could result in different apparent signal
intensities due to binding of more antibodies to one 30Stalk-His when compared to one 30LBD-His
molecule, the same ELISA experiment was performed using the peptide immunized anti-NKp30 antibody
ensuring similar binding properties for the detection of both NKp30 ectodomain proteins. Strikingly,
only oligomeric but no dimeric or monomeric NKp30 ectodomain proteins were detected upon binding
to immobilized B7-H6-Ig fusion proteins (Fig. 18G and H). Possibly, the affinity of monomeric and
dimeric NKp30 ectodomain variants might be very low or the epitopes on dimeric andmonomeric NKp30
ectodomain proteins were occupied by interacting ligand molecules. Thus, these results do not only
confirm ligand binding capacities of the NKp30 ectodomain oligomers, but could further provide new
insights into possible interaction sites for NKp30 dimer and even oligomer formation.
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Fig. 18: The NKp30 ectodomain self-assembles oligomers, which bind to the ligand B7-H6
(A/B) Oligomers, dimers and monomers of (A) 30Stalk-His and (B) 30LBD-His were separated by size exclusion
chromatography (Superdex 200 10/300 GL column). Asterisk, lower molecular mass compounds. (C/D) Elution
fractions (500 µl) of size exclusion chromatography containing (C) 30Stalk-His and (D) 30LBD-His proteins were
identified by ELISA with an anti-NKp30 (polyclonal) antibody. Binding of different oligomeric species of (E/G)
30Stalk-His and (F/H) 30LBD-His proteins to recombinant B7-H6-Ig fusion protein was validated by ELISA with
anti-NKp30 antibodies (polyclonal, E/F; peptide immunized, G/H). (Modified from [233].)
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3.4.3 Influence of the Stalk Domain on NKp30 Self-Assembly
In order to study the geometric arrangement of the oligomers formed by the 30Stalk-His and 30LBD-
His proteins, the oligomers were isolated by SEC on a Superose 6 column for improved separation of
large protein complexes (2.5.2). Although the individual peaks of the monomers and dimers could not
be resolved on this column, again monodisperse peaks of the expected molecular mass for the NKp30
ectodomain oligomers were observed (Fig. 19A and C). After immobilization of the elution fractions
corresponding to the peak maxima of the 30Stalk-His and 30LBD-His oligomers on EM grids, complexes
were stained with uranyl acetate and subjected to EM (2.5.10).
Fig. 19: The stalk domain modulates the geometric arrangement of the NKp30 ectodomain oligomers
(A) 30Stalk-His and (C) 30LBD-His oligomers were separated from the monomer/dimer fractions by size exclusion
chromatography (Superose 6 10/300 GL column). 100 µl elution fractions were collected. (B/D) Geometry and
3D-arrangement of the (B) 30Stalk-His and (D) 30LBD-His oligomers were analyzed by electron microscopy using
the oligomer elution fractions with the highest protein amount from size exclusion chromatography (see A/C). Size
bars correspond to 100 nm. (Modified from [233].)
Strikingly, particles with a diameter of about 15 nmwere observed for both NKp30 ectodomain proteins
confirming formation of oligomers rather than non-functional aggregates. Interestingly, the 30LBD-His
oligomers appeared more homogeneous than the 30Stalk-His oligomers (Fig. 19B and D). To identify
groups of congruent oligomeric particles and thereby shed more light on the geometric arrangement
of the 30Stalk-His and 30LBD-His oligomers, 2D class averaging was performed. Notably, the more
definite the local positions of the monomers within an oligomeric particle the better would be the fine
resolution of their geometric arrangement. For this purpose, more than 6.000 globular particles for both
30Stalk-His and 30LBD-His oligomers were analyzed. In preliminary experiments, a surprisingly large
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number of rougly 120 different 2D classes was calculated for the 30LBD-His oligomers. Furthermore,
2D class averaging for 30Stalk-His oligomers was not possible at all, which might be due to more struc-
tural flexibility mediated by the stalk domain. Although the individual numbers of monomers within one
oligomer were conserved for both 30LBD-His and 30Stalk-His proteins, a fixed position of the globular
Ig domains within the oligomeric complexes was most probably inhibited by a local flexibility of the
monomers. Since both 30LBD-His and 30Stalk-His oligomers displayed similar shapes without congru-
ency, the precise orientation of the NKp30 ectodomain molecules within the oligomers remains unknown.
For the NK cell-target cell interaction a head-to-head (in cis) orientation is most plausible. However,
based on decoration experiments with NKp30 ectodomain proteins and pNK cells analyzed by flow cy-
tometry (2.4.12) and CLSM (2.4.13), a head-to-tail (in trans) orientation is an additional possibility. This
interaction was strictly dependent on the stalk domain of NKp30 since no decoration of pNK cells was
observed with 30LBD-His proteins (Fig. 20A and B). Notably, the specificity of the interaction of the
30Stalk-His proteins with NKp30 on the NK cell surface was validated by inhibition experiments with
an anti-NKp30 blocking antibody (clone 210845, Fig. 20B). These findings are in accordance with the
identification of a head-to-tail dimer in the crystal structure of the NKp30 ectodomain derived from E.
coli [116]. However, it remains unclear whether this head-to-tail dimer is of physiological relevance or a
product of crystallization. Taken together, these EM and pNK cell decoration experiments again demon-
strate that the ectodomain of NKp30 has an intrinsic ability to form physiologically relevant oligomers.
Furthermore, these results confirm the impact of the stalk domain on NKp30 self-association facilitat-
ing high-affinity interaction with corresponding ligands, thereby increasing NKp30-dependent NK cell
cytotoxicity.
Fig. 20: The stalk domain of NKp30 is essential for recognition of NKp30 on NK cells in trans
(A) NK-92MI cells were decorated with an anti-NKp30 antibody, 30Stalk-His or 30LBD-His proteins. Binding of
the NKp30 ectodomain proteins was detected with an anti-NKp30 antibody. The degree of surface staining was
monitored by CLSM (anti-NKp30, red; DAPI, blue; size bar corresponds to 4 µm). (B) Quantification of surface
decoration of primary NK cells by flow cytometry. Cells were stained with an anti-NKp30 antibody (black line) to
quantify the level of NKp30 surface expression (antibody control, solid gray). Binding of 30Stalk-His and 30LBD-
His proteins (red lines) on primary NK cells and specific blocking with an anti-NKp30 blocking antibody (dashed
lines) were analyzed (NKp30 surface expression, solid gray, modified from [233].)
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The human activating NK cell receptor NKp30 plays an important role in immunosurveillance of malig-
nantly transformed and virus-infected cells. For this purpose, NKp30 is able to recognize diverse ligands
that are not related in sequence or structure. Previously, N-linked glycosylation of the ligand binding
domain as well as the stalk domain of NKp30 were identified as important modules for engagement of
cellular ligands and intracellular signal transduction to activate NK cell cytotoxicity [170]. Along this
line, the molecular understanding of the NKp30 function in tumor immunosurveillance is instrumental
in discovering novel access points to develop new tumor therapies. Therefore, structural modules and
putative key mechanisms were investigated, which enable variations of the binding interfaces of NKp30
to enhance ligand binding affinity for corresponding ligands by increased avidity. Based on soluble
NKp30 ectodomain variants comprising either the entire ectodomain or only the ligand binding domain,
NKp30 self-assembly was identified as an important module to mediate high-affinity binding to the cel-
lular ligand B7-H6. Moreover, the stalk domain was found to affect the three-dimensional arrangement
and geometry within oligomeric NKp30 ectodomain particles. Two distinct sites for NKp30 ectodomain
homo-oligomerization were identified, one present within the Ig domain of NKp30 and one within its
membrane proximal stalk domain.
4.1 Modell: Homo-Oligomerization of the Activating NK Cell Receptor
NKp30 to Enhance Specific NK Cell Cytotoxicity
Within this thesis, it was demonstrated for the first time that the ectodomain of NKp30 self-assembles
oligomers to increase its ligand binding affinity. Experimental data revealed that NKp30 homo-oligomeri-
zation is facilitated by two interaction sites, which are located within the ligand binding domain as well
as the stalk domain. Furthermore, a concentration-dependent equilibrium of monomers, dimers and
oligomers was observed, which remarkably shifted to oligomer formation in presence of the stalk do-
main.
Based on these data, the following modell is proposed: IL-2 stimulation of NK cells leads to a drastic
upregulation, and thereby increased local NKp30 receptor concentration on the plasma membrane. This
will in turn promote the formation of NKp30 oligomers, which might be a molecular transformer of
NK cell activation into enhanced cytotoxicity (Fig. 21). Notably, some targets induce serial killing by
one NK cell subset, whereas another NK cell population does not perform killing at all in presence of
the same target. Assuming accumulated and equally distributed surface NKp30 on different NK cell
surfaces, respectively, different thresholds for NKp30-mediated NK cell killing are suggested. Whereas
NK cells with accumulated surface NKp30 are able to form oligomeric complexes immediately upon
cytokine activation, much more surface NKp30 has to be presented on the surface of the other NK cell
subset to exceed the oligomerization threshold. Accordingly, NKp30 homo-oligomerization might also
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induce NKp44- and NKp46-mediated signaling due to the NCR cross-talk, and thereby enhance NK cell
cytotoxicity. Hence, pre-assembly of NKp30 receptor molecules prior to ligand binding could result in
more efficient signaling events. In addition, an enhanced ligand binding affinity by increased avidity
might be induced by NKp30 self-association.
Fig. 21: NKp30 oligomerization drives NK cell cytotoxicity
Upon IL-2 stimulation a variety of activating NK cell receptors including NKp30 are upregulated on the plasma
membrane of NK cells. Based on the data, increased plasma membrane NKp30 leads to formation of NKp30
oligomers, which contact cellular ligands in the plasma membrane of target cells. This interaction is mediated
by two binding sites within the NKp30 ectodomain resulting in an enhanced ligand binding affinity by increased
avidity. Finally, these presumably cooperative receptor-ligand interactions promote robust NKp30-dependent NK
cell cytotoxicity. (Modified from [233].)
4.2 Self-Assembly of the NKp30 Ectodomain for Increased Ligand
Binding Affinity
Putative interaction sites for ligand binding and NKp30 self-assembly are expected to be located within
the extracellular part of the receptor. Investigating the characteristics of single NKp30 ectodomain pro-
teins could raise the potential of finding new interaction partners on both, the NK cell and the target
cell. To obtain structural information on the activating NK cell receptors NKp44, NKp46 and NKG2D,
respective recombinant ectodomains were produced in E. coli strains to obtain large amounts of proteins
for biochemical and biophysical approaches [114,115,240–242]. Notably, since all of these recombinant
receptor ectodomains were found in inclusion bodies, sophisticated refolding protocols were developed
to obtain soluble receptor ectodomains. However, this strategy is not only time-consuming, but it also
remains unclear if proteins display their native conformation upon refolding. At the beginning of this
thesis, the 3D structure of the NKp30 ligand binding domain was unsolved. Therefore, a de novo model
of the NKp30LBD was calculated using a protein structure prediction service. Based on this predicted
model, a C-terminally truncated version (30LBDtr, amino acids L19-G120) was used for the expression
in E. coli and subsequent purification analyses. To circumvent refolding of inclusion body-derived pro-
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tein, expression conditions such as tags for affinity purification and host strains were varied to obtain
soluble 30LBDtr protein. Although small amounts of soluble MBP-30LBDtr could be purified (Fig. S4),
this protein was not able to decorate NKp30 ligand expressing target cells. When compared to the un-
bound and B7-H6-bound structures of the NKp30LBD, which were solved in 2011 by two independent
groups, the predicted model lacked eight amino acids at the C-terminus (unbound NKp30LBD: residues
A18-E130 [116], B7-H6-bound NKp30LBD: residues L19-G135 [117]), which might explain its inability
to bind on target cells. In accordance, both groups reported the crystallizable NKp30LBD as an Ig-like
domain, which displays a two-layer β-sandwich (Fig. S5). The front and back sheets, composed of an-
tiparallel β-strands GFC and ABED, respectively, are linked by a canonical intersheet disulfide bond
(C39-C108) [116, 117]. In addition, NKp30 contains two α-helices (α1 and α2) preceding β-strands D
and E, respectively. One of these helices (α1) is unique to NKp30 among Ig-like domains [116, 117].
Within both structures, the amino acids N121-E128 represent more than the half G strand. Although
there is no direct participation in the interaction with B7-H6, a truncated G strand could influence the
arrangement of the opposing A and/or neighboring F strands, thereby causing a conformational change.
As a consequence, the respective amino acids within the binding interface would be inaccessible, thus
reducing the affinity. Furthermore, the N-terminal MBP-tag (42.5 kDa) is 2.5 fold bigger than the NKp30
ectodomain protein. Although this improves the solubility, it could inhibit ligand binding due to steri-
cal hindrance. However, since the MBP-30LBDtr protein did not recognize the known cellular ligand
B7-H6, the overall fold could not be used to investigate NKp30 self-assembly as mechanism to vary
receptor-ligand interfaces. Notably, B7-H6 binding activity was demonstrated for the NKp30LBD re-
folded from E. coli-derived inclusion bodies comprising the amino acids L19-G135 [117]. And further,
based on the same construct design and refolding protocol, Grave and colleagues [185] reported of higher
mass species in size exclusion chromatography and sedimentation velocity analyses probably reflecting
the presence of NKp30 ectodomain oligomers.
According to both structures of the NKp30 ectodomain, there is a disulfide bond (C39-C108) that links
the front and back sheets of the two-layer β-sandwich. Furthermore, it was shown that NKp30 isN-linked
glycosylated at three asparagines (N42, N68 andN121) within the LBD. Intensive analyses of the NKp30-
B7-H6 interaction clearly demonstrated that glycosylation at residues N42 and N68 is critical for NKp30
function, whereas glycosylation at N121 has little influence on ligand binding and signaling of NKp30
[170]. Additional studies investigated host-specific differences of protein glycosylation. In contrast to
NKp30-IgG1-Fc fusion proteins derived from HEK293T cells, those expressed in the human NK cell
line NK-92 were resistant to complete enzymatic deglycosylation applying PNGase F or a mixture of
glycosidases specific forN- andO-linked oligosaccharides. Since PNGase F is not able to cleaveN-linked
oligosaccharides when the innermost GlcNAc residue is linked to an α1-3-fucose residue [226], NK cells
might modify NKp30 with fucose moieties allowing a different ligand binding mechanism of NKp30
[119]. Studies on glycosylation-dependent receptor-ligand interactions as well as in vitro approaches to
identify new NKp30 ligands were performed using the well-established NKp30-IgG1-Fc fusion proteins
[40, 128, 170, 243–245]. Despite disulfide bond formation and post-translational modification of the
NKp30LBD upon expression in mammalian hosts, these bivalent fusion proteins were not suitable for
the investigation of NKp30 ectodomain association due to an avidity-mediated increase of the ligand
binding affinity, which is induced by the antibody-like architecture. Moreover, the induced dimerization
could either induce or prevent further NKp30 self-assembly due to the sterical influence of the C-terminal
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Fc part. But even though bivalent proteins were obtained from mammalian expression hosts, NKp30
ectodomain proteins without stabilizing IgG1-Fc part could not be produced.
Beside mammalian cell lines, insect cells are a suitable expression host for human glycoprotein pro-
duction due to their ability to perform post-translational modifications. Insect cells were already used for
the surface expression of individual natural killer cell ligands such as the intercellular adhesion molecule
(ICAM)-1 or ULBP1 to analyze granule polarization and degranulation of NK cells within a system
of reduced immunological background [246–248]. In addition, glycosylated type I interferon recep-
tor ectodomains were produced in insect cells to analyze the ligand-induced assembling of the ternary
complex on a mechanistic level [249]. Along this line, in this thesis, insect cells were used to express
a ligand binding receptive NKp30 ectodomain as surface receptor alone or in combination with NKp44
and NKp46 as well as soluble NKp30 ectodomain proteins. WhileO- linked glycosylation of mammalian
and insect cell-derived proteins is very similar (i.e. various numbers of sugars including galactose, Glc-
NAc, N-acetylgalactosamine, and neuramic acids), N-linked glycoproteins differ in their branched struc-
tures. Mammalian N-linked glycoproteins contain standard branched structures, which are composed of
mannose, galactose, GlcNAc and neuramic acids, whereas insect cells add oligosaccharides of the high-
mannose type. Notably, mimic Sf 9 insect cells stably express a variety of mammalian glycosyltrans-
ferases, which allow for production of biantennary, terminally sialyated N-glycans. Nevertheless, due to
very long doubling times, protein production in mimic Sf 9 cells was too inefficient (data not shown). By
contrast, High Five insect cells produced large amounts of soluble NKp30 ectodomain proteins. Upon
enzymatic deglycosylation with PNGase F under varying assay conditions, a distinct pattern of protein
bands was observed due to incomplete removal of the oligosaccharides at the positions N42, N68 and/or
N121 corresponding to tri-, di-, mono- and non-glycosylated NKp30LBD variants. Since tunicamycin
treatment quantitatively blocked N-linked glycosylation, insect cell-derived NKp30 ectodomain proteins
are most likely α1-3 fucosylated at some or all of the innermost GlcNAc residues dependent on yet un-
known conditions. Notably, the exact protein size and glycosylation pattern of NKp30 from primary NK
cells remains still elusive since a large protein band (with a molecular mass of 30-45 kDa) detected in a
biochemical analysis suggests diverse glycosylation patterns of NKp30 within a polyclonal NK cell pop-
ulation. In addition, even mono-deglycosylation of bivalent NKp30-IgG1-Fc fusion protein derived from
the human NK-92 cell line using PNGase F failed almost completely again implying α1-3 fucosylated
glycosylation of NKp30 by its natural host. The soluble NKp30 ectodomain produced in insect cells,
therefore, represents a molecular equivalent to the ectodomain of human NKp30 which can be employed
for further studies.
All of the NCRs consist of a crystallizable extracellular Ig domain, which is connected via a proxi-
mal stalk domain to the transmembrane domain followed by a short cytoplasmic tail [114–117]. How-
ever, it appears that the NCRs are much more different than anticipated from their domain organization
and structure. NKp30 is known to be only N-linked-glycosylated, which is important for ligand bind-
ing [170], whereas the O-glycosylation of NKp46 at position 225 is essential for binding to viral hemag-
glutinins [243]. Along this line, there are also variations in the contribution of the NCR stalk domains
on ligand binding and signaling. Sialic acid moieties attached to the stalk domain of NKp44 bind to
viral hemagglutinin proteins [63, 128, 132], whereas the stalk domain of NKp30 displays a completely
different mode of action. Previously, the so far neglected stalk domain of NKp30 was identified as an
essential component for signal transduction into the effector cell. In addition, it is an important module to
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enhance the ligand binding affinity [170]. Hence, the stalk domain could be a feature to provide diversity
by induction of NKp30 self-assembly. Notably, the stalk domain has no influence on the physiologi-
cal role of the different isoforms of NKp30 since alternative splicing results in variations of the LBD
and cytoplasmic region without changing the amino acid sequence of the stalk domain (Isoforms a-c:
K129-R143, isoforms d-f: K104-R118, Fig. S1). Consistently with the construct design of the above-
mentioned study, NKp30 ectodomain proteins were produced in insect cells, which comprised either the
entire ectodomain of NKp30 including the stalk domain (30Stalk-His) or the crystallizable ligand binding
domain alone (30LBD-His). Molecular and cellular interaction studies of the insect cell-derived NKp30
ectodomain variants with B7-H6 confirmed the beneficial effect of the stalk domain on ligand binding.
Moreover, both 30LBD-His and 30Stalk-His mediated a high-affinity interaction when compared to the
B7-H6 binding affinities of E. coli-derived or bivalent NKp30 ectodomain fusion proteins [117, 170].
To investigate the impact of the stalk domain on ligand binding affinity and putative NKp30 ectodomain
self-assembly by different biochemical approaches, it is essential to employ an anti-NKp30 antibody with
a defined epitope located within the LBD. This anti-NKp30 antibody should recognize the native or de-
natured state of both NKp30 ectodomain variants, 30LBD-His and 30Stalk-His, with identical affinity.
Since the receptor NKp30 was identified by detection with a mouse monoclonal antibody (clone AZ20)
in 1998 [101], further monoclonal and polyclonal anti-NKp30 antibodies were developed. Some of these
mouse monoclonal anti-NKp30 antibodies (e.g. clones AZ20, 210845 or P30-15) were able to specifi-
cally inhibit NKp30-mediated NK cell cytotoxicity [134, 244]. Their individual epitopes are unknown,
but an interaction with the NKp30LBD in its native conformation is most likely since these monoclonal
antibodies are recommended for cellular assays or ELISA. Nevertheless, it remains unclear whether the
blocking capacity could influence the results by lower ligand decoration efficiencies. The polyclonal
goat anti-NKp30 antibody recognizes native and denatured NKp30 in cellular assays, ELISA and im-
munoblot analyses. The immunogen is denoted with L19-T138 comprising the whole extracellular part
of NKp30 including the stalk domain, which could result in recognition of additional binding sites on
the 30Stalk-His protein leading most likely to misinterpretations in favor of the stalk domain. Despite
a variety of commercially available antibodies recognizing NKp30 in a lot of biochemical and cellular
applications, none of these is extensively characterized concerning binding epitopes within the LBD.
Therefore, an antibody detecting a defined epitope (amino acids R62-R75) comprising the N-linked gly-
cosylation acceptor site N68 as well as the unique α1 helix within the LBD of NKp30 was generated by
peptide-immunization of two rabbits. Upon immunoaffinity purification from rabbit serum, a polyclonal
pool of different rabbit IgG subtypes was purified, which was suitable in several cellular and molecu-
lar approaches. This rabbit anti-NKp30 antibody could bind to a consecutive region of 37 amino acids
including R62-R75, thus suggesting the recognition of three or more different epitopes. Furthermore,
although the membrane proximal stalk domain is rather flexible, a sterical influence within this region
is not assumed, thereby providing identical interaction sites for antibody binding with the same extent
on 30LBD-His and 30Stalk-His proteins. Notably, the chosen peptide stretch including the glycosyla-
tion acceptor site N68 is located outside of the NKp30-B7-H6 binding pocket, and should therefore not
participate in the NKp30-B7-H6 interaction. By contrast, N68 was recently identified to be essential
for intracellular signaling upon B7-H6 engagement [170]. Investigations using the anti-NKp30 antibody
from peptide immunization thus might shed more light on this discrepance. Along this line, the relevance
of the glycosylation at N68 within the epitope sequence of the rabbit anti-NKp30 antibody was inves-
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tigated by pre-incubation of soluble NKp30 ectodomain proteins with the anti-NKp30 antibody prior to
decoration of B7-H6 expressing target cell lines or ELISA setups with immobilized recombinant B7-H6.
Cell decoration efficiencies and ligand binding affinities remained unchanged suggesting no capacity of
the rabbit anti-NKp30 antibody to interfere with the receptor-ligand interaction (data not shown). How-
ever, NKp30 ectodomain proteins immobilized in ELISA or on target cells could be decorated with the
anti-NKp30 antibody from peptide immunization suggesting that the glycosylation at position N68 does
not interfere with the recognition of the epitope sequence. It is most likely that the epitope for the anti-
NKp30 antibody from peptide-immunization is not accessible in the native, folded and unbound protein.
By contrast, pre-incubation with a mouse monoclonal anti-NKp30 antibody (clone 210845) could inhibit
NKp30-B7-H6 interaction in equivalent experimental setups. Notably, peptide spot arrays revealed no
linear epitope sequence for the binding of this blocking antibody, but further suggested conformational
epitopes close to the NKp30-B7-H6 interface (data not shown). Therefore, glycosylation at position N68,
at least insect cell-specific, might not be essential for ligand binding. These data support the NKp30-B7-
H6 interface of the 3D structure that implies no direct influence of the position N68 on the receptor-ligand
interaction [117]. However, pre-incubation of NKp30-functionalized reporter cells with the anti-NKp30
antibody binding in close proximity to N68 could again demonstrate its impact on NKp30-dependent sig-
naling. Association with this antibody could prevent a conformational change within this region contain-
ing the unique α1 helix, which might be necessary to induce a yet unknown mechanism for intracellular
signal transduction.
Both NKp30 ectodomain proteins exhibited a considerably higher affinity to the recombinant ligand
B7-H6-Ig than the bivalent NKp30-Ig fusion proteins [170] or the E. coli-derived NKp30 ectodomain
employed to determine the structure of the NKp30-B7-H6 complex [117]. This increased affinity might
be due to an avidity effect, which is attributed to NKp30 ectodomain oligomerization. Furthermore,
30Stalk-His and 30LBD-His proteins were efficient competitors of NKp30-dependent signaling when
bound to B7-H6-expressing target cells with a strong contribution of the stalk domain to quantitative
blocking of the NKp30-B7-H6 interaction. Decoration of these target cells with both NKp30 ectodomain
variants thereby revealed that the number of clusters was mainly dependent on the ligand concentration
on the target cell, but the mean cluster size was significantly increased after binding of 30Stalk-His when
compared to 30LBD-His proteins. These observations argued for a stalk-dependent difference in the
architecture of the oligomeric self-assembly of the NKp30 ectodomain, which might in turn lead to a
different degree of avidity and apparent affinity to B7-H6. In addition, the impact of the stalk domain
on NKp30 ectodomain self-assembly was confirmed by size exclusion chromatography. Although an
equilibrium of monomers, dimers and oligomers was found for both NKp30 ectodomain variants, the
stalk domain definitely induced oligomerization. Whereas 30LBD-His monomers, dimers and oligomers
were equally distributed, for 30Stalk-His proteins the ratio shifted tremendously to oligomers with dimers
being rather an intermediate state. Based on these data, two distinct sites for NKp30 ectodomain homo-
oligomerization are proposed, one present within the Ig domain of NKp30 and one within its membrane
proximal stalk domain. Strikingly, all oligomeric forms of both NKp30 ectodomain variants were B7-H6
binding receptive as demonstrated by different ELISA setups with the commercially available polyclonal
goat anti-NKp30 and the rabbit anti-NKp30 antibody from peptide immunization. Notably, the poly-
clonal goat anti-NKp30 cocktail comprises antibodies with specificity for different epitopes within the
entire NKp30 ectodomain including the stalk domain. Therefore, more than one antibody molecule might
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be able to bind per one 30Stalk-His or 30LBD-His protein. By contrast, the rabbit anti-NKp30 antibody
recognizes a distinct epitope sequence, which allows for more quantitative results, but in turn leads to
lower signal intensities in ELISA. Along this line, monomeric and dimeric NKp30 ectodomain variants
could not be detected by the rabbit anti-NKp30 antibody, whereas subsets of the goat anti-NKp30 pool
with different specificity were still able to associate with NKp30 ectodomainmonomers and dimers. Most
probably the peptide epitope on dimeric and monomeric NKp30 ectodomain proteins was occupied by
interacting ligand molecules. By contrast, oligomeric NKp30 ectodomains bound to B7-H6-Ig were de-
tected by both anti-NKp30 antibodies since the respective peptide sequence might be present on multiple
NKp30LBDs situated at the outer area of the oligomeric particle, and therefore did not participate in the
NKp30-B7-H6 interaction. Thus, oligomers were not quantitatively (equivalent to the respective number
of monomers) occupied by B7-H6 ligand molecules. These results do not only confirm ligand binding
capacities of the NKp30 ectodomain oligomers, but also provide new access points for the investigation
of possible interaction sites for NKp30 dimer and even oligomer formation. On the one hand, NKp30
ectodomain clusters were found on B7-H6 expressing target cells. On the other hand, NKp30 ectodomain
monomers and dimers could not be detected by the rabbit anti-NKp30 antibody upon binding to recombi-
nant B7-H6-Ig in ELISA. Therefore, an NKp30 oligomer dissociation upon B7-H6 engagement in respect
of providing a certain number of NKp30 monomers for monovalent receptor-ligand interactions can be
excluded.
Gel filtration experiments revealed a concentration-dependent increase of 30Stalk-His and 30LBD-His
oligomers (reflected by increased peak areas), while the composition of the oligomer particles (reflected
by the consistent retention volumes) remained constant. According to their theoretical molecular mass,
it was estimated that 30Stalk-His oligomers were assembled by more monomers (e.g. 30Stalk-His: 20
monomers vs. 30LBD-His: 16 monomers). To investigate the impact of the stalk domain on the parti-
cle size of the oligomers as well as its influence on the geometric arrangement, negative stain electron
microscopy was employed. This method is especially useful for imaging the size and shape of single
proteins and larger molecules (especially larger than 100 kDa) with a complex internal structure at the
nanometer level [250]. Strikingly, both 30Stalk-His and 30LBD-His particles had an average diameter of
15 nm, although the larger number of monomers within one oligomer would imply a stalk-dependent in-
crease of the particle size. By contrast, most probably, an association of the stalk domain led to formation
of a condensed or even the densest packing of monomers, which was further confirmed by the constant
retention volumes for the 30Stalk-His and 30LBD-His oligomers at higher protein concentrations. Inter-
estingly, 30LBD-His monomers also were able to assemble suggesting a certain affinity, which might be
promoted by close proximity. Notably, no preferred areas or cavities for self-association were identified
in this thesis, but biophysical calculations and/or analyses with interfering peptides could help to locate
the interfaces of the NKp30LBD-NKp30LBD contact. In addition, oligomer formation was remarkably
increased for the 30Stalk-His proteins, thus suggesting a two-step process for NKp30 cluster formation
in general. NKp30 self-assembly is mainly characterized by affinity-mediated interaction of the stalk
domains, which then in turn induces association of the LBDs due to avidity. Therefore, an ”open flower”
configuration is assumed for both 30LBD-His and 30Stalk-His particles in solution (Fig. 22A and B).
Since both NKp30 ectodomain variants form particles with similar spherical geometry, a circular ar-
rangement of LBDs and self-assembling stalk domains within the center is most likely. As determined
from the 3D structure (using the PyMol software) [116], the two-layer β-sandwich of the NKp30LBD
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is approximately 40 Å in length and 20 Å in width. Assuming two opposing LBDs and a diameter of
15 nm for one particle, there would be a residual center of approximately 7 nm in diameter for two stalk
domains, each comprising 15 amino acids. Within secondary protein structures, the α-helical conforma-
tion reflects the densest packing. As estimated from the pitch of a helix (5.4 Å), which is the product of
3.6 residues per turn with a translation of 1.5 Å the corresponding minimum length for a α-helical stalk
domain would be 22.5 Å. By contrast, the distance between two amino acids is about 3.8 Å (determined
from the structure of the NKp30 ectodomain [116]) resulting in a maximum length of approximately 53 Å
for a totally unstructured sequence of 15 amino acids. Since the stalk domain is very flexible and was
therefore not resolved in the structures of the NKp30 ectodomain, an α-helical conformation is excluded.
Furthermore, the interaction site for self-assembly is unknown, hence a more detailed analysis of the
length of the stalk domain is not possible. However, an association at the C-terminal part of the stalk
domain or an influence by the C-terminal His-tags is unlikely due to the diameter of the center.
Fig. 22: Putative arrangements of the NKp30 ectodomain within particles and on the NK cell membrane
A selection of symmetric NKp30 ectodomain arrangements suggested from size exclusion chromatography and
subsequent electronmicroscopy analyses of 30LBD-His (A) and 30Stalk-His oligomeric particles. Despite different
numbers of monomers within the 30LBD-His and 30Stalk-His oligomers, same particle sizes were observed. (A) 16
globular NKp30 ligand binding domains are ordered exemplarily in three different arrangements to form an ”open
flower” configuration. Thus, different interaction sites for ligand binding can be formed. (B) Due to the affinty of
the stalk domains, there is a more condensed packing, which allows for 20 monomers to form an ”open flower”
configuration within the particle. As demonstrated exemplarily by five different arrangements for 30Stalk-His
oligomers, a larger number of monomers results in more variants of symmetric arrangement, thereby increasing
the number of different binding interfaces. Notably, different numbers of monomers within the oligomers and
asymmetric compositions of 30LBD-His or 30Stalk-His particles further increase variability. (C) On the NK cell
membrane, a head-to-head orientation within NKp30 clusters is assumed. Cell decoration experiments of NK cells
with NKp30 ectodomain proteins showed that an interaction of the stalk domain is essential for self-assembly since
30LBD-His binding was not detected. Therefore, NKp30 clustering in a ”closed flower” configuration is proposed
and shown exemplarily by two different arrangements.
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It still remains unclear, how the stalk domain is able to increase ligand recognition and oligomer for-
mation. Suggesting a change of orientation for the interaction within the LBDs, which could be in-
duced by the affinity-mediated self-assembly of multiple stalk domains, there would be space for a few
more stalk-containing proteins within the particle, thereby forming additional de novo cavities for homo-
oligomerization and/or recognition of additional ligands [170]. Notably, this change of orientation would
explain the increased number of monomers as well as the unchanged diameter of the particle for the
30Stalk-His when compared to the 30LBD-His oligomers.
As illustrated by the model in Figures 22A and B, one interaction site within the LBD could be situated
in close proximity to the stalk domain, which would further foster the hypothesis of ”facilited binding”
of the NKp30LBD. Since there is a slight conformational reorganization of the NKp30LBD underneath
the binding pocket upon interaction with B7-H6, this might be a promising surface stretch for NKp30
ectodomain self-assembly within the LBD. To get more information on the complex internal structure,
2D images of the 30Stalk-His and 30LBD-His oligomeric particles were sorted into classes and averaged.
According to the number of classes, both NKp30 ectodomain variants formed a large variety of globular
particles with different structural arrangements. A circular or spherical arrangement of several LBDs
within one particle implied the presence of more than one binding interface for self-assembly. Due to
the number of 2D classes for 30LBD-His particle arrangements, preferred sites for self-interaction within
the LBD are assumed. Along this line, multiple putative sites for association might increase the number
of possible LBD combinations in solution resulting in heterogeneous surfaces of the oligomeric parti-
cles. However, due to an interaction of the stalk domains, more ordered 30Stalk-His oligomers could
be expected. By contrast, these particles were even more heterogeneous in their 3D arrangements and
geometry. The degrees of freedom might be increased by the flexibility of the stalk domains, which al-
low for assembly of more monomers within one particle, and a facilited self-assembly of NKp30LBDs
suggests interaction sites without strict perference, thus increasing the number of 2D classes. In fig-
ures 22A and B the influence of the stalk domain on the 3D geometry heterogeneity is demonstrated by a
selection of symmetric NKp30 ectodomain arrangements. Larger numbers of monomers and asymmetric
compositions would further increase the variability to form ligand binding receptive cavities. However,
a spherical geometry of the oligomeric particles in solution is of no physiological relevance since NKp30
self-assembly in its native environment would be constricted by the anchorage within the NK cell plasma
membrane. Based on the identification of two interaction sites, a ”closed flower” configuration of NKp30
ectodomain self-assembly on the plasma membrane is proposed (Fig. 22C). Considering the intrinsic po-
tential of the NKp30LBD to homo-oligomerize as well as the rather short stalk domain, which would
prevent an alternating dimerization, a head-to-head arrangement of an unknown number of molecules
within the NKp30 cluster was most likely. In fact, this type of interaction was strictly dependent on the
stalk domain of NKp30 since no decoration of primary NK cells was observed with 30LBD-His pro-
teins. Notably, homo-oligomerization of full-length NKp30 receptors on the NK cell surface would be
stabilized by their anchorage within the plasma membrane. Accordingly, interaction of entire NKp30
ectodomains without plasma membrane fixation would lead to faster dissociation when compared to full-
length NKp30 interaction. Along this line, self-association of the NKp30 ligand binding domain alone
might be too unstable to detect in decoration experiments of primary NK cells. However, a head-to-tail
orientation remains an additional possibility, which would be in accordance with the identification of a
head-to-tail dimer in the crystal structure of the NKp30 ectodomain derived from E. coli [116]. Nev-
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ertheless, it remains obscure whether this head-to-tail dimer is of physiological relevance or a product
of crystallization. Beside NK cells, NKp30 is expressed by distinct T cell subsets [105–108]. There-
fore, a head-to-tail interaction of NKp30 could provide a way for NK cells to bind to other immune cells
expressing surface NKp30. This could be important for the regulation of immune responses.
Based on experimental data, mainly obtained from soluble NKp30 ectodomain proteins in solution,
individual functions for both subdomains of the NKp30 extracellular part are proposed: i) the major
role of the NKp30LBD is to facilitate receptor-ligand interactions, which might be fostered by avidity-
induced self-assembly, whereas ii) the receptor-receptor interaction is affinity-mediated by the stalk do-
main. These mechanistically different steps of a sophisticated process act in concert to allow for high-
affinity binding to a multiplicity of diverse ligands as well as subsequent intracellular signal transduction
to assure most efficient NKp30-dependent NK cell activity.
4.3 Surface Receptor Oligomerization for Efficient Cellular Cytotoxicity
Cellular cytotoxicity is mediated by lymphocytes of the innate (NK cells) and the adaptive immunity
(CTLs) to protect the host from parasites, viral and bacterial infection as well as malignantly transformed
cells. In this respect, NK cells and CTLs share a common killing mechanism, which is a form of ”as-
sisted suicide” as the endogenous apoptosis program is activated within the target cell. When a cytotoxic
lymphocyte encounters a transformed or infected cell, selectins and integrins (such as L-selectin or lym-
phocyte function-associated antigen (LFA)-1) are ligated for an effective conjugation between NK cells
or CTLs and their targets in the initial adhesion step [251–254]. This adhesion allows for activating
receptors (e.g TCR or NCRs and activating KIRs) to focus in the direction of the target cells, which re-
sults in formation of a tight interface, the mature immunological synapse. The contact site organizes into
three concentric circular zones (bull’s eye pattern) comprising i) the inner circle also known as central
supramolecular activation cluster (cSMAC), ii) the peripheral adhesion ring (pSMAC), and iii) the outer
(distal) ring (dSMAC). Although it remains unclear how these highly organized ring structure is gener-
ated, it is known that T cell costimulation as well as a dynamic filamentous actin (F-actin) cytoskeleton
are essential for formation of these protein clusters. Within the cSMAC of a CTL, receptors involved
in cell activation and specific signal transduction cascades are concentrated (i.e. TCR/CD3 complex,
accessory receptors CD4 and CD28, and protein kinase C θ (PKCθ)), whereas adhesion molecules in-
volved in formation and maintenance of the IS are located in the pSMAC (i.e. LFA-1, LFA-2, and the
membrane anchor talin). The dSMAC comprises molecules with a large extracellular part such as CD45
(protein tyrosine phosphatase, receptor type, C, PTPRC) and CD43 (sialophorin or leukosialin). Upon
F-actin polymerization and reorganization, the cytotoxic cell is able to focus the activating receptors to
the interface and polarize microtubule organizing centers (MTOCs) to transport lytic granules (perforin
and granzymes) toward the IS for directed secretion [252, 255–257]. Notably, beside Ca2+-dependent
killing by the pore-forming molecule perforin and cell-death promoting molecules such as granzymes,
NK cells and CTLs are able to kill Ca2+-independently by induction of the death receptor pathway via
the Fas ligand (FasL) binding to Fas (CD95) on target cells [258–260]. However, there are several im-
portant differences between NK cells and CTLs. For example, lytic granules are preformed in resting
human NK cells but not in CTLs [261]. Furthermore, the analysis of the NK cell synapse revealed both
a cytotoxic synapse and an inhibitory synapse in which the negative regulatory receptors are dominant.
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Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural
killer cells [262]. However, NK cells readily form cSMAC and pSMAC-like compartments in 1-10 min,
regardless of whether the synapses would lead to cytotoxicity or inhibition [260].
There are several studies concerning F-actin polymerization, cytoskeleton organization, lytic granule
transport to the synapse and further, but there are no reliable information on activating NK cell recep-
tor migration or clustering within the plasma membrane with respect to IS formation so far. Recently,
it has been shown for T cells that kinases, adaptor molecules and antigen receptors accumulate in struc-
tures termed microclusters within immunological synapses [263–265]. In addition, small clusters of CD3
were formed prior to concentrating in the cSMAC of the T cell [266], suggesting a clustering of the TCR
within the immunological synapse. Along this line, Giurisato and colleagues demonstrated that receptor
clustering at the NK-cell lytic synapse is important for the induction of robust signaling in NK cells [267].
Although functional microclusters have been identified in NK cells, these have only been investigated at
the supramolecular inhibitory cluster [236, 263]. So, it is unclear whether the level of signaling organi-
zation that is observed in T cells can be similarly applied to the NK-cell lytic synapse [71].
The TCR/CD3 complex is an ordered assembly process organized around three trimeric intramembrane
interactions: CD3δϵ associates with TCRα, and CD3γϵ with TCRβ through the centrally placed lysine
residues, and then the ζζ module associates with TCRα through an arginine residue in the upper third
of the transmembrane domain. The ζζ dimer is one of four homodimeric modules known to provide
the signaling capacity to many activating receptors in the immune system such as the NK cell receptors
NKp30 and NKp46 [268, 269]. By contrast to the invariant NK cell receptors, there is a large variety
of TCRs due to somatic recombination for recognition of diverse ligands. However, the precise mecha-
nism linking MHC binding outside the cell to early biochemical events inside the cell are controversially
discussed. In this respect, triggering models are proposed, which range from receptor clustering and core-
ceptor recruitment to an array of conformational change models, in which TCR proteins are proposed to
physically impinge on the CD3 modules to transmit signals [269–271]. Along this line, it is possible that
CD3ζ clustering might also induce NKp30 self-assembly within the NK cell IS. Upon association with
CD3ζ, the local concentration of NKp30 receptors might increase up to formation of NKp30 clusters to
enhance the NK cell-target cell adhesion by high-affinity receptor-ligand interactions. In addition, de
novo binding sites for further ligands could be formed. In this respect, NKp30 ectodomain self-assembly
in solution might be a first hint to confirm NKp30 clustering within the NK cell membrane for mature IS
formation and efficent NK cell cytotoxicity.
Despite less than 30 % sequence similarity, the crystal structure of the NKp30LBD revealed an I-type
Ig-like domain which displays significant structural homology with CTLA-4 (cytotoxic T lymphocyte
antigen 4, PDB: 1I8L) and CD28 (PDB: 1YJD) [116, 117]. CD28 and CTLA-4 belong to the family of
T cell coreceptors, which are type I transmembrane proteins having a single extracellular V-type Ig-like
domain [272,273]. Their respective ligands B7-1 (CD80) and B7-2 (CD86) comprise two extracellular Ig
domains, which is also known for the cellular ligand of NKp30 belonging to the B7 family (B7-H6). Inter-
estingly, CTLA-4 and CD28 form disulfide-bonded homodimers and, moreover, their ligands B7-1 and
B7-2 are also found to be homodimers. On the one hand, covalent dimerization of the receptor CTLA-4 is
required for its high avidity binding. On the other hand, oligomerization of the ligands CD80/CD86 is also
required for high avidity CTLA-4 binding since CTLA-4 bound with low avidity to monomeric CD86.
Therefore, engagement of CD28 and/or CTLA-4 receptors by clustered CD80/CD86 ligands would in-
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crease the local receptor concentration. Thus, covalent receptor dimerization and ligand oligomerization
are two key features of the CD28/CTLA-4/CD80/CD86 receptor system that control ligand binding and
provide a the structural basis for forming unusually stable signaling complexes at the T-cell surface to
regulate signal transduction by controlling the duration of receptor occupancy [274–276]. Strikingly,
beside a common killing mechanism of NK and T cells, there are also structural similarities of the acti-
vating NK cell receptor NKp30 and the T cell coreceptors CD28/CTLA-4 with their respective ligands
belonging to the B7 family. Biochemical studies revealed the intrinsic potential of the NKp30LBD to
dimerize and even oligomerize to a certain extent. Furthermore, the flexible stalk domain, which is not
present in any crystal structure, promoted homo-oligomerization of the NKp30 ectodomain in solution.
Although there are no data available for NKp30 clustering on the plasma membrane so far, the potential
of NKp30 ectodomain self-assembly was demonstrated. Notably, ligand-induced receptor clustering is a
common mechanism for receptor-mediated signaling in immune responses [234–236]. As described for
the structurally related CTLA-4, ligand oligomerization on the target cell might therefore be an additional
option to increase the local NKp30 concentration on the cell surface to induce NKp30 cluster formation.
Both inhibitory and activating NK cell receptors of the KIR family have been shown to assemble dimers
or even oligomers. For instance, inhibitory KIR2DL2 dimerizes with both receptor ectodomainmolecules
in the same orientation via two different interaction sites. Therefore, Snyder and co-workers [189] sug-
gested formation of KIR2DL2 oligomers within the plasmamembrane by alternating dimerization. More-
over, studies with soluble activating KIR2DS1 ectodomain proteins refolded fromE. coli inclusion bodies
demonstrated self-association in rod-like shapes of similar dimensions, suggesting that the KIR2DS1
homo-oligomerization is a well-defined process [190]. By contrast, the activating NK cell receptor
NKG2D assembles a composite binding site for the interaction with its corresponding cellular ligands
by homo-dimerization [187, 188]. For efficient intracellular signaling, a hexameric complex composed
of one NKG2D dimer, which associates with two dimeric DAP10 adaptor molecules, is formed, resem-
bling the structure of the TCR/CD3 complex. Similar to formation of the mature T cell IS, clusters of
activating NKG2Dwere also found in lipid rafts. Along this line, coengagement of the inhibitory receptor
NKG2A partially disrupted NKG2D recruitment into rafts [277]. Despite structural diversity of NKG2D
and NKp30, both activating NK cell receptors play important roles in immune surveillance. NKG2D is a
functional surface receptor in mice and man, whereas functional NKp30 is not found in mice indicating
the unique role of NKp30. Considering the longer life span of man, it is conceivable that NKp30 has
mainly developed for the defense against constantly changing viruses and malignantly transformed cells.
In addition, a phylogenetic study suggests the possibility of a staged appearance of the NCRs with the
following progression: NKp46-NKp30-NKp44. This progressive NCR appearance might again reflect
an increase in the complexity and in the fine-tuning of the innate immune response [151]. Notably, the
phylogenetically youngest NCR NKp44 is expressed only on activated NK cells, possibly providing a
supportive function in regulation of NK cell activity. Along this line, NKp30 oligomerization might also
act as an activation marker on cytotoxic NK cells, whereas monomeric oder dimeric NKp30 receptors
could adopt regulatory functions to identify cognate antigens on the target cell upon the first contact. In-
deed, a sharp difference in cytotoxicity against neural tumors was demonstrated between NCRbright and
NCRdull NK clones, supporting the notion that the NCRs play a critical role in the induction of cytotox-
icity against tumor target cells [278]. In this respect, a strongly increased expression of NKp30, NKp44,
NKp46, and NKG2D upon IL-2 stimulation of freshy isolated peripheral blood NK cells was observed,
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thereby increasing cellular cytotoxicity [179–182, 184]. Interestingly, IL-2 activated human peripheral
blood NK cells were not only more cytotoxic but also twice as big as resting NK cells [72]. Because
the degree of oligomerization is dependent on the local receptor concentration, which is upregulated by
IL-2 upon NK cell activation, oligomerization of NKp30 might be a molecular transformer of NK cell
activation into enhanced cytotoxicity.
As suggested from their structures, monovalent receptor-ligand interactions are expected for the NCRs.
Strikingly, within this thesis, it was shown that NKp30 oligomerization might lead to formation of ligand
binding competent multivalent complexes. Although this has not been described for the other NCRs,
formation of de novo binding places by homo-oligomerization of the NKp30 ectodomain could be a
mechanism of how the NK cell is able to recognize multiple ligands that are unrelated in sequence and
structure. Another way to provide diversity would be a cooperation of NKp30 with the other NCR family
members NKp44 and NKp46 [101], further suggested as selective cross-talk between the NCRs [173],
but experimental data confirming these hypotheses are scarce. Notably, NKp46 is able to form ligand
binding-induced dimers most likely via its membrane proximal domain NKp46D2, which in turn leads
to intracellular signaling and target cell lysis [186]. Within this respective study, NKp46 ectodomain
dimerization was mediated by a monoclonal antibody and further validated by specific peptide inhibition.
However, the precise dimerization interface of NKp46 remains unclear as steric hindrance and a possible
direct contribution of the epitope sequence of the antibody to dimerization could not be distinguished in
these studies [186].
Oligomerization of proteins is a common principle in nature as illustrated by the fact that 35 % of
all proteins within a cell are oligomers [279–281]. Therefore, oligomerization of NKp30 is likely to
be of physiological relevance. However, at this point of investigation, the exact process of NKp30
ectodomain self-assembly remains speculation. The intrinsic potential for homo-oligomerization might
be enough to assemble pre-formed clusters. An appealing consideration for this hypothesis is that recep-
tor oligomerization prior to ligand interaction would lead to faster activation of signaling. Notably, local
concentration and oligomerization might even be fostered by ligand-induced assembly of a condensed
immunological synapse between the NK cell and its target cell. Along this line, multivalent interactions
with trimeric influenza virus hemagglutinin complexes [63] or multimeric ligand structures such as mul-
timeric N-acetylneuraminic acid (NeuNAc)-containing N-glycans binding to NKp44 or NKp46 [282]
suggest homo- or heteromeric NCR association [176–178], but to date there is no evidence for neither
pre-formed nor ligand-induced receptor oligomerization. However, as mainly demonstrated for T cells
so far, ligand-induced receptor clustering is a common mechanism for receptor-mediated signaling in
immune responses [234–236]. For instance, approximately 50 % of surface MHC class II protein resided
in lipid rafts and this clustering of MHC protein was necessary for presentation of low doses of antigen to
T cells [283]. In addition, the NKG2D ligands MICA and the ULBPs were also expressed in lipid rafts at
the cell surface, both proteins accumulating at the activating human NK cell immune synapse. Moreover,
electron microscopy revealed constitutive clusters of ULBP at the cell surface [284]. This is in line with
the dotted decoration pattern upon binding of NKp30 ectodomain proteins on ligands on the target cell
surface observed in this thesis. Comparison of the same B7-H6 expressing target cell population deco-
rated with soluble NKp30 oligomers comprising the entire NKp30 ectodomain or only the ligand binding
domain revealed a constant number of ligand clusters, suggesting a pre-assembly of B7-H6 monomers
on the target cell plasma membrane prior to interaction with NKp30. In any case, NKp30 self-assembly
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induced by increased local receptor concentration due to IL-2 activation or upon binding to pre-formed
ligand complexes, however, might be a potent instrument to facilitate high-affinity receptor-ligand in-
teraction, stabilization of the immunological synapse as well as extensive amplification of intracellular
signal transduction for efficient NK cell-mediated target cell lysis.
4.4 Outlook
Within this thesis, NKp30 homo-oligomerization was identified as important key feature to improve lig-
and binding affinity for enhanced NK cell cytotoxicity. Based on biochemical data, the beneficial effect
of the stalk domain on ligand binding and intracellular signal transduction [170] might be attributed to
self-binding following avidity-mediated attraction of the NKp30LBDs. However, despite this obvious
intrinsic potential for self-assembly, it remains unclear whether there are pre-existing NKp30 clusters
on the plasma membrane of the resting NK cell or cluster formation is induced by IL-2 activation, lig-
and engagement oder association with its adaptor molecule CD3ζ. To identify putative pre-clustering
of functional NKp30 receptors on a cellular background, anti-NKp30 antibody decorated NKp30 ex-
pressing cell lines could be analyzed by confocal immunofluorescence microscopy. For this purpose,
A5-30FL-His reporter cell lines with and without expression of the accessory protein CD3ζ might be
used to identify whether there is any impact of the adaptor molecule on receptor clustering on the A5
cell plasma membrane. Along this line, decoration of these cell lines with recombinant B7-H6 protein
could shed more light on the hypothesis of ligand-induced NKp30 homo-oligomerization. There are
only few experimantal data on the NKp30-CD3ζ so far. On the one hand, it was shown that NKp30
and CD3ζ are sufficient to mediate intracellular signaling [170]. In addition, stable expression of CD3ζ
significantly increased NKp30 surface levels at constant total NKp30 expression level within the cell
whereas surface NKp30 full-length expression alone was rather challenging in several cell types. These
results suggest that beside its role in signal transduction, CD3ζ might also target NKp30 to the plasma
membrane and/or promote the surface retention of NKp30 [238]. As mediator for stable and constant
NKp30 surface expression, CD3ζ might further increase the local receptor concentration, thereby pro-
moting NKp30 clustering. However, total internal reflection fluorescence microscopy (TIRFM) of liv-
ing HeLa cells, which expressed fluorescence-coupled NKp30 receptors alone or in combination with
CD3ζ, revealed that the organization status of NKp30 remained unchanged, even upon decoration with
its ligand B7-H6. Most probably, the fluorescent tags fused to the N-terminus of NKp30, which had the
same size or were even larger, interfered with the NKp30 ectodomain self-assembly. In addition, B7-
H6 binding was decreased, which might be attributed to the receptor-ligand binding interface, which is
located close to the N-terminus of NKp30. In this respect, both B7-H6 binding as well as NKp30 homo-
oligomerization might be hampered by masked residues or even structural rearrangements mediated by
the large fluorescence-tags [238]. By contrast, dimerization of NKp46 was observed within this study.
Since the dimerization interface of NKp46 is located within the membrane-proximal D2 domain [186]
and due to the larger molecular mass of NKp46, less structural influence by the respective tags is suggsted.
Therefore, analysis of NKp30 homo-oligomerization by TIRF microscopy might be an option, if there
will be smaller fluorescent tags available to prevent conformational changes of the NKp30 ectodomain
due to the experimental setup. Another method to investigate lateral mobility of NKp30within the plasma
membrane using TIRFM could be the micropatterning analysis. Fluorescence-coupled NKp30 receptors
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situated within the plasma membrane of a living cell would be captured by the respective fluorophore
ligand, which was coated in a specific pattern on a solid support. Redistribution of NKp30 coupled to
another fluorophore to this ligand-immobilized NKp30 could then be followed by TIRFM. Coating of
NKp30 ligands to investige their influence on NKp30 mobility and cluster formation is a further pos-
sibility [238]. However, single receptor trafficking experiments in a more physiological context, such
as TIRFM of NKp30 receptor expressing A5 reporter cells or NK cell lines, are even more difficult to
realize since this sophisticated experimental setup has been established only for HeLa cells so far.
Up to now, it is known that oppositely charged amino acids mediate the association of NKp30 (positive
arginine residue) and CD3ζ (negative aspartatic acid residue), but the concrete mechanism and time point
of interaction remain elusive. It is possible that ligand binding might induce a conformational rearrange-
ment of the extracellular part of NKp30 and a subsequent shift of the transmembrane domain towards the
cytosol. Due to the altered position of the arginine residue within the transmembrane region, a stronger
interaction with the aspartatic acid residue might be possible, which in turn could initiate the intracel-
lular signal transduction. Furthermore, the arginine residue could be located outside the transmembrane
region and be pushed into the plasma membrane upon ligand binding. Both models suggesting a change
in the relative arginine position could be validated by electron spin resonance spectroscopy as introduced
spin labels are sensitive to the polarity of their environment [238]. In another approach, R143 could be
deleted by point mutation to investigate the crosstalk of the individual NCRs in more detail. Therefore,
the NKp30dull NK cell line [119] could be employed to introduce a codon-optimized NKp30 receptor
devoid of transmembrane arginine to analyze whether the signal transduction cascade following NKp46
and/or NKp44 triggering could be induced by NKp30 ligand binding. However, based on the data, at least
NKp30 homo-oligomerization is mainly mediated by stalk-induced self-binding. To verify the effect on
NKp30 ectodomain self-assembly in solution and on the plasma membrane, the stalk-mediated interac-
tion could be inhibited by sterical hindrance employing a specific anti-NKp30Stalk-antibody (CLSM).
Pre-incubation of soluble 30Stalk-His proteins and even stalk domain-containing NKp30-IgG1-Fc vari-
ants could decrease or even diminish binding on soluble or immobilized ligand molecules in biochem-
ical (ELISA) and cellular assays (cell decoration and signaling reporter assay). Furthermore, the equi-
librium of oligomers, dimers and monomers should be shifted completely towards the dimeric (and/or
monomeric) state upon pre-incubation with an anti-NKp30Stalk antibody. Moreover, binding of this an-
tibody could further influence the signaling capacity of NKp30 by hampering the flexibility of the stalk
domain. Nevertheless, the ligand binding domain of NKp30 has an intrinsic potential to self-associate,
which could be further analyzed by bioinformatics identifying putative surface residues suitable for homo-
oligomerization. In parallel or subsequently, peptide libraries or peptides calculated for interaction with
the respective surface stretches could be used for inhibition assays to further validate distinct surface
areas participating in NKp30 ectodomain homo-oligomerization. With these findings, a manipulation of
the balance between activation and inhibition could be possible by enhancing NKp30 self-association for
improved immunological synapse formation, thereby promoting NK cell activity. Furthermore, deeper
insights into the molecular details of ligand recognition and NKp30-dependent NK cell cytotoxicity as
well as the identification of new cellular NKp30 ligands can contribute to the future development and
improvement of NK cell-based cancer therapies.
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5 Summary
5.1 Summary
Natural killer (NK) cells are large granular lymphocytes of the innate immune system that spontaneously
kill foreign, tumor and virus-infected cells without prior sensitization. In addition, NK cells act as immune
regulators by secretion of chemokines and cytokines as well as direct interaction with other immune cells
such as dendritic cells. NK cell function is regulated by a balance between inhibitory and activating
signals that are transduced into the cell upon target cell interaction. One of the major activating NK cell
receptors is the natural cytotoxicity receptor NKp30. Notably, NKp30 plays a unique role since it is the
only NK cell receptor involved in triggeringNK cell-mediated cytotoxicity as well as shaping the adaptive
immune response. Reduced NKp30 expression has clinical implications in patients with acute myeloid
leukemia, cervical cancer, and high grade squamous intraepithelial lesions as well as gastrointestinal
sarcoma. Furthermore, downregulation of NKp30 expression resulted in an impaired natural cytotoxicity
against leukemia cells and was directly correlated with reduced survival.
NKp30 is a type I transmembrane protein of approximately 30 kDa comprised of an I-type Ig-like ligand
binding domain (LBD), a flexible membrane proximal stalk domain, a single transmembrane helix, and
a short cytosolic tail. For intracellular signal transduction, NKp30 associates with the immunoreceptor
tyrosine-based activating motif (ITAM)-bearing adaptor molecule CD3ζ via oppositely charged amino
acid residues within their transmembrane domains. In 2011, the 3D structure of the NKp30LBD was
solved in an unbound and a ligand-bound form. However, so far, only few cellular ligands (BAG-6
and B7-H6) have been discovered, and the molecular details of ligand recognition by NKp30 are poorly
understood. Recently, it was shown that the membrane proximal stalk domain of NKp30 is important for
efficient ligand binding and signaling with respect to its length and amino acid composition. Additionally,
it was demonstrated that properN-linked glycosylation of the ligand binding domain is essential for ligand
binding. But it is still vague, how this germline-encoded receptor is able to recognize multiple non-
related ligands. Interestingly, a crystallographic dimer of the NKp30 ectodomain was observed arguing
for potential intrinsic capability to self-assemble. Moreover, a fraction of NKp30 expressed in E. coli
forms oligomers as detected by size exclusion chromatography.
The aim of this thesis was to identify structural models and mechanisms, which enable variations of the
ligand binding interface of NKp30 to recognize a multiplicity of diverse ligands. In this respect, soluble
NKp30 ectodomain variants as well as an anti-NKp30 antibody specifically recognizing an epitope within
the LBD of NKp30 were generated for molecular and cellular investigation to address the intrinsic ability
of NKp30 to form oligomers, which might impact ligand binding affinity and the efficiency of target cell
killing by NK cells.
In this thesis, it was demonstrated that baculovirus-infected insect cells were a suitable expression
system to produce correctly folded, post-translationally modified and ligand binding-receptive NKp30
proteins, which were functionally equivalent to those derived from human expression hosts. Further-
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more, a polyclonal anti-NKp30 antibody, which is specific for an epitope located within the NKp30LBD,
was purified from the blood serum of a peptide-immunized rabbit and validated for several molecular and
cellular applications. Based on soluble NKp30 proteins comprising either the entire NKp30 ectodomain
(LBD and stalk domain) or the ligand binding domain alone, a concentration-dependent formation of
NKp30 ectodomain homo-oligomers was found, which was effected by two specific binding sites, one
present within the Ig domain of NKp30 and one within its membrane proximal stalk domain. Moreover,
both NKp30 ectodomain variant oligomers were functional in ligand binding and contributed to a high-
affinity interaction with its cellular ligand B7-H6, which was strongly promoted by the stalk domain.
Although both NKp30 ectodomain variant oligomers formed spherical particles of the same diameter in
solution, in presence of the stalk domain one oligomer was composed of more monomers. Single particle
electron microscopy analyses revealed that the number of calculated 2D classes increased tremendously
for the particles of the longer NKp30 ectodomain variant. Therefore, a densest packing of spheres for the
monomers within both NKp30 ectodomain variant oligomers is suggested, whereas the flexibility of the
stalk domain might allow for a more variable orientation of these monomers within the particle, thereby
increasing the heterogeneity of structural arrangements. However, based on decoration experiments with
soluble NKp30 ectodomain proteins and primary NK cells facilitating more physiological conditions for
NKp30 self-assembly, an ordered arrangement of several NKp30 receptors on the plasma membrane in
head-to-head orientation is proposed. Based on these data, oligomerization of the NKp30 ectodomain
represents a potent mechanism to modulate the ligand binding affinity of NKp30 for corresponding lig-
ands by increased avidity. Because the degree of oligomerization is dependent on the local receptor
concentration, which is upregulated by IL-2 upon NK cell activation, oligomerization of NKp30 might
be a molecular transformer of NK cell activation into enhanced cytotoxicity. Future experiments are now
focused to investigate NKp30 self-assembly on the plasma membrane of NK cells to enable modulation
of the cytotoxicity of NK cell based therapeutics.
5.2 Summary (German)
Natürliche Killerzellen (NK-Zellen) sind große, granuläre Lymphozyten des angeborenen Immunsys-
tems, welche fremdartige, krankhaft veränderte sowie virus-infizierte Zellen spontan und ohne vorherige
Sensibilisierung töten. Weiterhin agieren NK-Zellen durch Sekretion von Chemokinen und Zytokinen
sowie durch direkte Interaktion mit anderen Immunzellen wie z.B. Dendritischen Zellen als Immunre-
gulatoren. Ihre Funktion wird dabei durch ein Gleichgewicht zwischen inhibierenden und aktivieren-
den Signalen gesteuert, welche durch die Interaktion mit einer Zielzelle in das NK-Zellinnere übermittelt
werden. Einer der wichtigsten aktivierenden NK-Zellrezeptoren ist NKp30, ein Mitglied der Familie der
natürlichen Zytotoxizitätsrezeptoren (natural cytotoxicity receptors, NCRs). NKp30 ist einmalig unter
den aktivierenden NK-Zellrezeptoren, da er als einziger sowohl die NK-Zell-vermittelte Zytotoxizität
auslöst als auch die erworbene Immunantwort beeinflusst. Eine verringerte NKp30 Expression hat kli-
nische Folgen für Patienten, die an akuter myeloider Leukämie (AML), Gebärmutterhalskrebs, Platten-
epithelkarzinom (high grade squamous intraepithelial lesions, HGSIL) oder auch Weichgewebstumoren
(gastrointestinal sarcoma, GIST) erkrankt sind. Zudem resultiert aus der NKp30 Herunterregulation
eine geringere natürliche Zytotoxizität gegenüber Leukämiezellen, welche direkt mit einer verringerten
Überlebensrate korreliert.
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NKp30 ist ein Typ I Transmembranprotein von etwa 30 kDa, welches aus einer I-Typ Ig-ähnlichen
Ligandenbindedomäne (LBD), einer flexiblen membrannahen Stalkdomäne, einer einzelnen Transmem-
branhelix und einem kurzen zytoplasmatischen Schwanz aufgebaut ist. Um Signale im Zellinneren
weiterleiten zu können, assoziiert NKp30 mit dem ITAM (immunoreceptor tyrosin-based activatin mo-
tif )-enthaltenden Adapterprotein CD3ζ über entgegengesetzt geladene Aminosäurereste innerhalb ihrer
Transmembrandomänen. Im Jahr 2011 wurde die 3D-Struktur der Ligangenbindedomäne von NKp30
sowohl in einer ungebunden als auch einer Liganden-gebundenen Form gelöst. Da bisher nur wenige
zelluläre Liganden (BAG-6, B7-H6) entdeckt wurden, sind die molekularen Einzelheiten der Liganden-
erkennung durch NKp30 weitgehend unbekannt. Vor kurzem konnte jedoch gezeigt werden, dass sowohl
die Länge als auch die Aminosäuresequenz der membrannahen Stalkdomäne von NKp30 bedeutsam für
eine effiziente Ligandenbindung und Signalweiterleitung sind. Außerdem wurde bewiesen, dass eine
korrekte N-verknüpfte Glykosylierung der LBD essentiell für die Ligandenbindung ist. Es bleibt aber
weiterhin unklar, wodurch dieser keimbahn-kodierte Rezeptor in der Lage ist, verschiedene nicht ver-
wandte Liganden zu erkennen. Interessanterweise wurde ein kristallographisches Dimer der NKp30 Ek-
todomäne beobachtet, was auf ein intrinsisches Potential zur Selbstassemblierung schließen lässt. Zudem
konnte aus einer Präparation von NKp30 Protein, welches aus E. coli hergestellt wurde, mittels Größen-
ausschlusschromatographie eine Oligomer-enthaltende Fraktion isoliert werden.
Das Ziel dieser Arbeit war es, strukturelle Modelle und Mechanismen zu identifizieren, welche eine
Variabilität der Interaktionsfläche zwischen NKp30 und seinen Liganden ermöglicht, um eine Vielzahl
von verschiedenen Liganden zu erkennen. Es wurden lösliche Varianten der NKp30 Ektodomäne sowie
ein anti-NKp30 Antikörper, welcher spezifisch ein Epitop innerhalb der LBD von NKp30 erkennt, für
molekulare und zelluläre Analysemethoden hergestellt. Mit Hilfe dieser Proteine wurde die intrinsische
Fähigkeit von NKp30, Oligomere auszubilden, untersucht, welche die Ligandenbindeaffinität sowie auch
die effiziente Zielzelltötung durch NK-Zellen beeinflussen könnte.
In dieser Arbeit konnte gezeigt werden, dass Baculovirus-infizierte Insektenzellen ein geeignetes Ex-
pressionssystem zur Herstellung von richtig gefalteten, post-translational modifizierten und liganden-
bindungskompetentenNKp30 Proteinen sind, welche in ihrer Funktionalität den in humanen Expressions-
wirten hergestellten Proteinen gleichgestellt sind. Außerdem wurde ein polyklonaler anti-NKp30 Anti-
körper aus demBlutserum eines Peptid-immunisiertenKaninchens gereinigt, welcher spezifisch ein in der
NKp30LBD lokalisiertes Epitop erkennt, und für verschiedene molekulare und zelluläre Anwendungen
validiert. Basierend auf löslichen NKp30 Proteinen, welche entweder die gesamte NKp30 Ektodomäne
(LBD und Stalkdomäne) oder nur die LBD enthielten, wurde eine konzentrationsabhängige Ausbildung
von Homo-Oligomeren der NKp30 Ektodomäne gefunden. Die Selbstassemblierung der NKp30 Ek-
todomäne wird durch zwei spezifische Bindestellen ermöglicht, welche sich in der Ig-Domäne sowie
in der membrannahen Stalkdomäne von NKp30 befinden. Diese NKp30 Ektodomänenoligomere waren
funktional hinsichtlich der Ligandenbindung und trugen zudem zu einer hoch-affinen Interaktion mit dem
zellulären Liganden B7-H6 bei, welche besonders stark durch die Stalkdomäne begünstigt wurde. Ob-
wohl beide NKp30 Ektodomänenoligomere in Lösung sphärische Partikel mit dem gleichen Durchmesser
ausbildeten, waren die Oligomere bestehend aus der NKp30 Ektodomänvariante mit Stalkdomäne aus
mehr Monomeren aufgebaut. Elektronenmikroskopische Untersuchungen von Einzelpartikeln ergaben
zudem eine immens erhöhte Zahl berechneter 2D Klassen für die Oligomerpartikel der vollständigen
NKp30 Ektodomäne. Daher wird für die Monomere beider NKp30 Ektodomänvarianten eine Anordnung
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in Form der dichtesten Kugelpackung vorgeschlagen. Aufgrund der Flexibilität der Stalkdomäne könn-
ten vielfältigere Orientierungen der Monomere innerhalb der Partikel ermöglicht werden, wodurch sich
die Heterogenität der strukturellen Anordnung weiter erhöht. Aufgrund von Dekorationsexperimenten
mit löslichen NKp30 Ektodomänenproteinen und primären NK-Zellen, welche physiologischere Beding-
ungen für die NKp30 Selbstassemblierung widerspiegeln, wird jedoch eine geordnete Aneinanderreih-
ung von NKp30 Rezeptoren in der Plasmamembran mit einer Kopf-an-Kopf-Orientierung zueinander
vorgeschlagen. Basierend auf diesen Daten stellt die Oligomerisierung der NKp30 Ektodomäne einen
wirksamen Mechanismus dar, um die Ligandenbindeaffinität von NKp30 durch zunehmende Avidität
zu verstärken. Da der Grad der Oligomerisierung von der lokalen Rezeptorkonzentration abhängig ist,
welche durch IL-2 während der NK-Zellaktivierung hochreguliert wird, könnte die Homo-Oligomerisier-
ung von NKp30 ein molekularer Überträger der NK-Zellaktivierung zu verstärkter Zytotoxizität sein.
Zukünftige Experimente sind nun auf die Untersuchung der NKp30 Selbstassemblierung auf der Plas-
mamembran von NK-Zellen ausgerichtet, um die Regulierung der Zytotoxizität von NK-Zell-basierten
Therapien zu ermöglichen.
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7.1 Supplemental Data
7.1.1 Isoforms of NKp30
Fig. S1: The human NKp30 gene encodes six splice variants
(A) The genomic organization of the exons contributing to the six transcript variants of NKp30. Exon 1 (E1)
encodes the leader sequence, exon 2 (E2) the ectodomain, exon 3 (E3) the transmembrane domain, and exon 4
(E4) the intracellular domain of NKp30. (B) Transcript variants of NKp30. In transcripts a-c, the complete exon
2 is used, whereas in transcripts d-f, exons 2I and 2II are transcribed, resulting in a 75-nucleotide deletion of the
extracellular part. In transcripts a and e exon 4III is used, whereas in transcripts b and d exon 4II and in transcripts c
and f exon 4I are transcribed. The initiation and stop codons are indicated by the arrowheads. (C) Protein structure
of each splice variant of NKp30. Isoform a consists of 201 amino acids and was defined as canonical isoform
of NKp30. It harbors the complete ectodomain of NKp30 and the longest intracellular domain (36 amino acids).
Isoform b consists of 177 amino acids due to alternative splicing of exon 4. It harbors the complete ectodomain
of NKp30 and the shortest intracellular domain (12 amino acids). Isoform c consists of 190 amino acids, harbors
the complete ectodomain of NKp30 and an intracellular domain of 25 amino acids. Isoforms d, e and f harbor a
partially deleted ectodomain of NKp30, which lacks 25 amino acids within the ligand binding domain. Isoform d,
with its intracellular domain corresponding to isoform b, consists of 152 amino acids. Isoform e with the longest
intracellular domain consists of 176 and isoform f consists of 165 amino acids due to the intracellular domain
corresponding to isoform c with 25 amin acids. (Modified from [285].)
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7.1.2 Upregulation of NCR Surface Expression Upon IL-2 Activation
Fig. S2: Induced surface NCR expression upon IL-2 activation of NK cells
In vitro upregulation of the NCRs under the influence of IL-2. Mean fluorescence intensity (MFI) of NCRs (NKp30,
NKp44, andNKp46) on CD56+CD16−CD3− NKcells. Notably, the CD56+CD16+CD3− NKcell subset displays
comparable NCR surface expressions. Freshly isolated (gray bars) and IL-2 stimulated NK cells (white bars) are
shown. Significant differences in up-regulation are marked (**P < 0.005, ***P < 0.001). (Modified from [184].)
7.1.3 Constitutive YFP Expression Upon Transfection and Baculoviral Infection of
Insect Cells
Fig. S3: Normalized YFP fluorescence intensities
Intracellular YFP fluorescence intensities (excitation: 485 nm, emission: 520 nm) of supernatants from centrifu-
gation after sonication of insect cells were measured. To estimate transfection and infection efficiencies, YFP
fluorescence intensities were normalized to non-infected insect cells. (A) Fold YFP fluorescence of transfected
Sf 9 insect cells from one 6-well six days post transfection. (B-F) Fold YFP fluorescence of 1x106 infected High
Five insect cells one to three/four days post infection (gray: non-infected, black: NKp30-His functionalization,
white: NKp30-His/NKp44-His/NKp46-His functionalization, red: 30Stalk-His secretion, blue: 30LBD-His secre-
tion, pink: 30Stalk-His secretion, tunicamycin-treated).
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7.1.4 Expression of the NKp30 Ligand Binding Domain in Escherichia coli
Since the 3D structure of theNKp30LBDhad not been solved until 2011 [116,117], a de novomodel of the
globular NKp30 LBDwas calculated using the protein structure prediction service PHYRE [216]. There-
fore, the truncated version of the NKp30 LBD (30LBDtr) lacking eight amino acids at the C-terminus
(amino acids M1 to G120, see 7.3) was used. To identify the optimal construct design, expression and
purification analyses with variants of 30LBDtr fused to an N- or C-terminal deca-histidine tag (His) for
affinity purification were performed. Therefore, E. coli BL21 cells were transformed with the plasmids
pET16b-His10-TEV-NKp30EC or pET16b-NKp30EC-TEV-His10 encoding His-30LBDtr or 30LBDtr-
His, respectively (2.2.2). Upon inoculation of expression cultures and induction of recombinant gene
expression by IPTG at optimized conditions (2.4.1), samples were collected for reducing SDS-PAGE
and immunoblot analyses. Though both variants were expressed (Fig. S4A and B), highest recombinant
protein levels were obtained for His-30LBDtr as demonstrated by immunoblot analyses (anti-NKp30,
polyclonal). At 4 h post induction, recombinant protein levels remained static and bacteria cells were
harvested by centrifugation.
Fig. S4: Production of soluble NKp30 ligand binding domain proteins in E. coli
E. coli cells were transformed with plasmids encoding the truncated NKp30 ligand binding domain (30LBDtr)
fused to different purification tags (His, deca-histidine; MBP, maltose binding protein). Aliquots of bacteria trans-
formed with plasmids encoding for (A) N-terminal and (B) C-terminal His-tagged 30LBDtr were collected post
IPTG induction at indicated time points. Optimal conditions for recombinant protein production were identified
by reducing SDS-PAGE (coomassie-stained) and immunoblot (anti-NKp30) analyses. Pellet (P) and soluble frac-
tion (S) of sonicated bacteria cells expressing (C) His-30LBDtr or (D) MBP-30LBDtr proteins were analyzed by
reducing SDS-PAGE (coomassie-stained) and immunoblot (anti-NKp30).
It is known that E. coli derived recombinant proteins are often found in inclusion bodies. Therefore,
the bacteria cells were resuspended and sonicated for separation of cytosolic proteins and an insoluble
pellet fraction (2.4.1). Reducing SDS-PAGE and corresponding immunoblot (anti-NKp30, polyclonal)
analyses revealed complete aggregation of the recombinant His-30LBDtr proteins within inclusion bod-
ies (Fig. S4C). Even expression of His-30LBDtr in E. coliOrigami (DE3) cells, which facilitate disulfide
bond formation and thereby possibly sustaining correct folding of the NKp30 ligand binding domain,
did not increase protein solubility (data not shown). To circumvent elaborate refolding screenings, larger
purification tags such as GST (plasmid pGEX-4T-1-NKp30EC) or MBP (plasmid pMal-p5X-NKp30EC)
were fused at the N-terminus of 30LBDtr, which were expressed in E. coli BL21 (DE3) upon transfor-
mation. Interestingly, immunoblot analysis (anti-NKp30, polyclonal) revealed the presence of soluble
MBP-30LBDtr proteins within the cytosolic fraction, at least to some extent (Fig. S4D). However, flow
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cytometry analyses of decorated target cells with recombinant MBP-30LBDtr proteins did not demon-
strate any ligand binding capacities (data not shown).
7.1.5 B7-H6-Bound Structure of the NKp30 Ligand Binding Domain
Fig. S5: The ligand binding domain of NKp30 is a two-layer β-sandwich
B7-H6 (gray)-bound crystal structure of the NKp30 ectodomain. The Ig-like domain of NKp30 is a two-layer β-
sandwich. The front (red) and back sheets (blue) are composed of β-strands GFC and ABED, respectively, are
linked by a canonical intersheet disulfide bond (C39-C108, in yellow stick representation). In addition, NKp30
contains two α-helices (α1 and α2) preceding β-strands D and E, respectively. One of these helices (α1) is unique
to NKp30 among Ig-like domains. Notably, the predicted model of the NKp30 ligand binding domain lacks eight
amino acids at the C-terminus (N121-E128 of the G strand, depicted in brown). (Modified from [117].)
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7.2 Plasmid and Vector Maps
7.2.1 Expression Plasmids (E. coli)
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7.2.2 Expression Plasmids (Mammalian Cells)
7.2.3 Expression Plasmids (Insect Cells)
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7.2.4 Multigene Transfer Vectors (Insect Cells)
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7.3 Protein Sequences
Unless otherwise denoted, nucleotide sequences originate from commercial plasmid vectors or can be
found at the NCBI database (www.ncbi.nlm.nih.gov). Respective accession numbers and used base pairs
are indicated for each fragment. The color code of the corresponding amino acid sequences refers to the
construct scheme. Amino acids depicted in black result from the cloning strategy. Enzymatic cleavage
sites for removal of the purification tag are italicized. Domain borders within the amino acid sequence
of one fragment (one color) are separated by vertical lines.
Codon-optimized DNA of full-length NKp30 (synthesized by GenScript)
1 ATGGCCTGGA TGCTGCTGCT GATTCTGATT ATGGTCCACC CTGGGTCCTG TGCCCTGTGG
61 GTCTCTCAGC CTCCCGAAAT TAGAACTCTG GAGGGCAGCT CCGCTTTCCT GCCTTGCTCC
121 TTTAACGCTT CTCAGGGGAG ACTGGCAATC GGAAGTGTGA CATGGTTCAG GGACGAGGTG
181 GTCCCAGGCA AGGAAGTGCG CAATGGGACT CCAGAATTCA GGGGACGCCT GGCCCCTCTG
241 GCTTCTAGTC GGTTTCTGCA CGATCATCAG GCAGAGCTGC ACATCAGAGA CGTGCGGGGC
301 CATGATGCTT CCATCTACGT GTGCAGAGTG GAAGTGCTGG GACTGGGAGT GGGAACAGGA
361 AACGGGACAA GGCTGGTGGT CGAAAAGGAG CACCCACAAT TAGGAGCAGG GACCGTGCTG
421 CTGCTGAGAG CAGGGTTCTA TGCCGTCTCA TTTCTGAGCG TGGCCGTCGG CAGCACCGTG
481 TACTATCAGG GGAAGTGTCT TACTTGGAAG GGCCCACGGC GTCAGCTGCC CGCCGTGGTC
541 CCTGCCCCTC TGCCCCCTCC TTGTGGCTCA TCTGCTCATC TGCTGCCCCC AGTCCCAGGC
601 GGATGA
NKp30opt-His/NKp30-His
MAWMLLLILIMVHPGSCA|LWVSQPPEIRTLEGSSAFLPCSFNASQGRLAIGSVTWFRDEVVPGKEVRN
GTPEFRGRLAPLASSRFLHDHQAELHIRDVRGHDASIYVCRVEVLGLGVGTGNGTRLVVE|KEHPQLGA
GTVLLLR|AGFYAVSFLSVAVGSTVYYQG|KCLTWKGPRRQLPAVVPAPLPPPCGSSAHLLPPVPGGHH
HHHHHHHH
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NKp44-His
MAWRALHPLLLLLLLFPGSQA|QSKAQVLQSVAGQTLTVRCQYPPTGSLYEKKGWCKEASALVCIRLVT
SSKPRTMAWTSRFTIWDDPDAGFFTVTMTDLREEDSGHYWCRIYRPSDNSVSKSVRFYL|VVSPASAST
QTSWTPRDLVSSQTQTQSCVPPTAGARQAPESPSTIPVPSQPQNSTLRPGPAAPIA|LVPVFCGLLVAK
SLVLSALLV|WWGDIWWKTMMELRSLDTQKATCHLQQVTDLPWTSVSSPVEREILYHTVARTKISDDDD
EHTLHHHHHHHHHH
NKp46-His
MSSTLPALLCVGLCLSQRISAQQQ|TLPKPFIWAEPHFMVPKEKQVTICCQGNYGAVEYQLHFEGSLFA
VDRPKPPERINKVKFYIPDMNSRMAGQYSCIYRVGELWSEPSNLLDLVVTEMYDTPTLSVHPGPEVISG
EKVTFYCRLDTATSMFLLLKEGRSSHVQRGYGKVQAEFPLGPVTTAHRGTYRCFGSYNNHAWSFPSEPV
KLLV|TGDIENTSLAPEDPTFPADTWGTYLLTTETGLQKDHALWDHTAQNLLR|MGLAFLVLVALVWFL
VEDWLS|RKRTRERASRASTWEGRRRLNTQTLHHHHHHHHHH
His-TEV-NKp30LBDtr
MGHHHHHHHHHHGSENLYFQGGSLWVSQPPEIRTLEGSSAFLPCSFNASQGRLAIGSVTWFRDEVVPGK
EVRGTPEFRGRLAPLASSRFLHDHQAELHIRDVRGHDASIYVCRVEVLGLGVGTG
NKp30LBDtr-TEV-His
MGLWVSQPPEIRTLEGSSAFLPCSFNASQGRLAIGSVTWFRDEVVPGKEVRNGTPEFRGRLAPLASSRF
LHDHQAELHIRDVRGHDASIYVCRVEVLGLGVGTGGSENLYFQGGSHHHHHHHHHH
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GST-NKp30LBDtr
MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSM
AIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLC
HKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQ
ATFGGGDHPPKSDLVPRGSPEFLWVSQPPEIRTLEGSSAFLPCSFNASQGRLAIGSVTWFRDEVVPGKE
VRNGTPEFRGRLAPLASSRFLHDHQAELHIRDVRGHDASIYVCRVEVLGLGVGTG
MBP-NKp30LBDtr
MKIKTGARILALSALTTMMFSASALAKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKL
EEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEA
LSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDV
GVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTF
KGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAA
TMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSNNNNNNNNNNLGIEGRIS
HMSMGGRDIVDGSEFLWVSQPPEIRTLEGSSAFLPCSFNASQGRLAIGSVTWFRDEVVPGKEVRNGTPE
FRGRLAPLASSRFLHDHQAELHIRDVRGHDASIYVCRVEVLGLGVGTG
NKp30LBD-His
MLLVNQSHQGFNKEHTSKMVSAIVLYVLLAAAAHSAFAADLGSLWVSQPPEIRTLEGSSAFLPCSFNAS
QGRLAIGSVTWFRDEVVPGKEVRNGTPEFRGRLAPLASSRFLHDHQAELHIRDVRGHDASIYVCRVEVL
GLGVGTGNGTRLVVEGSENLYFQGGSHHHHHHHHHH
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NKp30LBD-Stalk-His
MLLVNQSHQGFNKEHTSKMVSAIVLYVLLAAAAHSAFAADLGSLWVSQPPEIRTLEGSSAFLPCSFNAS
QGRLAIGSVTWFRDEVVPGKEVRNGTPEFRGRLAPLASSRFLHDHQAELHIRDVRGHDASIYVCRVEVL
GLGVGTGNGTRLVVE|KEHPQLGAGTVLLLRGSENLYFQGGSHHHHHHHHHH
B7-H6-Ig
MEQRGQNAPAASGARKRHGPGPREARGARPGPRVPKTLVLVVAAVLLLVSAESALGSDLKVEMMAGGTQ
ITPLNDNVTIFCNIFYSQPLNITSMGITWFWKSLTFDKEVKVFEFFGDHQEAFRPGAIVSPWRLKSGDA
SLRLPGIQLEEAGEYRCEVVVTPLKAQGTVQLEVVASPASRLLLDQVGMKENEDKYMCESSGFYPEAIN
ITWEKQTQKFPHPIEISEDVITGPTIKNMDGTFNVTSCLKLNSSQEDPGTVYQCVVRHASLHTPLRSNF
TLTAARHSLSETEKTDNFSIHWWPDITHTCPPCPAPEAEGAPSVFLFPPKPKDTLMISRTPEVTCVVVD
VSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEK
TISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGS
FFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
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7.4 Peptide Spot Sequences
NKp30 (18 aa, off-set 1 aa)
A1 MAWMLLLILIMVHPGSCA B5 FNASQGRLAIGSVTWFRD C9 ASSRFLHDHQAELHIRDV
A2 AWMLLLILIMVHPGSCAL B6 NASQGRLAIGSVTWFRDE C10 SSRFLHDHQAELHIRDVR
A3 WMLLLILIMVHPGSCALW B7 ASQGRLAIGSVTWFRDEV C11 SRFLHDHQAELHIRDVRG
A4 MLLLILIMVHPGSCALWV B8 SQGRLAIGSVTWFRDEVV C12 RFLHDHQAELHIRDVRGH
A5 LLLILIMVHPGSCALWVS B9 QGRLAIGSVTWFRDEVVP C13 FLHDHQAELHIRDVRGHD
A6 LLILIMVHPGSCALWVSQ B10 GRLAIGSVTWFRDEVVPG C14 LHDHQAELHIRDVRGHDA
A7 LILIMVHPGSCALWVSQP B11 RLAIGSVTWFRDEVVPGK C15 HDHQAELHIRDVRGHDAS
A8 ILIMVHPGSCALWVSQPP B12 LAIGSVTWFRDEVVPGKE C16 DHQAELHIRDVRGHDASI
A9 LIMVHPGSCALWVSQPPE B13 AIGSVTWFRDEVVPGKEV C17 HQAELHIRDVRGHDASIY
A10 IMVHPGSCALWVSQPPEI B14 IGSVTWFRDEVVPGKEVR C18 QAELHIRDVRGHDASIYV
A11 MVHPGSCALWVSQPPEIR B15 GSVTWFRDEVVPGKEVRN C19 AELHIRDVRGHDASIYVC
A12 VHPGSCALWVSQPPEIRT B16 SVTWFRDEVVPGKEVRNG C20 ELHIRDVRGHDASIYVCR
A13 HPGSCALWVSQPPEIRTL B17 VTWFRDEVVPGKEVRNGT C21 LHIRDVRGHDASIYVCRV
A14 PGSCALWVSQPPEIRTLE B18 TWFRDEVVPGKEVRNGTP C22 HIRDVRGHDASIYVCRVE
A15 GSCALWVSQPPEIRTLEG B19 WFRDEVVPGKEVRNGTPE C23 IRDVRGHDASIYVCRVEV
A16 SCALWVSQPPEIRTLEGS B20 FRDEVVPGKEVRNGTPEF C24 RDVRGHDASIYVCRVEVL
A17 CALWVSQPPEIRTLEGSS B21 RDEVVPGKEVRNGTPEFR C25 DVRGHDASIYVCRVEVLG
A18 ALWVSQPPEIRTLEGSSA B22 DEVVPGKEVRNGTPEFRG C26 VRGHDASIYVCRVEVLGL
A19 LWVSQPPEIRTLEGSSAF B23 EVVPGKEVRNGTPEFRGR C27 RGHDASIYVCRVEVLGLG
A20 WVSQPPEIRTLEGSSAFL B24 VVPGKEVRNGTPEFRGRL C28 GHDASIYVCRVEVLGLGV
A21 VSQPPEIRTLEGSSAFLP B25 VPGKEVRNGTPEFRGRLA C29 HDASIYVCRVEVLGLGVG
A22 SQPPEIRTLEGSSAFLPC B26 PGKEVRNGTPEFRGRLAP C30 DASIYVCRVEVLGLGVGT
A23 QPPEIRTLEGSSAFLPCS B27 GKEVRNGTPEFRGRLAPL C31 ASIYVCRVEVLGLGVGTG
A24 PPEIRTLEGSSAFLPCSF B28 KEVRNGTPEFRGRLAPLA C32 SIYVCRVEVLGLGVGTGN
A25 PEIRTLEGSSAFLPCSFN B29 EVRNGTPEFRGRLAPLAS C33 IYVCRVEVLGLGVGTGNG
A26 EIRTLEGSSAFLPCSFNA B30 VRNGTPEFRGRLAPLASS C34 YVCRVEVLGLGVGTGNGT
A27 IRTLEGSSAFLPCSFNAS B31 RNGTPEFRGRLAPLASSR C35 VCRVEVLGLGVGTGNGTR
A28 RTLEGSSAFLPCSFNASQ B32 NGTPEFRGRLAPLASSRF C36 CRVEVLGLGVGTGNGTRL
A29 TLEGSSAFLPCSFNASQG B33 GTPEFRGRLAPLASSRFL D1 RVEVLGLGVGTGNGTRLV
A30 LEGSSAFLPCSFNASQGR B34 TPEFRGRLAPLASSRFLH D2 VEVLGLGVGTGNGTRLVV
A31 EGSSAFLPCSFNASQGRL B35 PEFRGRLAPLASSRFLHD D3 EVLGLGVGTGNGTRLVVE
A32 GSSAFLPCSFNASQGRLA B36 EFRGRLAPLASSRFLHDH D4 VLGLGVGTGNGTRLVVEK
A33 SSAFLPCSFNASQGRLAI C1 FRGRLAPLASSRFLHDHQ D5 LGLGVGTGNGTRLVVEKE
A34 SAFLPCSFNASQGRLAIG C2 RGRLAPLASSRFLHDHQA D6 GLGVGTGNGTRLVVEKEH
A35 AFLPCSFNASQGRLAIGS C3 GRLAPLASSRFLHDHQAE D7 LGVGTGNGTRLVVEKEHP
A36 FLPCSFNASQGRLAIGSV C4 RLAPLASSRFLHDHQAEL D8 GVGTGNGTRLVVEKEHPQ
B1 LPCSFNASQGRLAIGSVT C5 LAPLASSRFLHDHQAELH D9 VGTGNGTRLVVEKEHPQL
B2 PCSFNASQGRLAIGSVTW C6 APLASSRFLHDHQAELHI D10 GTGNGTRLVVEKEHPQLG
B3 CSFNASQGRLAIGSVTWF C7 PLASSRFLHDHQAELHIR D11 TGNGTRLVVEKEHPQLGA
B4 SFNASQGRLAIGSVTWFR C8 LASSRFLHDHQAELHIRD D12 GNGTRLVVEKEHPQLGAG
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NKp30 (18 aa, off-set 1 aa)
D13 NGTRLVVEKEHPQLGAGT D31 VLLLRAGFYAVSFLSVAV E13 GSTVYYQGKCLTWKGPRR
D14 GTRLVVEKEHPQLGAGTV D32 LLLRAGFYAVSFLSVAVG E14 STVYYQGKCLTWKGPRRQ
D15 TRLVVEKEHPQLGAGTVL D33 LLRAGFYAVSFLSVAVGS E15 TVYYQGKCLTWKGPRRQL
D16 RLVVEKEHPQLGAGTVLL D34 LRAGFYAVSFLSVAVGST E16 VYYQGKCLTWKGPRRQLP
D17 LVVEKEHPQLGAGTVLLL D35 RAGFYAVSFLSVAVGSTV E17 YYQGKCLTWKGPRRQLPA
D18 VVEKEHPQLGAGTVLLLR D36 AGFYAVSFLSVAVGSTVY E18 YQGKCLTWKGPRRQLPAV
D19 VEKEHPQLGAGTVLLLRA E1 GFYAVSFLSVAVGSTVYY E19 QGKCLTWKGPRRQLPAVV
D20 EKEHPQLGAGTVLLLRAG E2 FYAVSFLSVAVGSTVYYQ E20 GKCLTWKGPRRQLPAVVP
D21 KEHPQLGAGTVLLLRAGF E3 YAVSFLSVAVGSTVYYQG E21 KCLTWKGPRRQLPAVVPA
D22 EHPQLGAGTVLLLRAGFY E4 AVSFLSVAVGSTVYYQGK E22 CLTWKGPRRQLPAVVPAP
D23 HPQLGAGTVLLLRAGFYA E5 VSFLSVAVGSTVYYQGKC E23 LTWKGPRRQLPAVVPAPL
D24 PQLGAGTVLLLRAGFYAV E6 SFLSVAVGSTVYYQGKCL E24 TWKGPRRQLPAVVPAPLP
D25 QLGAGTVLLLRAGFYAVS E7 FLSVAVGSTVYYQGKCLT E25 WKGPRRQLPAVVPAPLPP
D26 LGAGTVLLLRAGFYAVSF E8 LSVAVGSTVYYQGKCLTW E26 KGPRRQLPAVVPAPLPPP
D27 GAGTVLLLRAGFYAVSFL E9 SVAVGSTVYYQGKCLTWK E27 GPRRQLPAVVPAPLPPPC
D28 AGTVLLLRAGFYAVSFLS E10 VAVGSTVYYQGKCLTWKG E28 PRRQLPAVVPAPLPPPCG
D29 GTVLLLRAGFYAVSFLSV E11 AVGSTVYYQGKCLTWKGP E29 RRQLPAVVPAPLPPPCGS
D30 TVLLLRAGFYAVSFLSVA E12 VGSTVYYQGKCLTWKGPR E30 RQLPAVVPAPLPPPCGSS
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8 Abbreviations
The table of abbreviations does not contain SI (internationally accepted standard) based units or SI derived
units, the one and three letter amino acid code or metric prefixes.
Abbreviation Description
E. coli Escherichia coli
et al. et alii
Pf EMP1 Plasmodium falciparum erythrocyte membrane protein 1
2D 2 dimensional
A adenine
Amax absorbance maximum
aa amino acid
AcMNPV Autographa californica multicapsid nucleopolyhedrovirus
ADCC antibody-dependent cellular cytotoxicity
AML acute myeloid leukemia
Amp ampicillin
AmpR ampicillin resistence
APC antigen presenting cell
APC allophycocyanin
ATCC American Type Culture Collection
B cell lymphocyte that matures in the bone marrow
Bmax maximum number of binding sites
BAG-6 BCL2-associated anthanogene 6
BCL2 B cell lymphoma 2
BCR B cell receptor
BEVS baculovirus expression vector system
bp base pair
BSA bovine serum albumin
BV budded virus
C cytosine
CAM chloramphenicole
CD cluster of differentiation
CLSM confocal laser scanning microscopy
CMV cytomegalovirus
conjug. conjugated
cSMAC central supramolecular activation cluster
CTL cytotoxic T lymphocyte
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Abbreviation Description
CTLA-4 cytotoxic T lymphocyte antigen 4
CV column volume
DAMP damage-associated molecular pattern
DAP DNAX-activation protein
DAPI 4’,6-diamidino-2-phenylindole
DB dynabeads
DC dendritic cell
DMEM Dulbecco’s modified Eagle medium
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
ds double-stranded
dSMAC distal supramolecular activation cluster
DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen
DTT dithiothreitol
ECACC European Collection of Cell Cultures
ECL enhanced chemoluminescence
EDTA ethylene diamine tetra acetic acid
ELISA enzyme-linked immunosorbent assay
EtBr ethidium bromide
EtOH ethyl alcohol
FACS fluorescence activated cell sorting
FasL Fas ligand
Fc fragment, crystallizable
FCS fetal calf serum
fig. figure
FITC fluorescein isothiocyanate
G guanine
Gent gentamycin
GFP green fluorescent protein
GIST gastrointestinal sarcoma
GlcNAc N-Acetylglucosamine
Gln L-glutamine
gp glycoprotein
Grb2 growth factor receptor-bound protein 2
GST glutathione S-transferase
HA hemagglutinins
HCMV human cytomegalovirus
HEK human embryonic kidney
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HGSIL high grade squamous intraepithelial lesions
His-tag deca-histidine tag
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Abbreviation Description
HIV human immunodeficiency virus
HLA human leukocyte antigen
HMW high molecular weight
HPV human papilloma virus
HRP horseradish peroxidase
ICAM intercellular adhesion molecule
iDC immature dendritic cell
IFN interferon
Ifnar2 type I interferon receptor 2
Ig immunoglobulin
IL interleukin
IMAC immobilized metal ion affinity chromatography
IP immunoprecipitation
IPTG isopropyl β-D-1-thiogalactopyranoside
IRES internal ribosome entry site
IS immunological synapse
ITAM immunoreceptor tyrosine-based activation motif
ITIM immunoreceptor tyrosine-based inhibition motif
JAK janus kinase
KD equilibrium binding constant
Kan kanamycin
KIR killer-cell immunoglobulin-like receptor
KLH Keyhole Limpet Hemocyanin
LB lysogeny broth
LBD ligand binding domain
LBDtr truncated ligand binding domain
LFA lymphocyte function-associated antigen
LILR leukocyte Ig-like receptor
LMW low molecular weight
mAb monoclonal antibody
MAP mitogen-activated protein
MBP maltose binding protein
MEM modified Eagle medium
MHC major histocompatibility complex
MICA/B MHC class I chain-related gene A/B
MLL5 mixed-lineage leukemia-5
MOPS 3-(N-morpholino)propanesulfonic acid
MTOC microtubule organizing center
MW molecular mass
MWCO molecular weight-cut off
NCR natural cytotoxicity receptor
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Abbreviation Description
NEAA non-essential amino acids
NeuNAc N-acetylneuraminic acid
NF-AT nuclear factor of activated T cells
NK natural killer
NKG natural killer group
NKR natural killer cell receptor
No. number
NTA nitrilotriacetic acid
ODV occlusion-derived virus
opt codon-optimized
p.a. pro analysi
PAMP pathogen-associated molecular pattern
PBMC peripheral blood mononuclear cell
PBS phosphate-buffered saline
PBS-T PBS supplemented with Tween20
pCMV promotor of cytomegalovirus
PCNA proliferating cell nuclear antigen
PCR polymerase chain reaction
PDB protein data bank
PE phycoerythrin
PEG polyethylene glycole
PEI polyethylenimine
Pen penicillin
pep. immun. peptide-immunized
PHYRE Protein Homology/AnalogY Recognition Engine
PI protease inhibitor
PI3K phosphatidylinositol-3-kinase
PKCθ protein kinase C θ
PNGaseF Peptide-N-Glycosidase F
polh polyhedrin
polycl. polyclonal
pRR pattern recognition receptor
pSMAC peripheral supramolecular activation cluster
PTM post-translational modification
PTPRC protein tyrosine phosphatase, receptor type, C
RNA ribonucleic acid
RPMI roswell park memorial institute medium
RT room temperature
SDS sodium dodecyl sulfate
SDS-PAGE SDS polyacrylamide gel electrophoresis
SEC size exclusion chromatography
136
Abbreviations
Abbreviation Description
SFFV spleen focus forming virus
SH Scr homology domain
SHP-1 SH-1-domain containing protein tyrosine phosphatase
Src sarcoma
ss single-stranded
STAT signal transducers and activators of transcription
Strep streptomycin
T thymine
T cell lymphocyte that matures in the thymus
TH1 T helper cell of subtype 1
TM melting temperature
TA Tobias Abel
tab. table
TBS Tris-buffered saline
TBS-T TBS supplemented with Tween20
TCR T cell receptor
TEM molecular transmission electron microscopy
Tet tetracyclin
TEV tobacco etch virus
TFB transformation buffer
TIRFM total internal reflection fluorescence microscopy
TLR toll-like receptor
TMB 3,3’,5,5’-tetramethylbenzidine
TMD transmembrane domain
TNF tumor necrosis factor
TRAIL TNF-related apoptosis-inducing ligand
Tris tris(hydroxymethyl)aminomethane
ULBP unique long 16-binding protein
ultracent. ultracentrifuged
UV ultraviolet
V0 void volume
Vr retention volume
v/v volume per volume
Vol volume
VSV-G vesicular stomatitis virus
w/v weigth per volume
wt wild type
X-gal 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
YFP yellow fluorescent protein
ZAP-70 zeta-chain-associated protein kinase 70
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